New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
| Active as of 2024-07-29 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="nzpocs"/>
<meta>
<versionId value="1"/>
<lastUpdated value="2024-07-25T17:31:18.544+12:00"/>
</meta>
<url value="https://nzhts.digital.health.nz/fhir/ValueSet/nzpocs"/>
<version value="0.1.0"/>
<name value="NZPOCS"/>
<title value="NZPOCS"/>
<status value="active"/>
<experimental value="false"/>
<date value="2024-07-29T04:31:37+00:00"/>
<publisher value="Health New Zealand | Te Whatu Ora"/>
<contact>
<name value="Health New Zealand | Te Whatu Ora"/>
<telecom>
<system value="url"/>
<value value="https://www.tewhatuora.govt.nz/"/>
</telecom>
</contact>
<description value="A LOINC FHIR ValueSet of NZPOCS Observation Code Set"/>
<compose>
<include>
<system value="http://loinc.org"/>
<version value="2.77"/>
<concept>
<code value="1003-3"/>
<display
value="Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="AHG (indirect, complement)"/>
</designation>
</concept>
<concept>
<code value="100383-9"/>
<display
value="Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Monkeypox DNA NAA+probe Ql (Specimen)"/>
</designation>
</concept>
<concept>
<code value="1004-1"/>
<display
value="Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="AHG (direct, complement)"/>
</designation>
</concept>
<concept>
<code value="1005-8"/>
<display
value="Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="AHG (indirect, IgG)"/>
</designation>
</concept>
<concept>
<code value="1007-4"/>
<display
value="Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="AHG (direct, polyspecific)"/>
</designation>
</concept>
<concept>
<code value="100-8"/>
<display
value="Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefoperazone suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="1008-2"/>
<display
value="Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="AHG (indirect, polyspecific)"/>
</designation>
</concept>
<concept>
<code value="10331-7"/>
<display value="Rh [Type] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rh phenotype"/>
</designation>
</concept>
<concept>
<code value="10333-3"/>
<display value="Appearance of Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Appearance CSF"/>
</designation>
</concept>
<concept>
<code value="10334-1"/>
<display value="Cancer Ag 125 [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CA 125"/>
</designation>
</concept>
<concept>
<code value="104-0"/>
<display
value="Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceforanide suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="10501-5"/>
<display value="Lutropin [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="LH"/>
</designation>
</concept>
<concept>
<code value="10574-2"/>
<display value="Fructose [Moles/?volume] in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fructose seminal fluid"/>
</designation>
</concept>
<concept>
<code value="10579-1"/>
<display value="Leukocytes [#/volume] in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Leucocytes semen"/>
</designation>
</concept>
<concept>
<code value="10580-9"/>
<display value="Liquefaction [Time] in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Liquefaction semen"/>
</designation>
</concept>
<concept>
<code value="10602-1"/>
<display value="Spermatozoa Abnormal Head/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Abnormal forms (head) semen"/>
</designation>
</concept>
<concept>
<code value="10603-9"/>
<display
value="Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Abnormal forms (midpiece) semen"/>
</designation>
</concept>
<concept>
<code value="10604-7"/>
<display value="Spermatozoa Abnormal Tail/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Abnormal forms (tail) semen"/>
</designation>
</concept>
<concept>
<code value="10605-4"/>
<display value="Spermatozoa Agglutinated/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Agglutination semen"/>
</designation>
</concept>
<concept>
<code value="10611-2"/>
<display value="Spermatozoa Immotile/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Non-motile semen"/>
</designation>
</concept>
<concept>
<code value="10613-8"/>
<display value="Spermatozoa Viable/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vitality semen"/>
</designation>
</concept>
<concept>
<code value="10620-3"/>
<display value="Spermatozoa Nonprogressive/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Non-progressive semen"/>
</designation>
</concept>
<concept>
<code value="10622-9"/>
<display value="Spermatozoa Normal/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Normal forms semen"/>
</designation>
</concept>
<concept>
<code value="10624-5"/>
<display value="Spermatozoa Rapid/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rapid progressive semen"/>
</designation>
</concept>
<concept>
<code value="10626-0"/>
<display value="Spermatozoa Slow/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Slow progressive semen"/>
</designation>
</concept>
<concept>
<code value="10635-1"/>
<display
value="Acanthamoeba sp identified in Eye by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amoebae culture"/>
</designation>
</concept>
<concept>
<code value="10653-4"/>
<display
value="Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clotrimazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="10697-1"/>
<display
value="Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nystatin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="10715-1"/>
<display
value="Schistosoma sp identified in Urine sediment by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Schistosoma urine"/>
</designation>
</concept>
<concept>
<code value="10718-5"/>
<display
value="Strongyloides sp Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Strongyloides Ab"/>
</designation>
</concept>
<concept>
<code value="10720-1"/>
<display
value="Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Terbinafine suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="10728-4"/>
<display
value="Trichomonas sp identified in Genital specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trichomonas culture"/>
</designation>
</concept>
<concept>
<code value="10739-1"/>
<display
value="Virus identified in Unspecified specimen by Electron microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Viruses (EM)"/>
</designation>
</concept>
<concept>
<code value="10753-2"/>
<display
value="Fat.microscopic observation [Identifier] in Stool by Sudan IV stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fat faeces (stain)"/>
</designation>
</concept>
<concept>
<code value="108-1"/>
<display
value="Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotaxime suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="10835-7"/>
<display value="Lipoprotein a [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lipoprotein (a) - mass/volume"/>
</designation>
</concept>
<concept>
<code value="10839-9"/>
<display value="Troponin I.cardiac [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Troponin I"/>
</designation>
</concept>
<concept>
<code value="10840-7"/>
<display value="Atropine [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Atropine "/>
</designation>
</concept>
<concept>
<code value="10860-5"/>
<display
value="Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Varicella zoster (culture)"/>
</designation>
</concept>
<concept>
<code value="10886-0"/>
<display
value="Prostate Specific Ag Free [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PSA (free)"/>
</designation>
</concept>
<concept>
<code value="10998-3"/>
<display value="Oxycodone [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxycodone, urine"/>
</designation>
</concept>
<concept>
<code value="11011-4"/>
<display
value="Hepatitis C virus RNA [Units/?volume] (viral load) in Serum or Plasma by Probe and target amplification method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis C Viral Load (IU/mL)"/>
</designation>
</concept>
<concept>
<code value="11018-9"/>
<display
value="Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Peroxidase stain"/>
</designation>
</concept>
<concept>
<code value="11060-1"/>
<display value="Reducing substances [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reducing substances faeces "/>
</designation>
</concept>
<concept>
<code value="11067-6"/>
<display value="Bleeding time"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bleeding time"/>
</designation>
</concept>
<concept>
<code value="11084-1"/>
<display value="Reagin Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reagin Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="11085-8"/>
<display value="Schistosoma sp identified in Stool by Concentration"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Schistosome faeces"/>
</designation>
</concept>
<concept>
<code value="11135-1"/>
<display value="Appearance of Spun Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Supernatant CSF"/>
</designation>
</concept>
<concept>
<code value="11227-6"/>
<display value="Pyruvate kinase [Presence] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyruvate kinase (screen)"/>
</designation>
</concept>
<concept>
<code value="112-3"/>
<display
value="Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotetan suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="11257-3"/>
<display
value="Haemophilus influenzae B IgG Ab [Mass/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="H Influenza Type2 Ab"/>
</designation>
</concept>
<concept>
<code value="11266-4"/>
<display
value="Streptococcus agalactiae Ag [Presence] in Unspecified specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Grp B Strep Ag"/>
</designation>
</concept>
<concept>
<code value="11483-5"/>
<display
value="Varicella zoster virus DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Varicella zoster (NAAT)"/>
</designation>
</concept>
<concept>
<code value="11545-1"/>
<display
value="Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microscopy (acid fast stain)"/>
</designation>
</concept>
<concept>
<code value="11546-9"/>
<display
value="Microscopic observation [Identifier] in Unspecified specimen by Other stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microscopy (other stain)"/>
</designation>
</concept>
<concept>
<code value="11555-0"/>
<display value="Base excess in Blood by calculation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Base excess blood "/>
</designation>
</concept>
<concept>
<code value="11556-8"/>
<display value="Oxygen [Partial pressure] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PO2 blood "/>
</designation>
</concept>
<concept>
<code value="11557-6"/>
<display value="Carbon dioxide [Partial pressure] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PCO2 blood "/>
</designation>
</concept>
<concept>
<code value="11558-4"/>
<display value="pH of Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="pH blood "/>
</designation>
</concept>
<concept>
<code value="11572-5"/>
<display value="Rheumatoid factor [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rheumatoid factor"/>
</designation>
</concept>
<concept>
<code value="11573-3"/>
<display value="Rheumatoid factor IgM [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rheumatoid factor IgM"/>
</designation>
</concept>
<concept>
<code value="11579-0"/>
<display
value="Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="TSH DL <= 0.05 mIU/L Qn"/>
</designation>
</concept>
<concept>
<code value="11580-8"/>
<display
value="Thyrotropin [Units/?volume] in Serum or Plasma by Detection limit <= 0.005 mIU/?L"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="TSH - by Detection limit <= 0.005 mIU/?L"/>
</designation>
</concept>
<concept>
<code value="116-4"/>
<display
value="Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefoxitin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="120-6"/>
<display
value="Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefpodoxime suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="12176-4"/>
<display value="Amino acids [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amino Acids"/>
</designation>
</concept>
<concept>
<code value="12195-4"/>
<display value="Creatinine renal clearance/1.73 sq M in 24 hour"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Creat clearance (1.73 body SA)"/>
</designation>
</concept>
<concept>
<code value="12241-6"/>
<display value="Osmotic fragility of Red Blood Cells by Diluted RBC"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Osmotic fragility"/>
</designation>
</concept>
<concept>
<code value="12254-9"/>
<display value="Volume of Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Volume body fluid"/>
</designation>
</concept>
<concept>
<code value="12256-4"/>
<display
value="Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Semen (post vasectomy)"/>
</designation>
</concept>
<concept>
<code value="12293-7"/>
<display value="Cotinine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cotinine urine"/>
</designation>
</concept>
<concept>
<code value="12308-3"/>
<display value="Hydrocodone [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hydrocodone, urine"/>
</designation>
</concept>
<concept>
<code value="12319-0"/>
<display value="Thioridazine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thioridazine"/>
</designation>
</concept>
<concept>
<code value="12327-3"/>
<display value="Ketamine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ketamine urine"/>
</designation>
</concept>
<concept>
<code value="12389-3"/>
<display value="Olanzapine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Olanzapine"/>
</designation>
</concept>
<concept>
<code value="12467-7"/>
<display value="Amino acids [Identifier] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amino Acids urine (ident)"/>
</designation>
</concept>
<concept>
<code value="124-8"/>
<display
value="Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefprozil suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="12-5"/>
<display
value="Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="12708-4"/>
<display value="Tin [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tin urine"/>
</designation>
</concept>
<concept>
<code value="12841-3"/>
<display
value="Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PSA (free/total)"/>
</designation>
</concept>
<concept>
<code value="12851-2"/>
<display
value="Protein Fractions [interpretation] in Serum or Plasma by Electrophoresis"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein (electrophoresis)"/>
</designation>
</concept>
<concept>
<code value="128-9"/>
<display
value="Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefsulodin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="12916-3"/>
<display
value="Porphobilinogen synthase [Enzymatic activity/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ala Dehydratase blood"/>
</designation>
</concept>
<concept>
<code value="12998-1"/>
<display value="Methylene chloride [Mass/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methylene chloride blood"/>
</designation>
</concept>
<concept>
<code value="13000-5"/>
<display value="Mandelate [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mandelic acid urine"/>
</designation>
</concept>
<concept>
<code value="1304-5"/>
<display value="D Ab [Titer] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rh D Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="13046-8"/>
<display value="Variant lLymphocytes/100 leukocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphocytes (atypical) (%)"/>
</designation>
</concept>
<concept>
<code value="13087-2"/>
<display
value="Complement alternate pathway AH50 [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alternative pathway activity / AH50"/>
</designation>
</concept>
<concept>
<code value="13238-1"/>
<display value="Epstein Barr virus Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV Ab"/>
</designation>
</concept>
<concept>
<code value="13304-1"/>
<display value="HLA-DR [Type]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HLA-DR typing "/>
</designation>
</concept>
<concept>
<code value="13309-0"/>
<display value="Duffy group Ag [Type] on Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Duffy Phenotype"/>
</designation>
</concept>
<concept>
<code value="13310-8"/>
<display value="Kell group Ag [Type] on Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Kell Phenotype"/>
</designation>
</concept>
<concept>
<code value="13311-6"/>
<display value="MNS group Ag [Type] on Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MNS Phenotype"/>
</designation>
</concept>
<concept>
<code value="13316-5"/>
<display
value="Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VRE (culture)"/>
</designation>
</concept>
<concept>
<code value="13317-3"/>
<display
value="Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MRSA (culture)"/>
</designation>
</concept>
<concept>
<code value="13359-5"/>
<display value="Character of Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Appearance semen"/>
</designation>
</concept>
<concept>
<code value="133-9"/>
<display
value="Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftazidime suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="13438-7"/>
<display
value="Protein Fractions [interpretation] in Urine by Electrophoresis"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein urine (elph)"/>
</designation>
</concept>
<concept>
<code value="13488-2"/>
<display
value="aPTT in Control Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="APTT (control)"/>
</designation>
</concept>
<concept>
<code value="13513-7"/>
<display
value="Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iron stain"/>
</designation>
</concept>
<concept>
<code value="13514-5"/>
<display
value="Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hb electrophoresis - alkaline"/>
</designation>
</concept>
<concept>
<code value="13532-7"/>
<display
value="Xanthochromia [Presence] of Cerebral spinal fluid Qualitative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Xanthochromia CSF"/>
</designation>
</concept>
<concept>
<code value="13533-5"/>
<display value="Acid hemolysis [Presence] of Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ham's test"/>
</designation>
</concept>
<concept>
<code value="13539-2"/>
<display value="Phosphate [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phosphate urine"/>
</designation>
</concept>
<concept>
<code value="13590-5"/>
<display
value="Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="APCR"/>
</designation>
</concept>
<concept>
<code value="137-0"/>
<display
value="Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftizoxime suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="13956-8"/>
<display
value="Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mycobacterium tuberculosis DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="13964-2"/>
<display value="Methylmalonate [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methylmalonic Acid - in serum or plasma"/>
</designation>
</concept>
<concept>
<code value="13965-9"/>
<display value="Homocysteine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Homocysteine"/>
</designation>
</concept>
<concept>
<code value="13967-5"/>
<display
value="Sex hormone binding globulin [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SHBG"/>
</designation>
</concept>
<concept>
<code value="13969-1"/>
<display value="Creatine kinase.MB [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CKMB (mass)"/>
</designation>
</concept>
<concept>
<code value="13996-4"/>
<display
value="Hydroxyproline/?Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hydroxyproline/creat urine 24h"/>
</designation>
</concept>
<concept>
<code value="14116-8"/>
<display
value="IgG synthesis rate [Mass/?time] in Serum and CSF by calculation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgG Synthesis "/>
</designation>
</concept>
<concept>
<code value="14117-6"/>
<display
value="IgG clearance/Albumin clearance [ratio] in Serum and CSF"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgG Index serum/CSF"/>
</designation>
</concept>
<concept>
<code value="141-2"/>
<display
value="Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftriaxone suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="14122-6"/>
<display value="Pyruvate [Moles/?volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CSF Lactate & Pyruvate"/>
</designation>
</concept>
<concept>
<code value="14135-8"/>
<display
value="CD3+?CD8+? (T8 suppressor cells) cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="lymphocyte markers - Cells.CD3+CD8+"/>
</designation>
</concept>
<concept>
<code value="14136-6"/>
<display value="CD34 cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CD34 Assay, blood"/>
</designation>
</concept>
<concept>
<code value="14196-0"/>
<display value="Reticulocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reticulocytes"/>
</designation>
</concept>
<concept>
<code value="14207-5"/>
<display value="Streptococcal DNAse B [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Strep DNAse B Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="14210-9"/>
<display
value="Giardia lamblia Ag [Presence] in Stool by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Giardia Ag faeces (IF)"/>
</designation>
</concept>
<concept>
<code value="14236-4"/>
<display value="Mitochondria Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mitochondria Antibody"/>
</designation>
</concept>
<concept>
<code value="14252-1"/>
<display value="Smooth muscle Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Smooth muscle Antibody"/>
</designation>
</concept>
<concept>
<code value="14272-9"/>
<display value="Liver kidney microsomal Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Liver/Kidney Ab - Presence"/>
</designation>
</concept>
<concept>
<code value="14286-9"/>
<display
value="Carnitine free (C0) [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carnitine (free) "/>
</designation>
</concept>
<concept>
<code value="14314-9"/>
<display
value="Benzoylecgonine [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Benzoylecgonine urine by Screen Method"/>
</designation>
</concept>
<concept>
<code value="14316-4"/>
<display
value="Benzodiazepines [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Benzodiazepine urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="14332-1"/>
<display
value="Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="P-aminosalicylate suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="14334-7"/>
<display value="Lithium [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lithium"/>
</designation>
</concept>
<concept>
<code value="14398-2"/>
<display value="Creatinine [Mass/?volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Creatinine CSF"/>
</designation>
</concept>
<concept>
<code value="14503-7"/>
<display
value="Human papilloma virus 16+?18 Ag [Presence] in Cervix"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HPV Screen"/>
</designation>
</concept>
<concept>
<code value="14522-7"/>
<display
value="Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pneumocystis jiroveci Ag"/>
</designation>
</concept>
<concept>
<code value="145-3"/>
<display
value="Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefuroxime inject suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="14567-2"/>
<display value="11-Deoxycortisol [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="11Deoxycortisol"/>
</designation>
</concept>
<concept>
<code value="14569-8"/>
<display
value="17-Hydroxyprogesterone [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="17-Hydroxy progesterone"/>
</designation>
</concept>
<concept>
<code value="14573-0"/>
<display
value="5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="5HIAA urine 24h"/>
</designation>
</concept>
<concept>
<code value="14575-5"/>
<display
value="Blood group antibody investigation [interpretation] in Plasma or RBC"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blood Group Ab (interpretation) "/>
</designation>
</concept>
<concept>
<code value="14581-3"/>
<display value="Acetaminophen [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Paracetamol"/>
</designation>
</concept>
<concept>
<code value="14586-2"/>
<display value="Aldosterone [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aldosterone"/>
</designation>
</concept>
<concept>
<code value="14593-8"/>
<display value="Aluminum [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aluminium"/>
</designation>
</concept>
<concept>
<code value="14597-9"/>
<display value="Amitriptyline [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amitriptyline - moles/volume"/>
</designation>
</concept>
<concept>
<code value="14603-5"/>
<display value="Androstenedione [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Androstenedione"/>
</designation>
</concept>
<concept>
<code value="14611-8"/>
<display value="Nuclear Ab pattern [interpretation] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antinuclear Ab (pattern)"/>
</designation>
</concept>
<concept>
<code value="14622-5"/>
<display value="Ascorbate [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ascorbate"/>
</designation>
</concept>
<concept>
<code value="14628-2"/>
<display value="Bile acid [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bile Salts"/>
</designation>
</concept>
<concept>
<code value="14629-0"/>
<display value="Bilirubin.direct [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bilirubin (conj)"/>
</designation>
</concept>
<concept>
<code value="14630-8"/>
<display
value="Bilirubin.indirect [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bilirubin (unconj)"/>
</designation>
</concept>
<concept>
<code value="14631-6"/>
<display value="Bilirubin.total [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bilirubin"/>
</designation>
</concept>
<concept>
<code value="14635-7"/>
<display value="Calcidiol [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vitamin D "/>
</designation>
</concept>
<concept>
<code value="14637-3"/>
<display value="Calcium [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcium urine 24h"/>
</designation>
</concept>
<concept>
<code value="14638-1"/>
<display value="Calculus analysis [interpretation] in Stone"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calculus analysis"/>
</designation>
</concept>
<concept>
<code value="14639-9"/>
<display value="Carbamazepine [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carbamazepine"/>
</designation>
</concept>
<concept>
<code value="14642-3"/>
<display value="Carotene [Moles/?volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Beta Carotene"/>
</designation>
</concept>
<concept>
<code value="14645-6"/>
<display value="Chlorpromazine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chlorpromazine"/>
</designation>
</concept>
<concept>
<code value="14646-4"/>
<display
value="Cholesterol in HDL [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholesterol (HDL)"/>
</designation>
</concept>
<concept>
<code value="14647-2"/>
<display value="Cholesterol [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholesterol"/>
</designation>
</concept>
<concept>
<code value="14650-6"/>
<display value="Citrate [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Citrate urine"/>
</designation>
</concept>
<concept>
<code value="14651-4"/>
<display value="Clobazam [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clobazam"/>
</designation>
</concept>
<concept>
<code value="14652-2"/>
<display value="Clomipramine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clomipramine - moles/volume"/>
</designation>
</concept>
<concept>
<code value="14654-8"/>
<display
value="Clomipramine+?Norclomipramine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clomipramine+Norclomipramine�- moles/volume"/>
</designation>
</concept>
<concept>
<code value="14655-5"/>
<display value="Clonazepam [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clonazepam"/>
</designation>
</concept>
<concept>
<code value="14656-3"/>
<display value="Clozapine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clozapine"/>
</designation>
</concept>
<concept>
<code value="14665-4"/>
<display value="Copper [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Copper"/>
</designation>
</concept>
<concept>
<code value="14666-2"/>
<display value="Copper [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Copper urine 24hr"/>
</designation>
</concept>
<concept>
<code value="14674-6"/>
<display value="Corticotropin [Moles/?volume] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adrenocorticotropic hormone"/>
</designation>
</concept>
<concept>
<code value="14675-3"/>
<display value="Cortisol [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cortisol"/>
</designation>
</concept>
<concept>
<code value="14676-1"/>
<display value="Cortisol Free [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cortisol (free) urine 24h"/>
</designation>
</concept>
<concept>
<code value="14678-7"/>
<display
value="Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cortisol (PM)"/>
</designation>
</concept>
<concept>
<code value="14679-5"/>
<display
value="Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cortisol (AM)"/>
</designation>
</concept>
<concept>
<code value="14682-9"/>
<display value="Creatinine [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Creatinine"/>
</designation>
</concept>
<concept>
<code value="14683-7"/>
<display value="Creatinine [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Creatinine urine"/>
</designation>
</concept>
<concept>
<code value="14684-5"/>
<display value="Creatinine [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Creatinine urine 24h"/>
</designation>
</concept>
<concept>
<code value="14685-2"/>
<display
value="Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vitamin B12"/>
</designation>
</concept>
<concept>
<code value="14688-6"/>
<display
value="Dehydroepiandrosterone sulfate (DHEA-S) [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dehydroepiandrosterone Sulphate"/>
</designation>
</concept>
<concept>
<code value="14691-0"/>
<display value="Desipramine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Desipramine - moles/volume"/>
</designation>
</concept>
<concept>
<code value="14695-1"/>
<display value="Nordoxepin [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nordoxepin - moles/volume"/>
</designation>
</concept>
<concept>
<code value="14698-5"/>
<display value="Digoxin [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Digoxin"/>
</designation>
</concept>
<concept>
<code value="14702-5"/>
<display value="Disopyramide [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Disopyramide"/>
</designation>
</concept>
<concept>
<code value="14703-3"/>
<display value="Dopamine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dopamine"/>
</designation>
</concept>
<concept>
<code value="14705-8"/>
<display value="Doxepin [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Doxepin - moles/volume"/>
</designation>
</concept>
<concept>
<code value="14711-6"/>
<display value="Epinephrine [Moles/?volume] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adrenaline"/>
</designation>
</concept>
<concept>
<code value="14712-4"/>
<display value="Epinephrine [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adrenaline urine 24h"/>
</designation>
</concept>
<concept>
<code value="14715-7"/>
<display value="Estradiol (E2) [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oestradiol"/>
</designation>
</concept>
<concept>
<code value="14719-9"/>
<display value="Ethanol [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethanol"/>
</designation>
</concept>
<concept>
<code value="14720-7"/>
<display value="Ethosuximide [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethosuximide"/>
</designation>
</concept>
<concept>
<code value="14722-3"/>
<display value="Extractable nuclear Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ENA screen"/>
</designation>
</concept>
<concept>
<code value="14726-4"/>
<display value="Fluoride [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fluoride"/>
</designation>
</concept>
<concept>
<code value="14731-4"/>
<display value="Folate [Moles/volume] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Folate RBC"/>
</designation>
</concept>
<concept>
<code value="14732-2"/>
<display value="Folate [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Folate"/>
</designation>
</concept>
<concept>
<code value="14744-7"/>
<display value="Glucose [Moles/volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose CSF"/>
</designation>
</concept>
<concept>
<code value="14745-4"/>
<display value="Glucose [Moles/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose body fluid"/>
</designation>
</concept>
<concept>
<code value="14749-6"/>
<display value="Glucose [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose"/>
</designation>
</concept>
<concept>
<code value="14754-6"/>
<display
value="Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose (1h post 50g glucose)"/>
</designation>
</concept>
<concept>
<code value="14761-1"/>
<display
value="Glucose [Moles/volume] in Serum or Plasma --2 hours post meal"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose (2h post meal)"/>
</designation>
</concept>
<concept>
<code value="14770-2"/>
<display
value="Fasting glucose [Moles/volume] in Capillary blood by Glucometer"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose (fasting) blood"/>
</designation>
</concept>
<concept>
<code value="14771-0"/>
<display value="Fasting glucose [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose (fasting)"/>
</designation>
</concept>
<concept>
<code value="14782-7"/>
<display value="Homovanillate [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Homovanillate urine"/>
</designation>
</concept>
<concept>
<code value="14783-5"/>
<display value="Homovanillate [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Homovanillate urine 24h"/>
</designation>
</concept>
<concept>
<code value="14785-0"/>
<display value="Hydroxyproline [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hydroxyproline urine 24h"/>
</designation>
</concept>
<concept>
<code value="14796-7"/>
<display value="Insulin [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Insulin (total)"/>
</designation>
</concept>
<concept>
<code value="14798-3"/>
<display value="Iron [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iron"/>
</designation>
</concept>
<concept>
<code value="14799-1"/>
<display value="Iron [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iron urine 24h"/>
</designation>
</concept>
<concept>
<code value="14800-7"/>
<display
value="Iron binding capacity [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iron binding capacity"/>
</designation>
</concept>
<concept>
<code value="14801-5"/>
<display value="Iron saturation [Molar fraction] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Transferrin saturation - molar fraction"/>
</designation>
</concept>
<concept>
<code value="14803-1"/>
<display
value="Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="LDH fluid by Lactate to pyruvate reaction"/>
</designation>
</concept>
<concept>
<code value="14804-9"/>
<display
value="Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="LDH by Lactate to pyruvate reaction"/>
</designation>
</concept>
<concept>
<code value="14805-6"/>
<display
value="Lactate dehydrogenase [Enzymatic activity/?volume] in Serum or Plasma by Pyruvate to lactate reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="LDH by Pyruvate to lactate reaction"/>
</designation>
</concept>
<concept>
<code value="14807-2"/>
<display value="Lead [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lead blood"/>
</designation>
</concept>
<concept>
<code value="14809-8"/>
<display value="Lead [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lead urine 24hr"/>
</designation>
</concept>
<concept>
<code value="14812-2"/>
<display value="Lidocaine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lignocaine"/>
</designation>
</concept>
<concept>
<code value="14833-8"/>
<display value="Metanephrines [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Metanephrines urine 24h"/>
</designation>
</concept>
<concept>
<code value="14835-3"/>
<display value="Methanol [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methanol"/>
</designation>
</concept>
<concept>
<code value="14836-1"/>
<display value="Methotrexate [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methotrexate"/>
</designation>
</concept>
<concept>
<code value="14852-8"/>
<display value="Norepinephrine [Moles/?volume] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Noradrenaline"/>
</designation>
</concept>
<concept>
<code value="14853-6"/>
<display value="Norepinephrine [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Noradrenaline urine"/>
</designation>
</concept>
<concept>
<code value="14854-4"/>
<display value="Norepinephrine [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Noradrenaline urine 24h"/>
</designation>
</concept>
<concept>
<code value="14856-9"/>
<display value="Nortriptyline [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nortriptyline - moles/volume"/>
</designation>
</concept>
<concept>
<code value="14862-7"/>
<display value="Oxalate [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxalate urine 24hr"/>
</designation>
</concept>
<concept>
<code value="14866-8"/>
<display
value="Parathyrin.intact [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parathyroid Hormone (intact) - moles/volume"/>
</designation>
</concept>
<concept>
<code value="14874-2"/>
<display value="Phenobarbital [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phenobarbitone"/>
</designation>
</concept>
<concept>
<code value="14877-5"/>
<display value="Phenytoin [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phenytoin"/>
</designation>
</concept>
<concept>
<code value="14879-1"/>
<display value="Phosphate [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phosphate"/>
</designation>
</concept>
<concept>
<code value="14881-7"/>
<display value="Phosphate [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phosphate urine 24h"/>
</designation>
</concept>
<concept>
<code value="14883-3"/>
<display value="Porphyrins [interpretation] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fluorescence"/>
</designation>
</concept>
<concept>
<code value="14885-8"/>
<display value="Pregnanediol [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pregnanediol urine 24h"/>
</designation>
</concept>
<concept>
<code value="14890-8"/>
<display value="Progesterone [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Progesterone"/>
</designation>
</concept>
<concept>
<code value="14899-9"/>
<display value="Quinidine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Quinidine"/>
</designation>
</concept>
<concept>
<code value="14905-4"/>
<display value="Retinol [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vitamin A"/>
</designation>
</concept>
<concept>
<code value="14909-6"/>
<display value="Salicylates [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Salicylate - moles/volume"/>
</designation>
</concept>
<concept>
<code value="14913-8"/>
<display value="Testosterone [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Testosterone"/>
</designation>
</concept>
<concept>
<code value="14914-6"/>
<display value="Testosterone Free [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Testosterone (free)"/>
</designation>
</concept>
<concept>
<code value="14915-3"/>
<display value="Theophylline [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Theophylline"/>
</designation>
</concept>
<concept>
<code value="14920-3"/>
<display
value="Thyroxine (T4) free [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T4 (free)"/>
</designation>
</concept>
<concept>
<code value="14921-1"/>
<display value="Thyroxine (T4) [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T4 (total)"/>
</designation>
</concept>
<concept>
<code value="14927-8"/>
<display value="Triglyceride [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Triglycerides"/>
</designation>
</concept>
<concept>
<code value="14928-6"/>
<display
value="Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T3 (free)"/>
</designation>
</concept>
<concept>
<code value="14930-2"/>
<display
value="Triiodothyronine (T3) [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T3 (total)"/>
</designation>
</concept>
<concept>
<code value="14931-0"/>
<display value="Trimipramine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trimipramine"/>
</designation>
</concept>
<concept>
<code value="14933-6"/>
<display value="Urate [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urate"/>
</designation>
</concept>
<concept>
<code value="14934-4"/>
<display value="Urate [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urate urine"/>
</designation>
</concept>
<concept>
<code value="14935-1"/>
<display value="Urate [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urate urine 24h"/>
</designation>
</concept>
<concept>
<code value="14939-3"/>
<display value="Urea nitrogen [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urea urine 24h"/>
</designation>
</concept>
<concept>
<code value="14946-8"/>
<display value="Valproate [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Valproate"/>
</designation>
</concept>
<concept>
<code value="14947-6"/>
<display value="Vanillylmandelate [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VMA urine 24h"/>
</designation>
</concept>
<concept>
<code value="14948-4"/>
<display value="Vanillylmandelate/Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VMA/creat urine"/>
</designation>
</concept>
<concept>
<code value="14949-2"/>
<display value="Vasopressin [Moles/?volume] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Arginine Vasopressin"/>
</designation>
</concept>
<concept>
<code value="149-5"/>
<display
value="Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephalexin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="14955-9"/>
<display value="Zinc [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Zinc"/>
</designation>
</concept>
<concept>
<code value="14956-7"/>
<display value="Microalbumin [Mass/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microalbumin urine 24h"/>
</designation>
</concept>
<concept>
<code value="14957-5"/>
<display value="Microalbumin [Mass/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microalbumin urine"/>
</designation>
</concept>
<concept>
<code value="14959-1"/>
<display value="Microalbumin/Creatinine [Mass Ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microalbumin/creat urine"/>
</designation>
</concept>
<concept>
<code value="14979-9"/>
<display value="aPTT in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="APTT"/>
</designation>
</concept>
<concept>
<code value="14995-5"/>
<display
value="Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose (2h post 75g glucose)"/>
</designation>
</concept>
<concept>
<code value="15009-4"/>
<display value="5-Hydroxyindoleacetate [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="5HIAA urine"/>
</designation>
</concept>
<concept>
<code value="15032-6"/>
<display value="Angiotensin II [Moles/?volume] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Angiotensin II"/>
</designation>
</concept>
<concept>
<code value="15034-2"/>
<display value="Bromide [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bromide"/>
</designation>
</concept>
<concept>
<code value="15038-3"/>
<display value="Citrate [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Citrate"/>
</designation>
</concept>
<concept>
<code value="15057-3"/>
<display value="Androstanolone [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dihydrotestosterone "/>
</designation>
</concept>
<concept>
<code value="15058-1"/>
<display value="Dopamine [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dopamine urine"/>
</designation>
</concept>
<concept>
<code value="15059-9"/>
<display value="Dopamine [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dopamine urine 24h"/>
</designation>
</concept>
<concept>
<code value="15061-5"/>
<display
value="Erythropoietin (EPO) [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Erythropoietin"/>
</designation>
</concept>
<concept>
<code value="15066-4"/>
<display
value="Fatty acids.nonesterified [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fatty Acids (free)"/>
</designation>
</concept>
<concept>
<code value="15067-2"/>
<display value="Follitropin [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="FSH"/>
</designation>
</concept>
<concept>
<code value="15069-8"/>
<display value="Fructosamine [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fructosamine"/>
</designation>
</concept>
<concept>
<code value="15072-2"/>
<display value="Gastrin [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gastrin - moles/volume"/>
</designation>
</concept>
<concept>
<code value="15074-8"/>
<display value="Glucose [Moles/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose blood"/>
</designation>
</concept>
<concept>
<code value="15076-3"/>
<display value="Glucose [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose urine"/>
</designation>
</concept>
<concept>
<code value="15081-3"/>
<display value="Prolactin [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Prolactin"/>
</designation>
</concept>
<concept>
<code value="15083-9"/>
<display value="Normetanephrine [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Normetanephrine urine 24h"/>
</designation>
</concept>
<concept>
<code value="15087-0"/>
<display
value="Parathyrin related protein [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parathyroid Hormone Related Peptide"/>
</designation>
</concept>
<concept>
<code value="15097-9"/>
<display value="Vanillylmandelate [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VMA urine"/>
</designation>
</concept>
<concept>
<code value="15099-5"/>
<display value="Amiodarone [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amiodarone"/>
</designation>
</concept>
<concept>
<code value="15105-0"/>
<display value="Flecainide [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Flecainide"/>
</designation>
</concept>
<concept>
<code value="15107-6"/>
<display value="Imipramine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Imipramine - moles/volume"/>
</designation>
</concept>
<concept>
<code value="15108-4"/>
<display value="Methadone [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methadone - moles/volume"/>
</designation>
</concept>
<concept>
<code value="15115-9"/>
<display value="Arsenic [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Arsenic urine"/>
</designation>
</concept>
<concept>
<code value="15117-5"/>
<display value="Cadmium [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cadmium blood"/>
</designation>
</concept>
<concept>
<code value="15120-9"/>
<display value="Ethanol [Moles/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethanol blood"/>
</designation>
</concept>
<concept>
<code value="15148-0"/>
<display
value="Alkaline phosphatase [Enzymatic activity/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alk Phosphatase,fluid"/>
</designation>
</concept>
<concept>
<code value="15176-1"/>
<display value="Cryoproteins identified in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cryoproteins"/>
</designation>
</concept>
<concept>
<code value="15179-5"/>
<display value="Fibrin D-dimer [Presence] in Platelet poor plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="D-dimer (qual)"/>
</designation>
</concept>
<concept>
<code value="15200-9"/>
<display value="Osmolality of Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Osmolality fluid"/>
</designation>
</concept>
<concept>
<code value="15210-8"/>
<display value="Thyroglobulin Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thyroglobulin Antibody - presence"/>
</designation>
</concept>
<concept>
<code value="15359-3"/>
<display value="dRVVT actual/normal (normalized LA screen)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dilute Russell viper venom time - actual normal"/>
</designation>
</concept>
<concept>
<code value="15363-5"/>
<display value="Busulfan [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Busulphan"/>
</designation>
</concept>
<concept>
<code value="153-7"/>
<display
value="Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephaloglycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="15374-2"/>
<display value="Sulfonylurea [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulphonylurea screen"/>
</designation>
</concept>
<concept>
<code value="15376-7"/>
<display value="Spermatozoa Abnormal/100 spermatozoa in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Abnormal forms semen"/>
</designation>
</concept>
<concept>
<code value="15410-4"/>
<display
value="Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Varicella zoster Ab IgG"/>
</designation>
</concept>
<concept>
<code value="157-8"/>
<display
value="Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephaloridine suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="16099-4"/>
<display
value="Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethionamide suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="161-0"/>
<display
value="Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephalothin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="16100-0"/>
<display
value="Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rifabutin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="16128-1"/>
<display value="Hepatitis C virus Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis C Ab"/>
</designation>
</concept>
<concept>
<code value="16130-7"/>
<display
value="Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection "/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV1 DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="16131-5"/>
<display
value="Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV2 DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="16195-0"/>
<display
value="Benzodiazepines [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Benzodiazepine urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16201-6"/>
<display
value="Oxazepam [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxazepam urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16206-5"/>
<display
value="Temazepam [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Temazepam urine"/>
</designation>
</concept>
<concept>
<code value="16208-1"/>
<display
value="Buprenorphine [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Buprenorphine urine by Confirmation method"/>
</designation>
</concept>
<concept>
<code value="16221-4"/>
<display
value="Phenothiazines [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phenothiazines urine - by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16226-3"/>
<display
value="Benzoylecgonine [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Benzoylecgonine urine - by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16227-1"/>
<display
value="Diazepam [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Diazepam urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16228-9"/>
<display
value="Nordiazepam [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nordiazepam urine - by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16235-4"/>
<display
value="Methamphetamine [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methamphetamine urine by Confirmation method"/>
</designation>
</concept>
<concept>
<code value="16249-5"/>
<display
value="Oxycodone [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxycodone urine - by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16250-3"/>
<display
value="Codeine [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Codeine urine - by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16251-1"/>
<display
value="Morphine [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Morphine urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16254-5"/>
<display
value="Phencyclidine [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phencyclidine urine - by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16276-8"/>
<display
value="Bartonella henselae DNA [Presence] in Blood by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bartonella DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="16284-2"/>
<display value="Polio virus Ab [Units/?volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Polio Ab"/>
</designation>
</concept>
<concept>
<code value="16337-8"/>
<display
value="Alkaline phosphatase [Enzymatic activity/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alk Phosphatase, urine"/>
</designation>
</concept>
<concept>
<code value="16348-5"/>
<display
value="Alpha hydroxyalprazolam [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Alpha hydroxy alprazolam urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="16362-6"/>
<display value="Ammonia [Moles/?volume] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ammonia"/>
</designation>
</concept>
<concept>
<code value="16429-3"/>
<display
value="Barbiturates [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Barbiturate urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="1648-5"/>
<display
value="Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tuberculin test (3d post 5TU)"/>
</designation>
</concept>
<concept>
<code value="165-1"/>
<display
value="Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephapirin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="16550-6"/>
<display value="Carbohydrates [Identifier] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carbohydrates urine"/>
</designation>
</concept>
<concept>
<code value="16-6"/>
<display
value="Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amoxicillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="16623-1"/>
<display
value="Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clofazimine suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="16676-9"/>
<display
value="Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C.diptheriae culture"/>
</designation>
</concept>
<concept>
<code value="16688-4"/>
<display
value="Creatine kinase [Enzymatic activity/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CK body fluid"/>
</designation>
</concept>
<concept>
<code value="16835-1"/>
<display
value="Escherichia coli shiga-like toxin identified in Stool by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Enterohaemorrhagic E. coli (EHEC) culture - shiga-like toxin"/>
</designation>
</concept>
<concept>
<code value="16836-9"/>
<display
value="Escherichia coli verotoxic identified in Stool by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Enterohaemorrhagic E. coli (EHEC) culture - verotoxic"/>
</designation>
</concept>
<concept>
<code value="16853-4"/>
<display value="Fat [Mass] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fat Stl Qn"/>
</designation>
</concept>
<concept>
<code value="16859-1"/>
<display value="Fibrinogen [Presence] in Platelet poor plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fibrinogen (qual)"/>
</designation>
</concept>
<concept>
<code value="16901-1"/>
<display value="Gliadin IgA Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gliadin Ab IgA"/>
</designation>
</concept>
<concept>
<code value="16902-9"/>
<display value="Gliadin IgG Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gliadin Ab IgG"/>
</designation>
</concept>
<concept>
<code value="169-3"/>
<display
value="Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephradine suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="16933-4"/>
<display value="Hepatitis B virus core Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B core Ab"/>
</designation>
</concept>
<concept>
<code value="16935-9"/>
<display
value="Hepatitis B virus surface Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B surface Ab"/>
</designation>
</concept>
<concept>
<code value="1714-5"/>
<display
value="Prostatic acid phosphatase [Enzymatic activity/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Acid phosphatase (prostatic)"/>
</designation>
</concept>
<concept>
<code value="17146-2"/>
<display value="CD4+?CD8+? cells/?100 cells in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CD4/CD8"/>
</designation>
</concept>
<concept>
<code value="1715-2"/>
<display
value="Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Acid phosphatase"/>
</designation>
</concept>
<concept>
<code value="17263-5"/>
<display value="Methemalbumin [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methaemalbumin"/>
</designation>
</concept>
<concept>
<code value="173-5"/>
<display
value="Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chloramphenicol suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="17395-5"/>
<display
value="Oxymorphone [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxymorphone urine "/>
</designation>
</concept>
<concept>
<code value="1742-6"/>
<display
value="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ALT"/>
</designation>
</concept>
<concept>
<code value="1746-7"/>
<display value="Albumin [Mass/?volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Albumin CSF"/>
</designation>
</concept>
<concept>
<code value="1747-5"/>
<display value="Albumin [Mass/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Albumin body fluid"/>
</designation>
</concept>
<concept>
<code value="1751-7"/>
<display value="Albumin [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Albumin"/>
</designation>
</concept>
<concept>
<code value="17547-1"/>
<display value="Rotavirus Ag [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rotavirus Ag faeces"/>
</designation>
</concept>
<concept>
<code value="1756-6"/>
<display value="Albumin in CSF/?Albumin in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Albumin CSF/Serum Ratio"/>
</designation>
</concept>
<concept>
<code value="17571-1"/>
<display value="Scopolamine [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Scopolamine urine"/>
</designation>
</concept>
<concept>
<code value="17607-3"/>
<display value="Volume of Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Volume CSF"/>
</designation>
</concept>
<concept>
<code value="1761-6"/>
<display
value="Aldolase [Enzymatic activity/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aldolase"/>
</designation>
</concept>
<concept>
<code value="177-6"/>
<display
value="Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chlortetracycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="1777-2"/>
<display
value="Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alk phosphatase (bone)"/>
</designation>
</concept>
<concept>
<code value="17793-1"/>
<display
value="Immunoglobulin light chains [Mass/volume] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="B-J protein urine 24h"/>
</designation>
</concept>
<concept>
<code value="17843-4"/>
<display value="Cancer Ag 72-4 [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CA 72-4"/>
</designation>
</concept>
<concept>
<code value="17857-4"/>
<display value="Rheumatoid factor [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rheumatoid factor (titre)"/>
</designation>
</concept>
<concept>
<code value="17869-9"/>
<display value="Orotate/Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Orotate/creatinine urine"/>
</designation>
</concept>
<concept>
<code value="1795-4"/>
<display value="Amylase [Enzymatic activity/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amylase body fluid"/>
</designation>
</concept>
<concept>
<code value="1798-8"/>
<display
value="Amylase [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amylase"/>
</designation>
</concept>
<concept>
<code value="1799-6"/>
<display value="Amylase [Enzymatic activity/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amylase urine"/>
</designation>
</concept>
<concept>
<code value="1-8"/>
<display value="Acyclovir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Acyclovir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="1805-1"/>
<display
value="Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amylase (pancreatic)"/>
</designation>
</concept>
<concept>
<code value="181-8"/>
<display
value="Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cinoxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="1824-2"/>
<display value="Alpha-1-Antichymotrypsin [Mass/?volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alpha 1 antichymotrypsin"/>
</designation>
</concept>
<concept>
<code value="1825-9"/>
<display
value="Alpha 1 antitrypsin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alpha 1 antitrypsin"/>
</designation>
</concept>
<concept>
<code value="18261-8"/>
<display
value="Cholesterol in LDL [Mass/?volume] in Serum or Plasma ultracentrifugate"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholesterol in LDL "/>
</designation>
</concept>
<concept>
<code value="18263-4"/>
<display
value="Cholesterol in HDL [Mass/?volume] in Serum or Plasma ultracentrifugate"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholesterol in HDL "/>
</designation>
</concept>
<concept>
<code value="18282-4"/>
<display value="Cannabinoids [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cannabinoids, urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="18286-5"/>
<display value="Donath Landsteiner Ab [Presence] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Donath-Landsteiner Ab"/>
</designation>
</concept>
<concept>
<code value="1834-1"/>
<display
value="Alpha-1-Fetoprotein [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alpha feto protein"/>
</designation>
</concept>
<concept>
<code value="18358-2"/>
<display
value="Methylenedioxymethamphetamine [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MDMA Urine by Confirmation method"/>
</designation>
</concept>
<concept>
<code value="18390-5"/>
<display value="Opiates [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Opiates urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="18481-2"/>
<display value="Streptococcus pyogenes Ag [Presence] in Throat"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Grp A Strep Ag throat (rapid)"/>
</designation>
</concept>
<concept>
<code value="185-9"/>
<display
value="Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ciprofloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="1863-0"/>
<display value="Anion gap 4 in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anion gap 4"/>
</designation>
</concept>
<concept>
<code value="1869-7"/>
<display
value="Apolipoprotein A-I [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Apolipoprotein A1"/>
</designation>
</concept>
<concept>
<code value="1884-6"/>
<display value="Apolipoprotein B [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Apolipoprotein B"/>
</designation>
</concept>
<concept>
<code value="18855-7"/>
<display value="5-Fluorocytosine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="5-Fluorocytosine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18857-3"/>
<display value="Almecillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Almecillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18859-9"/>
<display value="Amdinocillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amdinocillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18860-7"/>
<display value="Amikacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18861-5"/>
<display value="Amoxicillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amoxicillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18862-3"/>
<display value="Amoxicillin+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amoxicillin Clav suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18863-1"/>
<display value="Amphotericin B [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amphotericin B suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18864-9"/>
<display value="Ampicillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ampicillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18865-6"/>
<display value="Ampicillin+Sulbactam [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ampicillin Sulb suscept (qual)"/>
</designation>
</concept>
<concept>
<code value="18866-4"/>
<display value="Azithromycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Azithromycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18867-2"/>
<display value="Azlocillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Azlocillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18868-0"/>
<display value="Aztreonam [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aztreonam suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18869-8"/>
<display value="Bacampicillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bacampicillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18870-6"/>
<display value="Bacitracin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bacitracin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18871-4"/>
<display value="Butirosin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Butirosin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18872-2"/>
<display value="Capreomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Capreomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18873-0"/>
<display value="Carbenicillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carbenicillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18874-8"/>
<display value="Cefaclor [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefaclor suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18875-5"/>
<display value="Cefadroxil [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefadroxil suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18876-3"/>
<display value="Cefamandole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefamandole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18877-1"/>
<display value="Cefatrizine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefatrizine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18878-9"/>
<display value="Cefazolin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefazolin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18879-7"/>
<display value="Cefepime [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefepime suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18880-5"/>
<display value="Cefixime [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefixime suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18881-3"/>
<display value="Cefmetazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefmetazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18882-1"/>
<display value="Cefodizime [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefodizime suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18883-9"/>
<display value="Cefonicid [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefonicid suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18884-7"/>
<display value="Cefoperazone [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefoperazone suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18885-4"/>
<display value="Ceforanide [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceforanide suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18886-2"/>
<display value="Cefotaxime [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotaxime suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18887-0"/>
<display value="Cefotetan [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotetan suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18888-8"/>
<display value="Cefoxitin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefoxitin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18889-6"/>
<display value="Cefpirome [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefpirome suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18890-4"/>
<display value="Cefpodoxime [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefpodoxime suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18891-2"/>
<display value="Cefprozil [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefprozil suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18892-0"/>
<display value="Cefsulodin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefsulodin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18893-8"/>
<display value="Ceftazidime [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftazidime suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18894-6"/>
<display value="Ceftizoxime [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftizoxime suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18895-3"/>
<display value="Ceftriaxone [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftriaxone suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18896-1"/>
<display value="Cefuroxime Parenteral [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefuroxime inject suscep qual"/>
</designation>
</concept>
<concept>
<code value="18897-9"/>
<display value="Cephalexin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephalexin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18898-7"/>
<display value="Cephaloglycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephaloglycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18899-5"/>
<display value="Cephaloridine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephaloridine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18900-1"/>
<display value="Cephalothin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephalothin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18901-9"/>
<display value="Cephapirin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephapirin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18902-7"/>
<display value="Cephradine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephradine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18903-5"/>
<display value="Chloramphenicol [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chloramphenicol suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18904-3"/>
<display value="Chlortetracycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chlortetracycline suscep qual"/>
</designation>
</concept>
<concept>
<code value="18905-0"/>
<display value="Cinoxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cinoxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18906-8"/>
<display value="Ciprofloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ciprofloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18907-6"/>
<display value="Clarithromycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clarithromycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18908-4"/>
<display value="Clindamycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clindamycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18909-2"/>
<display value="Clotrimazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clotrimazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="189-1"/>
<display
value="Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clarithromycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="18910-0"/>
<display value="Cloxacillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cloxacillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18911-8"/>
<display value="Colistimethate"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Colistimethate suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18912-6"/>
<display value="Colistin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Colistin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18913-4"/>
<display value="Cyclacillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cyclacillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18914-2"/>
<display value="Cycloserine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cycloserine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18915-9"/>
<display value="Demeclocycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Demeclocycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18916-7"/>
<display value="Dicloxacillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dicloxacillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18917-5"/>
<display value="Doxycycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Doxycycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18918-3"/>
<display value="Enoxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Enoxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18919-1"/>
<display value="Erythromycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Erythromycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18921-7"/>
<display value="Ethambutol [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethambutol suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18922-5"/>
<display value="Ethionamide [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethionamide suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18923-3"/>
<display value="Floxacillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Floxacillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18924-1"/>
<display value="Fluconazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fluconazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18926-6"/>
<display value="Framycetin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Framycetin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18927-4"/>
<display value="Fusidate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fusidate suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18928-2"/>
<display value="Gentamicin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gentamicin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18929-0"/>
<display value="Gentamicin.high potency [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gentamicin high suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18930-8"/>
<display value="Gramicidin D [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gramicidin D suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18931-6"/>
<display value="Hetacillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hetacillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18932-4"/>
<display value="Imipenem [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Imipenem suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18934-0"/>
<display value="Isoniazid [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18935-7"/>
<display value="Kanamycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Kanamycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18936-5"/>
<display value="Kanamycin.high potency [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Kanamycin high suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18937-3"/>
<display value="Ketoconazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ketoconazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18938-1"/>
<display value="Lincomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lincomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18939-9"/>
<display value="Lomefloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lomefloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18940-7"/>
<display value="Loracarbef [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Loracarbef suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18941-5"/>
<display value="Lymecycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymecycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18942-3"/>
<display value="Meclocycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Meclocycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18943-1"/>
<display value="Meropenem [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Meropenem suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18944-9"/>
<display value="Methacycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methacycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18945-6"/>
<display value="Methicillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methicillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18946-4"/>
<display value="Metronidazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Metronidazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18947-2"/>
<display value="Mezlocillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mezlocillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18948-0"/>
<display value="Minocycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Minocycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18949-8"/>
<display value="Miocamycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Miocamycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18950-6"/>
<display value="Moxalactam [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxalactam suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18951-4"/>
<display value="Nafcillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nafcillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18952-2"/>
<display value="Nalidixate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nalidixate suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18953-0"/>
<display value="Neomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18954-8"/>
<display value="Netilmicin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Netilmicin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18955-5"/>
<display value="Nitrofurantoin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nitrofurantoin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18956-3"/>
<display value="Norfloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Norfloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18957-1"/>
<display value="Novobiocin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Novobiocin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18958-9"/>
<display value="Nystatin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nystatin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18959-7"/>
<display value="Ofloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ofloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18960-5"/>
<display value="Oleandomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oleandomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18961-3"/>
<display value="Oxacillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxacillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18962-1"/>
<display value="Oxytetracycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxytetracycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18963-9"/>
<display value="Pefloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pefloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18964-7"/>
<display value="Penicillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Penicillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18965-4"/>
<display value="Penicillin G [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Penicillin G suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18966-2"/>
<display value="Penicillin V [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Penicillin V suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18967-0"/>
<display value="Phenethicillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phenethicillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18968-8"/>
<display value="Pipemidate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pipemidate suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18969-6"/>
<display value="Piperacillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Piperacillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18970-4"/>
<display value="Piperacillin+Tazobactam [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Piperacillin Tazob suscep qual"/>
</designation>
</concept>
<concept>
<code value="18971-2"/>
<display value="Pivampicillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pivampicillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18972-0"/>
<display value="Polymyxin B [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Polymyxin B suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18973-8"/>
<display value="Pyrazinamide [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyrazinamide suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18974-6"/>
<display value="Rifampin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rifampin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18975-3"/>
<display value="Ristocetin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ristocetin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18976-1"/>
<display value="Rolitetracycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rolitetracycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18977-9"/>
<display value="Rosoxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rosoxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18978-7"/>
<display value="Roxithromycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Roxithromycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18979-5"/>
<display value="Sisomicin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sisomicin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18980-3"/>
<display value="Spectinomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Spectinomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18981-1"/>
<display value="Spiramycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Spiramycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18982-9"/>
<display value="Streptomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Streptomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18983-7"/>
<display value="Streptomycin.high potency [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Streptomycin high suscep qual"/>
</designation>
</concept>
<concept>
<code value="18984-5"/>
<display value="Sulfadiazine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulfadiazine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18985-2"/>
<display value="Sulfamethoxazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulfamethoxazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18986-0"/>
<display value="Sulfisoxazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulfisoxazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18987-8"/>
<display value="Sulfonamide [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulfonamide suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18988-6"/>
<display value="Talampicillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Talampicillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18989-4"/>
<display value="Teicoplanin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Teicoplanin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18990-2"/>
<display value="Temafloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Temafloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18991-0"/>
<display value="Temocillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Temocillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18992-8"/>
<display value="Terbinafine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Terbinafine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18993-6"/>
<display value="Tetracycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tetracycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18994-4"/>
<display value="Ticarcillin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ticarcillin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18995-1"/>
<display value="Ticarcillin+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ticarcillin Clav suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18996-9"/>
<display value="Tobramycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tobramycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18997-7"/>
<display value="Trimethoprim [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trimethoprim suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="18998-5"/>
<display value="Trimethoprim+Sulfamethoxazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trimethoprim Sulfa suscep qual"/>
</designation>
</concept>
<concept>
<code value="18999-3"/>
<display value="Troleandomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Troleandomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="19000-9"/>
<display value="Vancomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vancomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="19001-7"/>
<display value="Viomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Viomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="19048-8"/>
<display
value="Nucleated erythrocytes/100 leukocytes [Ratio] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RBC (nucleated)/100 WBC"/>
</designation>
</concept>
<concept>
<code value="19057-9"/>
<display value="ABO +? Rh group [Type] in Blood from newborn"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ABO + Rh Group New Born"/>
</designation>
</concept>
<concept>
<code value="19072-8"/>
<display
value="Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcium (pH 7.4 adjusted)"/>
</designation>
</concept>
<concept>
<code value="19077-7"/>
<display value="Cells identified in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Other cells body fluid"/>
</designation>
</concept>
<concept>
<code value="19080-1"/>
<display
value="Choriogonadotropin [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="hCG"/>
</designation>
</concept>
<concept>
<code value="19090-0"/>
<display value="Colony count [#/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Colony count urine"/>
</designation>
</concept>
<concept>
<code value="19113-0"/>
<display value="IgE [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgE"/>
</designation>
</concept>
<concept>
<code value="19141-1"/>
<display value="Propoxyphene [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Propoxyphene urine"/>
</designation>
</concept>
<concept>
<code value="19149-4"/>
<display value="Rifabutin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rifabutin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="19176-7"/>
<display
value="Alpha-1-Fetoprotein [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alpha fetoprotein"/>
</designation>
</concept>
<concept>
<code value="19180-9"/>
<display
value="Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="hCG (beta free)"/>
</designation>
</concept>
<concept>
<code value="1920-8"/>
<display
value="Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="AST"/>
</designation>
</concept>
<concept>
<code value="19261-7"/>
<display value="Amphetamines [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amphetamines-type substances urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="19270-8"/>
<display value="Barbiturates [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Barbiturate urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="1928-1"/>
<display value="Immunoglobulin light chains [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="B-J protein urine (qual)"/>
</designation>
</concept>
<concept>
<code value="19289-8"/>
<display
value="Cannabinoids [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cannabinoids, urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="19295-5"/>
<display value="Opiates [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Opiates urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="1929-9"/>
<display value="Immunoglobulin light chains [Mass/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="B-J protein urine"/>
</designation>
</concept>
<concept>
<code value="193-3"/>
<display
value="Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clindamycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="19360-7"/>
<display value="Cocaine [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cocaine urine - by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="19411-8"/>
<display value="Codeine [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Codeine urine - by Screen method"/>
</designation>
</concept>
<concept>
<code value="1942-2"/>
<display
value="Beta galactosidase [Enzymatic activity/?mass] in Tissue"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Disaccharidase tissue"/>
</designation>
</concept>
<concept>
<code value="19429-0"/>
<display value="Propoxyphene [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Propoxyphene urine - by Screen method"/>
</designation>
</concept>
<concept>
<code value="1952-1"/>
<display value="Beta-2-Microglobulin [Mass/volume] in Serum or"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Beta2-microglubulin "/>
</designation>
</concept>
<concept>
<code value="1953-9"/>
<display value="Beta-2-Microglobulin [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Beta2-microglubulin urine"/>
</designation>
</concept>
<concept>
<code value="19550-3"/>
<display value="Methadone [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methadone urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="19554-5"/>
<display
value="Methamphetamine [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methamphetamine urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="19561-0"/>
<display
value="Methylenediamine [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MDA Urine by Sceen method"/>
</designation>
</concept>
<concept>
<code value="19564-4"/>
<display
value="Methylenediamine cutoff [Mass/?volume] in Urine for Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MDA Urine by Confirmation method"/>
</designation>
</concept>
<concept>
<code value="19568-5"/>
<display
value="Methylenedioxymethamphetamine [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MDMA Urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="19577-6"/>
<display
value="Methylphenidate [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methylphenidate urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="19578-4"/>
<display
value="Methylphenidate [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methylphenidate urine - by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="1959-6"/>
<display value="Bicarbonate [Moles/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bicarbonate blood "/>
</designation>
</concept>
<concept>
<code value="19597-4"/>
<display value="Morphine [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Morphine urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="19624-6"/>
<display value="Nordiazepam [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nordiazepam urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="1963-8"/>
<display value="Bicarbonate [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bicarbonate"/>
</designation>
</concept>
<concept>
<code value="19638-6"/>
<display value="Oxazepam [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxazepam urine by Screen method"/>
</designation>
</concept>
<concept>
<code value="19642-8"/>
<display value="Oxycodone [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxycodone urine - by Screen method"/>
</designation>
</concept>
<concept>
<code value="19659-2"/>
<display value="Phencyclidine [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phencyclidine urine - by Screen method"/>
</designation>
</concept>
<concept>
<code value="19670-9"/>
<display value="Phenothiazines [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phenothiazines urine - by Screen method"/>
</designation>
</concept>
<concept>
<code value="19710-3"/>
<display value="Tramadol [Presence] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tramadol urine"/>
</designation>
</concept>
<concept>
<code value="197-4"/>
<display
value="Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cloxacillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="19762-4"/>
<display
value="General categories [interpretation] of Cervical or vaginal smear or scraping by Cyto stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cervical cytology general category"/>
</designation>
</concept>
<concept>
<code value="19763-2"/>
<display
value="Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cervical cytology specimen site"/>
</designation>
</concept>
<concept>
<code value="19764-0"/>
<display
value="Statement of adequacy [interpretation] of Cervical or vaginal smear or scraping by Cyto stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cervical cytology statement of adequacy"/>
</designation>
</concept>
<concept>
<code value="19765-7"/>
<display
value="Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cervical cytology interpretation"/>
</designation>
</concept>
<concept>
<code value="19772-3"/>
<display
value="Preparation techniques [Type] in Cervical or vaginal smear or scraping by Cyto stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cervical cytology preparation technique"/>
</designation>
</concept>
<concept>
<code value="19773-1"/>
<display
value="Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cervical cytology recommendation"/>
</designation>
</concept>
<concept>
<code value="1988-5"/>
<display value="C reactive protein [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CRP"/>
</designation>
</concept>
<concept>
<code value="1992-7"/>
<display value="Calcitonin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcitonin"/>
</designation>
</concept>
<concept>
<code value="1995-0"/>
<display value="Calcium.ionized [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcium (ionised)"/>
</designation>
</concept>
<concept>
<code value="2000-8"/>
<display value="Calcium [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcium"/>
</designation>
</concept>
<concept>
<code value="2004-0"/>
<display value="Calcium [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcium urine"/>
</designation>
</concept>
<concept>
<code value="201-4"/>
<display
value="Colistimethate by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Colistimethate suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="20388-5"/>
<display value="Nitrofurazone [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Furacin topical suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="20389-3"/>
<display value="Mupirocin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mupirocin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="20390-1"/>
<display value="Silver sulfadiazine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Silvadine topical suscep qual"/>
</designation>
</concept>
<concept>
<code value="20391-9"/>
<display value="Mafenide [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mafenide suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="2039-6"/>
<display
value="Carcinoembryonic Ag [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CEA"/>
</designation>
</concept>
<concept>
<code value="20396-8"/>
<display
value="Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Levofloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="20397-6"/>
<display
value="Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sparfloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="20402-4"/>
<display value="CD16+?CD56+? cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="lymphocyte markers - Cells.CD16+CD56+"/>
</designation>
</concept>
<concept>
<code value="20404-0"/>
<display value="Fibronectin.fetal [Presence] in Vaginal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Foetal Fibronectin (rapid)"/>
</designation>
</concept>
<concept>
<code value="20447-9"/>
<display
value="HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HIV Viral Load (#/volume)"/>
</designation>
</concept>
<concept>
<code value="20453-7"/>
<display
value="Epithelial cells [Presence] in Urine sediment by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Epithelial Cells urine"/>
</designation>
</concept>
<concept>
<code value="20454-5"/>
<display value="Protein [Presence] in Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="20460-2"/>
<display
value="Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefuroxime oral suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="20483-4"/>
<display value="Mitochondria Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mitochondria Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="20490-9"/>
<display value="Epstein Barr virus capsid IgG Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV VCA IgG (titre)"/>
</designation>
</concept>
<concept>
<code value="20491-7"/>
<display value="Epstein Barr virus capsid IgM Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV VCA IgM (titre)"/>
</designation>
</concept>
<concept>
<code value="20495-8"/>
<display
value="Gliadin IgA Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gliadin Ab IgA - units/volume"/>
</designation>
</concept>
<concept>
<code value="20496-6"/>
<display
value="Gliadin IgG Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gliadin Ab IgG - units/volume"/>
</designation>
</concept>
<concept>
<code value="20507-0"/>
<display value="Reagin Ab [Presence] in Serum by RPR"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Syphilis RPR (qual)"/>
</designation>
</concept>
<concept>
<code value="20510-4"/>
<display
value="Lipoprotein fractions [interpretation] in Serum or Plasma by Electrophoresis"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lipoprotein (electrophoresis)"/>
</designation>
</concept>
<concept>
<code value="20521-1"/>
<display
value="Carboxy tetrahydrocannabinol [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carboxy tetrahydronnabinol urine"/>
</designation>
</concept>
<concept>
<code value="205-5"/>
<display
value="Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Colistin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="20559-1"/>
<display
value="Temazepam [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Temazepam, urine"/>
</designation>
</concept>
<concept>
<code value="20563-3"/>
<display value="Carboxyhemoglobin/Hemoglobin.total in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carboxyhaemoglobin"/>
</designation>
</concept>
<concept>
<code value="20565-8"/>
<display value="Carbon dioxide, total [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CO2 blood ( total)"/>
</designation>
</concept>
<concept>
<code value="20569-0"/>
<display
value="Creatine kinase.MB/Creatine kinase.total in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CKMB/CK total"/>
</designation>
</concept>
<concept>
<code value="20570-8"/>
<display value="Hematocrit [Volume Fraction] of Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haematocrit"/>
</designation>
</concept>
<concept>
<code value="20575-7"/>
<display value="Hepatitis A virus Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis A Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="20576-5"/>
<display
value="Galactose 1 phosphate uridyl transferase [Presence] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Galactose 1 phosphate uridyl transferase blood (qual)"/>
</designation>
</concept>
<concept>
<code value="20578-1"/>
<display value="Vancomycin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vancomycin"/>
</designation>
</concept>
<concept>
<code value="20626-8"/>
<display
value="Reducing substances [Units/?volume] in Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reducing substances urine"/>
</designation>
</concept>
<concept>
<code value="20629-2"/>
<display value="Levofloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Levofloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="2064-4"/>
<display value="Ceruloplasmin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceruloplasmin"/>
</designation>
</concept>
<concept>
<code value="20662-3"/>
<display value="Allergens tested for in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Allergy Testing"/>
</designation>
</concept>
<concept>
<code value="2069-3"/>
<display value="Chloride [Moles/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chloride blood"/>
</designation>
</concept>
<concept>
<code value="20719-1"/>
<display
value="Brucella abortus Ab [Titer] in Serum by Tube agglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Br. abortus Ab (SAT)"/>
</designation>
</concept>
<concept>
<code value="2072-7"/>
<display value="Chloride [Moles/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chloride fluid"/>
</designation>
</concept>
<concept>
<code value="20728-2"/>
<display
value="Brucella abortus Ab [Presence] in Serum by Complement fixation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Br. abortus Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="2075-0"/>
<display value="Chloride [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chloride"/>
</designation>
</concept>
<concept>
<code value="2077-6"/>
<display value="Chloride [Moles/?volume] in Sweat"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chloride sweat"/>
</designation>
</concept>
<concept>
<code value="2078-4"/>
<display value="Chloride [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chloride urine - moles/volume"/>
</designation>
</concept>
<concept>
<code value="2079-2"/>
<display value="Chloride [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chloride urine - moles/time"/>
</designation>
</concept>
<concept>
<code value="20-8"/>
<display
value="Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amoxicillin Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="209-7"/>
<display
value="Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cyclacillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="20981-7"/>
<display value="Verotoxin identified in Isolate"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Verotoxin"/>
</designation>
</concept>
<concept>
<code value="2098-2"/>
<display
value="Cholinesterase [Enzymatic activity/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholinesterase"/>
</designation>
</concept>
<concept>
<code value="2099-0"/>
<display
value="Cholinesterase [Enzymatic activity/?volume] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholinesterase RBC"/>
</designation>
</concept>
<concept>
<code value="21027-8"/>
<display
value="Platelet aggregation [interpretation] in Platelet poor plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Plat Aggs"/>
</designation>
</concept>
<concept>
<code value="2106-3"/>
<display
value="Choriogonadotropin (pregnancy test) [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="hCG urine (qual)"/>
</designation>
</concept>
<concept>
<code value="21070-8"/>
<display
value="Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antibiotic XXX suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2118-8"/>
<display
value="Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="hCG (qual)"/>
</designation>
</concept>
<concept>
<code value="21198-7"/>
<display
value="Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="hCG (beta)"/>
</designation>
</concept>
<concept>
<code value="21233-2"/>
<display value="Cryptosporidium sp Ag [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cryptosporidia Ag faeces"/>
</designation>
</concept>
<concept>
<code value="21259-7"/>
<display
value="Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Entamoeba histolytica Ab"/>
</designation>
</concept>
<concept>
<code value="21363-7"/>
<display
value="Legionella pneumophila DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Legionella DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="21365-2"/>
<display value="Leptin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Leptin"/>
</designation>
</concept>
<concept>
<code value="21387-6"/>
<display value="Methylhippurate [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Xylene urine"/>
</designation>
</concept>
<concept>
<code value="213-9"/>
<display
value="Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cycloserine suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="21436-1"/>
<display value="Ovary Ab [Presence] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ovarian autoantibody"/>
</designation>
</concept>
<concept>
<code value="21566-5"/>
<display value="Tolazamide [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tolazamide"/>
</designation>
</concept>
<concept>
<code value="21567-3"/>
<display value="Tolbutamide [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tolbutamide"/>
</designation>
</concept>
<concept>
<code value="2157-6"/>
<display
value="Creatine kinase [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CK"/>
</designation>
</concept>
<concept>
<code value="21582-2"/>
<display value="Tryptase [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tryptase"/>
</designation>
</concept>
<concept>
<code value="21613-5"/>
<display
value="Chlamydia trachomatis DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C. trachomatis DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="2164-2"/>
<display value="Creatinine renal clearance in 24 hour"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Creatinine clearance"/>
</designation>
</concept>
<concept>
<code value="217-0"/>
<display
value="Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Demeclocycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="221-2"/>
<display
value="Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dicloxacillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="22150-7"/>
<display value="Brucella abortus Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Br. abortus Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="22244-8"/>
<display
value="Cytomegalovirus IgG Ab [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV IgG (qual)"/>
</designation>
</concept>
<concept>
<code value="22246-3"/>
<display value="Cytomegalovirus IgG Ab [Titer] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV IgG (titre)"/>
</designation>
</concept>
<concept>
<code value="22249-7"/>
<display value="Cytomegalovirus IgM Ab [Titer] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV IgM (titre)"/>
</designation>
</concept>
<concept>
<code value="22298-4"/>
<display value="Epstein Barr virus nuclear IgG Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV NA IgG (titre)"/>
</designation>
</concept>
<concept>
<code value="22312-3"/>
<display value="Hepatitis A virus Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis A Ab"/>
</designation>
</concept>
<concept>
<code value="22313-1"/>
<display value="Hepatitis A virus IgG Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis A IgG"/>
</designation>
</concept>
<concept>
<code value="22314-9"/>
<display value="Hepatitis A virus IgM Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis A IgM (qual)"/>
</designation>
</concept>
<concept>
<code value="22320-6"/>
<display value="Hepatitis B virus e Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B e Ab"/>
</designation>
</concept>
<concept>
<code value="22322-2"/>
<display value="Hepatitis B virus surface Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B surface Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="22396-6"/>
<display value="Legionella pneumophila Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Legionella Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="22425-3"/>
<display value="Mycoplasma pneumoniae Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="M. pneumoniae Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="22466-7"/>
<display value="Respiratory syncytial virus Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RSV Ab"/>
</designation>
</concept>
<concept>
<code value="22496-4"/>
<display value="Rubella virus Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rubella Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="22497-2"/>
<display value="Rubella virus Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rubella Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="225-3"/>
<display
value="Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Doxycycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="22568-0"/>
<display value="Streptolysin O Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Streptolysin O Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="22580-5"/>
<display value="Toxoplasma gondii IgG Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. gondii IgG (qual)"/>
</designation>
</concept>
<concept>
<code value="22582-1"/>
<display value="Toxoplasma gondii IgG Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. gondii IgG (titre)"/>
</designation>
</concept>
<concept>
<code value="22584-7"/>
<display value="Toxoplasma gondii IgM Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. gondii IgM (titre)"/>
</designation>
</concept>
<concept>
<code value="22664-7"/>
<display value="Urea [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urea"/>
</designation>
</concept>
<concept>
<code value="22689-4"/>
<display value="Zinc [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Zinc urine 24hr"/>
</designation>
</concept>
<concept>
<code value="22700-9"/>
<display value="Urea [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urea urine"/>
</designation>
</concept>
<concept>
<code value="22704-1"/>
<display
value="Carnitine free (C0)/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carnitine urine (free) "/>
</designation>
</concept>
<concept>
<code value="22708-2"/>
<display value="Homovanillate/Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Homovanillate/creat urine"/>
</designation>
</concept>
<concept>
<code value="2271-5"/>
<display value="Fat [Mass/time] in 72 hour Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fat faeces 72h (per 24h)"/>
</designation>
</concept>
<concept>
<code value="22745-4"/>
<display value="Ethanol [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethanol urine"/>
</designation>
</concept>
<concept>
<code value="22748-8"/>
<display
value="Cholesterol in LDL [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholesterol (LDL) (assay)"/>
</designation>
</concept>
<concept>
<code value="22749-6"/>
<display
value="Amylase.pancreatic [Enzymatic activity/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amylase (pancreatic) urine"/>
</designation>
</concept>
<concept>
<code value="2276-4"/>
<display value="Ferritin [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ferritin"/>
</designation>
</concept>
<concept>
<code value="229-5"/>
<display
value="Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Enoxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2306-9"/>
<display value="Galactose [Presence] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Galactose blood (qual)"/>
</designation>
</concept>
<concept>
<code value="23159-7"/>
<display
value="Leishmania sp DNA [Identifier] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Leishmania DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="23198-5"/>
<display value="Leptospira sp Ab [Titer] in Serum by Agglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Leptospira Ab (MAT)"/>
</designation>
</concept>
<concept>
<code value="2324-2"/>
<display
value="Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="GGT"/>
</designation>
</concept>
<concept>
<code value="2333-3"/>
<display value="Gastrin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gastrin - mass/volume"/>
</designation>
</concept>
<concept>
<code value="2335-8"/>
<display value="Hemoglobin.gastrointestinal [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Occult blood (non-spec screen)"/>
</designation>
</concept>
<concept>
<code value="233-7"/>
<display
value="Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Erythromycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2338-2"/>
<display value="Glucagon [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucagon"/>
</designation>
</concept>
<concept>
<code value="2356-4"/>
<display
value="Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="G6PD (screen)"/>
</designation>
</concept>
<concept>
<code value="23627-3"/>
<display value="Clofazimine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clofazimine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23628-1"/>
<display value="Sparfloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sparfloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23629-9"/>
<display value="Para aminosalicylate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="P-aminosalicylate suscep qual"/>
</designation>
</concept>
<concept>
<code value="23636-4"/>
<display value="Cefdinir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefdinir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23637-2"/>
<display
value="Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefdinir suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="23638-0"/>
<display value="Grepafloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Grepafloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23639-8"/>
<display
value="Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Grepafloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="23640-6"/>
<display value="Quinupristin+Dalfopristin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Quinupristin Dalfo suscep qual"/>
</designation>
</concept>
<concept>
<code value="23641-4"/>
<display
value="Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Quinupristin Dalfo suscep MIC"/>
</designation>
</concept>
<concept>
<code value="23642-2"/>
<display value="Trovafloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trovafloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23643-0"/>
<display
value="Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trovafloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="23658-8"/>
<display value="Other Antibiotic [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antibiotic XXX suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23659-6"/>
<display value="Apramycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Apramycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23709-9"/>
<display value="Ceftiofur [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftiofur suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23712-3"/>
<display value="Enrofloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Enrofloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23713-1"/>
<display value="Ethylene glycol [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethylene glycol"/>
</designation>
</concept>
<concept>
<code value="23740-4"/>
<display value="Florfenicol [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Florfenicol suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="23826-1"/>
<display
value="Bordetella pertussis DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="B. pertussis DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="23831-1"/>
<display
value="Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="B. pertussis toxin IgG"/>
</designation>
</concept>
<concept>
<code value="2387-9"/>
<display value="Glycerol [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glycerol"/>
</designation>
</concept>
<concept>
<code value="23883-2"/>
<display value="Inhibin A [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Inhibin A"/>
</designation>
</concept>
<concept>
<code value="23905-3"/>
<display value="Mycophenolate [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mycophenolic Acid"/>
</designation>
</concept>
<concept>
<code value="23971-5"/>
<display value="Epstein Barr virus early IgG Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV EA IgG (titre)"/>
</designation>
</concept>
<concept>
<code value="23991-3"/>
<display
value="Dengue virus IgG Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dengue virus IgG Ab"/>
</designation>
</concept>
<concept>
<code value="23992-1"/>
<display
value="Dengue virus IgM Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dengue virus IgM Ab"/>
</designation>
</concept>
<concept>
<code value="2399-4"/>
<display value="Glycosaminoglycans [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glycosamino Glycan urine (quant)"/>
</designation>
</concept>
<concept>
<code value="24-0"/>
<display
value="Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amphotericin B suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="241-0"/>
<display
value="Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethambutol suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="24108-3"/>
<display value="Cancer Ag 19-9 [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CA 19-9"/>
</designation>
</concept>
<concept>
<code value="24109-1"/>
<display value="Progesterone [Moles/?volume] in Saliva (oral fluid)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Progesterone saliva"/>
</designation>
</concept>
<concept>
<code value="24110-9"/>
<display
value="Treponema pallidum Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. pallidum Ab (EIA)"/>
</designation>
</concept>
<concept>
<code value="24111-7"/>
<display
value="Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="N. gonorrhoeae DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="24117-4"/>
<display
value="Ross river virus IgG Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ross River virus IgG Ab"/>
</designation>
</concept>
<concept>
<code value="24118-2"/>
<display
value="Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Barmah Forest virus IgM Ab"/>
</designation>
</concept>
<concept>
<code value="24120-8"/>
<display
value="Ross river virus IgM Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ross River virus IgM Ab"/>
</designation>
</concept>
<concept>
<code value="24121-6"/>
<display
value="Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Barmah Forest virus IgG Ab"/>
</designation>
</concept>
<concept>
<code value="24124-0"/>
<display
value="Casts [Presence] in Urine sediment by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Casts urine sediment"/>
</designation>
</concept>
<concept>
<code value="24125-7"/>
<display value="Androgen free Index in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Testosterone (free index)"/>
</designation>
</concept>
<concept>
<code value="24312-1"/>
<display
value="Treponema pallidum Ab [Presence] in Serum by Agglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Syphilis Ab Screen (Aggl)"/>
</designation>
</concept>
<concept>
<code value="24377-4"/>
<display
value="Platelet aggregation ADP induced [Presence] in Platelet rich plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Platelet aggregtion-ADP"/>
</designation>
</concept>
<concept>
<code value="24378-2"/>
<display
value="Platelet aggregation epinephrine induced [Presence] in Platelet rich plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Platelet aggregtion-epinephrine"/>
</designation>
</concept>
<concept>
<code value="24379-0"/>
<display
value="Platelet aggregation collagen induced [Presence] in Platelet rich plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Platelet aggregtion-collagen"/>
</designation>
</concept>
<concept>
<code value="24380-8"/>
<display
value="Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Platelet aggregtion-ristocetin"/>
</designation>
</concept>
<concept>
<code value="24383-2"/>
<display
value="Intrinsic factor Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Intrinsic factor Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="24390-7"/>
<display
value="Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cortisol (30m p 250ug Synacth)"/>
</designation>
</concept>
<concept>
<code value="24391-5"/>
<display
value="Cortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cortisol (1h p 250ug Synacth)"/>
</designation>
</concept>
<concept>
<code value="24393-1"/>
<display
value="Cortisol [Moles/volume] in Serum or Plasma --10 hours post 1 mg dexamethasone PO overnight"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cortisol (10h p 1mg Dexameth)"/>
</designation>
</concept>
<concept>
<code value="24419-4"/>
<display value="Pathology report gross observation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gross observation"/>
</designation>
</concept>
<concept>
<code value="24467-3"/>
<display value="CD3+?CD4+? (T4 helper) cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="lymphocyte markers - Cells.CD3+CD4+"/>
</designation>
</concept>
<concept>
<code value="24471-5"/>
<display
value="Platelet function (closure time) collagen+?Epinephrine induced [Time] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PFA Col/Epi"/>
</designation>
</concept>
<concept>
<code value="24472-3"/>
<display
value="Platelet function (closure time) collagen+?ADP induced [Time] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PFA Col/ADP"/>
</designation>
</concept>
<concept>
<code value="245-1"/>
<display
value="Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Floxacillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="24518-3"/>
<display value="Calcium/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcium/creatinine urine"/>
</designation>
</concept>
<concept>
<code value="24521-7"/>
<display value="Epinephrine [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adrenaline urine"/>
</designation>
</concept>
<concept>
<code value="24522-5"/>
<display value="Epinephrine/Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adrenaline/creat urine"/>
</designation>
</concept>
<concept>
<code value="24523-3"/>
<display value="Norepinephrine/Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Noradrenaline/creat urine"/>
</designation>
</concept>
<concept>
<code value="24524-1"/>
<display value="Dopamine/Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dopamine/creat urine"/>
</designation>
</concept>
<concept>
<code value="2458-8"/>
<display value="IgA [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgA"/>
</designation>
</concept>
<concept>
<code value="2460-4"/>
<display value="IgD [Mass/?volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgD"/>
</designation>
</concept>
<concept>
<code value="2464-6"/>
<display value="IgG [Mass/?volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgG CSF"/>
</designation>
</concept>
<concept>
<code value="2465-3"/>
<display value="IgG [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgG"/>
</designation>
</concept>
<concept>
<code value="2466-1"/>
<display value="IgG subclass 1 [Mass/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgG subclass 1"/>
</designation>
</concept>
<concept>
<code value="2467-9"/>
<display value="IgG subclass 2 [Mass/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgG subclass 2"/>
</designation>
</concept>
<concept>
<code value="2468-7"/>
<display value="IgG subclass 3 [Mass/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgG subclass 3"/>
</designation>
</concept>
<concept>
<code value="2469-5"/>
<display value="IgG subclass 4 [Mass/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgG subclass 4"/>
</designation>
</concept>
<concept>
<code value="2470-3"/>
<display value="IgG/?Albumin [Mass Ratio] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgG/Albumin CSF"/>
</designation>
</concept>
<concept>
<code value="2472-9"/>
<display value="IgM [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IgM"/>
</designation>
</concept>
<concept>
<code value="2483-6"/>
<display
value="Insulin-like growth factor binding protein 3 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IGF Binding Protein 3"/>
</designation>
</concept>
<concept>
<code value="2484-4"/>
<display
value="Insulin-like growth factor-I [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IGF1"/>
</designation>
</concept>
<concept>
<code value="249-3"/>
<display
value="Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fluconazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2495-0"/>
<display value="Iodine [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iodine urine - mass/volume"/>
</designation>
</concept>
<concept>
<code value="25095-1"/>
<display
value="Deoxypyridinoline/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="DPD / creat urine"/>
</designation>
</concept>
<concept>
<code value="25142-1"/>
<display
value="5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Flucytosine peak"/>
</designation>
</concept>
<concept>
<code value="25143-9"/>
<display
value="5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Flucytosine trough"/>
</designation>
</concept>
<concept>
<code value="25145-4"/>
<display
value="Bacteria [Presence] in Urine sediment by Light microscopy "/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bacteria urine sediment (microscopy)"/>
</designation>
</concept>
<concept>
<code value="2514-8"/>
<display value="Ketones [Presence] in Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ketones urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="25168-6"/>
<display value="Perhexiline [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Perhexiline"/>
</designation>
</concept>
<concept>
<code value="25170-2"/>
<display value="Mercury [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mercury blood"/>
</designation>
</concept>
<concept>
<code value="2520-5"/>
<display value="Lactate [Moles/?volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lactate CSF"/>
</designation>
</concept>
<concept>
<code value="2524-7"/>
<display value="Lactate [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lactate "/>
</designation>
</concept>
<concept>
<code value="25302-1"/>
<display
value="Alanine aminotransferase [Enzymatic activity/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ALT, fluid"/>
</designation>
</concept>
<concept>
<code value="253-5"/>
<display
value="5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="5-Fluorocytosine suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="25358-3"/>
<display value="C peptide [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C-Peptide urine 24hr"/>
</designation>
</concept>
<concept>
<code value="25360-9"/>
<display value="Cadmium [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cadmium urine"/>
</designation>
</concept>
<concept>
<code value="25361-7"/>
<display value="Caffeine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Caffeine"/>
</designation>
</concept>
<concept>
<code value="25374-0"/>
<display value="Chromium [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chromium"/>
</designation>
</concept>
<concept>
<code value="25375-7"/>
<display value="Chymotrypsin [Enzymatic activity/?mass] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chymotrypsin faeces"/>
</designation>
</concept>
<concept>
<code value="25378-1"/>
<display value="Cobalt [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cobalt"/>
</designation>
</concept>
<concept>
<code value="25386-4"/>
<display value="Creatinine [Moles/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Creatinine body fluid"/>
</designation>
</concept>
<concept>
<code value="25393-0"/>
<display
value="Desethylamiodarone [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Desethylamiodarone"/>
</designation>
</concept>
<concept>
<code value="25411-0"/>
<display
value="Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fleroxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="25428-4"/>
<display value="Glucose [Presence] in Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="25447-4"/>
<display value="Insulin Free [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Insulin (free)"/>
</designation>
</concept>
<concept>
<code value="25451-6"/>
<display value="Isoniazid [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid"/>
</designation>
</concept>
<concept>
<code value="25452-4"/>
<display
value="Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Itraconazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="25458-1"/>
<display value="Lamotrigine [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lamotrigine - moles/volume"/>
</designation>
</concept>
<concept>
<code value="25466-4"/>
<display value="Manganese [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Manganese blood - moles/volume"/>
</designation>
</concept>
<concept>
<code value="25471-4"/>
<display value="Mercury [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mercury urine 24hr"/>
</designation>
</concept>
<concept>
<code value="25474-8"/>
<display value="Metanephrines [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Metanephrines"/>
</designation>
</concept>
<concept>
<code value="25489-6"/>
<display value="Normetanephrine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Normetanephrines"/>
</designation>
</concept>
<concept>
<code value="25501-8"/>
<display value="Phosphate [Moles/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phosphate fluid"/>
</designation>
</concept>
<concept>
<code value="2550-2"/>
<display value="Lactate/?Pyruvate [Molar ratio] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lactate/pyruvate blood"/>
</designation>
</concept>
<concept>
<code value="25514-1"/>
<display value="Rubella virus IgG Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rubella IgG (qual)"/>
</designation>
</concept>
<concept>
<code value="25521-6"/>
<display value="Selenium [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Selenium"/>
</designation>
</concept>
<concept>
<code value="25524-0"/>
<display value="Serotonin [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Serotonin blood"/>
</designation>
</concept>
<concept>
<code value="25541-4"/>
<display value="Topiramate [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Topiramate"/>
</designation>
</concept>
<concept>
<code value="25542-2"/>
<display value="Toxoplasma gondii IgM Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. gondii IgM (qual)"/>
</designation>
</concept>
<concept>
<code value="25548-9"/>
<display value="Urate [Moles/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urate fluid"/>
</designation>
</concept>
<concept>
<code value="25549-7"/>
<display value="Urea [Moles/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urea fluid"/>
</designation>
</concept>
<concept>
<code value="25595-0"/>
<display value="Econazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Econazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="25596-8"/>
<display value="Fosfomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fosfomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="25597-6"/>
<display value="Josamycine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Josamycine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="25607-3"/>
<display value="Miconazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Miconazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="25608-1"/>
<display value="Nitroxoline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nitroxoline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="25637-0"/>
<display
value="Econazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Econazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="25638-8"/>
<display
value="Eosinophil cationic protein (ECP) [Mass/?volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ECP"/>
</designation>
</concept>
<concept>
<code value="25653-7"/>
<display
value="Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fosfomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="256-8"/>
<display value="Foscarnet [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Foscarnet suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="25702-2"/>
<display
value="Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Josamycine suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="25721-2"/>
<display value="Mianserin [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mianserin"/>
</designation>
</concept>
<concept>
<code value="25722-0"/>
<display
value="Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Miconazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="25723-8"/>
<display
value="Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nitroxoline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2572-6"/>
<display
value="Lipoprotein lipase [Enzymatic activity/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Liporotein lipase"/>
</designation>
</concept>
<concept>
<code value="258-4"/>
<display
value="Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Framycetin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="25867-3"/>
<display value="Echinococcus sp Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Echinococcus Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="2589-0"/>
<display value="Lysozyme [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Muramidase"/>
</designation>
</concept>
<concept>
<code value="25907-7"/>
<display value="Elastase.pancreatic [Mass/?mass] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Elastase faeces"/>
</designation>
</concept>
<concept>
<code value="25909-3"/>
<display
value="Epinephrine/Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adrenaline/creat urine 24h"/>
</designation>
</concept>
<concept>
<code value="25931-7"/>
<display
value="Homovanillate/Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Homovanillate/creat urine 24h"/>
</designation>
</concept>
<concept>
<code value="2596-5"/>
<display value="Magnesium [Moles/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Magnesium fluid"/>
</designation>
</concept>
<concept>
<code value="2597-3"/>
<display value="Magnesium [Moles/?volume] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Magnesium RBC"/>
</designation>
</concept>
<concept>
<code value="2598-1"/>
<display value="Magnesium [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Magnesium urine"/>
</designation>
</concept>
<concept>
<code value="2599-9"/>
<display value="Magnesium [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Magnesium urine 24h"/>
</designation>
</concept>
<concept>
<code value="26004-2"/>
<display
value="Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VMA/creat urine 24h"/>
</designation>
</concept>
<concept>
<code value="26009-1"/>
<display
value="Treponema pallidum Ab [Titer] in Serum by Hemagglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. pallidum Ab (HA)"/>
</designation>
</concept>
<concept>
<code value="2601-3"/>
<display value="Magnesium [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Magnesium"/>
</designation>
</concept>
<concept>
<code value="26023-2"/>
<display value="Extractable nuclear Ab identified in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ENA Identification"/>
</designation>
</concept>
<concept>
<code value="26043-0"/>
<display value="HLA-B27 [Presence] by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HLA B27"/>
</designation>
</concept>
<concept>
<code value="2606-2"/>
<display value="Melanin [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Melanogen urine (qual)"/>
</designation>
</concept>
<concept>
<code value="2614-6"/>
<display value="Methemoglobin/Hemoglobin.total in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methaemoglobin"/>
</designation>
</concept>
<concept>
<code value="262-6"/>
<display
value="Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fusidate suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2639-3"/>
<display value="Myoglobin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Myoglobin"/>
</designation>
</concept>
<concept>
<code value="2640-1"/>
<display value="Myoglobin [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Myoglobin urine"/>
</designation>
</concept>
<concept>
<code value="26444-0"/>
<display value="Basophils [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Basophils"/>
</designation>
</concept>
<concept>
<code value="26446-5"/>
<display value="Blasts/100 leukocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blasts (%)"/>
</designation>
</concept>
<concept>
<code value="26449-9"/>
<display value="Eosinophils [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Eosinophils"/>
</designation>
</concept>
<concept>
<code value="26450-7"/>
<display value="Eosinophils/100 leukocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Eosinophils (%)"/>
</designation>
</concept>
<concept>
<code value="26453-1"/>
<display value="Erythrocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RBC"/>
</designation>
</concept>
<concept>
<code value="26454-9"/>
<display value="Erythrocytes [#/volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RBC CSF"/>
</designation>
</concept>
<concept>
<code value="26455-6"/>
<display value="Erythrocytes [#/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RBC body fluid"/>
</designation>
</concept>
<concept>
<code value="26464-8"/>
<display value="Leukocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="WBC"/>
</designation>
</concept>
<concept>
<code value="26465-5"/>
<display value="Leukocytes [#/volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="WBC CSF"/>
</designation>
</concept>
<concept>
<code value="26466-3"/>
<display value="Leukocytes [#/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="WBC body fluid"/>
</designation>
</concept>
<concept>
<code value="26474-7"/>
<display value="Lymphocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphocytes"/>
</designation>
</concept>
<concept>
<code value="26475-4"/>
<display value="Lymphocytes [#/volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphocytes CSF"/>
</designation>
</concept>
<concept>
<code value="26476-2"/>
<display value="Lymphocytes [#/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphocytes body fluid"/>
</designation>
</concept>
<concept>
<code value="26477-0"/>
<display value="Variant lymphocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphocytes (atypical)"/>
</designation>
</concept>
<concept>
<code value="26478-8"/>
<display value="Lymphocytes/100 leukocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphocytes (%)"/>
</designation>
</concept>
<concept>
<code value="26484-6"/>
<display value="Monocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Monocytes"/>
</designation>
</concept>
<concept>
<code value="26485-3"/>
<display value="Monocytes/100 leukocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Monocytes (%)"/>
</designation>
</concept>
<concept>
<code value="26489-5"/>
<display
value="Mononuclear cells [#/volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mononuclear cells CSF"/>
</designation>
</concept>
<concept>
<code value="26490-3"/>
<display value="Mononuclear cells [#/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mononuclear cells body fluid"/>
</designation>
</concept>
<concept>
<code value="26499-4"/>
<display value="Neutrophils [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophils"/>
</designation>
</concept>
<concept>
<code value="26500-9"/>
<display value="Neutrophils [#/volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophils CSF"/>
</designation>
</concept>
<concept>
<code value="26507-4"/>
<display value="Band form neutrophils [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophils (band)"/>
</designation>
</concept>
<concept>
<code value="26508-2"/>
<display value="Band form neutrophils/100 leukocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophils (band) (%)"/>
</designation>
</concept>
<concept>
<code value="26511-6"/>
<display value="Neutrophils/100 leukocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophils (%)"/>
</designation>
</concept>
<concept>
<code value="26515-7"/>
<display value="Platelets [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Platelets"/>
</designation>
</concept>
<concept>
<code value="26523-1"/>
<display value="Promyelocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Promyelocytes"/>
</designation>
</concept>
<concept>
<code value="265-9"/>
<display value="Ganciclovir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ganciclovir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="26621-3"/>
<display value="Legionella sp Ag [Presence] in Unspecified specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Legionella Ag"/>
</designation>
</concept>
<concept>
<code value="26705-4"/>
<display value="Epstein Barr virus nuclear IgM Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV NA IgM (titre)"/>
</designation>
</concept>
<concept>
<code value="267-5"/>
<display
value="Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gentamicin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2676-5"/>
<display value="Organic acids [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Organic acids urine"/>
</designation>
</concept>
<concept>
<code value="26784-9"/>
<display
value="Diazepam [Mass/?volume] in Serum or Plasma by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Diazepam by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="26833-4"/>
<display value="Hippurate [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hippurate urine"/>
</designation>
</concept>
<concept>
<code value="2685-6"/>
<display
value="Alpha-1-Acid glycoprotein [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alpha 1 glycoprotein"/>
</designation>
</concept>
<concept>
<code value="26885-4"/>
<display
value="Ova and parasites identified in Unspecified specimen by Concentration."/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ova cysts parasites"/>
</designation>
</concept>
<concept>
<code value="2692-2"/>
<display value="Osmolality of Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Osmolality "/>
</designation>
</concept>
<concept>
<code value="2695-5"/>
<display value="Osmolality of Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Osmolality urine"/>
</designation>
</concept>
<concept>
<code value="26960-5"/>
<display value="Trypsin [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trypsin faeces"/>
</designation>
</concept>
<concept>
<code value="26969-6"/>
<display
value="Parietal cell Ab [Presence] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parietal cell Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="27071-0"/>
<display value="CD45 (Lymphs) cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="lymphocyte markers - Cells.CD45"/>
</designation>
</concept>
<concept>
<code value="27081-9"/>
<display
value="Itraconazole+?Hydroxyitraconazole [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Itraconazole"/>
</designation>
</concept>
<concept>
<code value="27109-8"/>
<display value="Paroxetine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Paroxetine urine"/>
</designation>
</concept>
<concept>
<code value="271-7"/>
<display
value="Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gramicidin D suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="27198-1"/>
<display
value="Bilirubin.total [Units/?volume] in Amniotic fluid by Spectrophotometry direct"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bilirubin amniotic fluid"/>
</designation>
</concept>
<concept>
<code value="27200-5"/>
<display value="Nuclear Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antinuclear Ab"/>
</designation>
</concept>
<concept>
<code value="2721-9"/>
<display
value="Pancreatic polypeptide [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pancreatic Polypeptide"/>
</designation>
</concept>
<concept>
<code value="27252-6"/>
<display
value="Choriogonadotropin.alpha subunit [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gonadotrophin Alpha subunit (total)"/>
</designation>
</concept>
<concept>
<code value="27265-8"/>
<display value="Giardia sp Ag [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Giardia Ag faeces"/>
</designation>
</concept>
<concept>
<code value="2731-8"/>
<display value="Parathyrin.intact [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parathyroid Hormone (intact) - mass/volume"/>
</designation>
</concept>
<concept>
<code value="27320-1"/>
<display value="Parietal cell Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parietal cell Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="27403-5"/>
<display
value="Gamma glutamyl transferase [Enzymatic activity/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="GGT urine"/>
</designation>
</concept>
<concept>
<code value="2742-5"/>
<display
value="Angiotensin converting enzyme [Enzymatic activity/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Angiotensin converting enzyme"/>
</designation>
</concept>
<concept>
<code value="2748-2"/>
<display value="pH of Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="pH body fluid"/>
</designation>
</concept>
<concept>
<code value="2752-4"/>
<display value="pH of Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="pH semen"/>
</designation>
</concept>
<concept>
<code value="275-8"/>
<display
value="Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hetacillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2758-1"/>
<display value="Phenol [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phenol urine"/>
</designation>
</concept>
<concept>
<code value="27811-9"/>
<display
value="Antithrombin actual/?normal in Platelet poor plasma by Chromogenic method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antithrombin"/>
</designation>
</concept>
<concept>
<code value="27812-7"/>
<display
value="Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antithrombin Ag"/>
</designation>
</concept>
<concept>
<code value="27815-0"/>
<display
value="Coagulation factor XIII activity actual/?normal in Platelet poor plasma by Chromogenic method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor XIII assay"/>
</designation>
</concept>
<concept>
<code value="27816-8"/>
<display
value="von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VWF:Ag"/>
</designation>
</concept>
<concept>
<code value="27818-4"/>
<display
value="Protein C actual/?normal in Platelet poor plasma by Chromogenic method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein C - by Chromogenic method"/>
</designation>
</concept>
<concept>
<code value="27819-2"/>
<display
value="Protein C actual/?normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein C - by Coagulation assay"/>
</designation>
</concept>
<concept>
<code value="27820-0"/>
<display
value="Protein C Ag actual/normal in Platelet poor plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein C Ag"/>
</designation>
</concept>
<concept>
<code value="27821-8"/>
<display
value="Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein S, Free"/>
</designation>
</concept>
<concept>
<code value="27822-6"/>
<display
value="Protein S actual/normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein S"/>
</designation>
</concept>
<concept>
<code value="279-0"/>
<display
value="Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Imipenem suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="27977-8"/>
<display
value="Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Noradrenaline/creat urine 24h"/>
</designation>
</concept>
<concept>
<code value="27978-6"/>
<display
value="Metanephrines/?Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Metanephrines/creat urine 24h"/>
</designation>
</concept>
<concept>
<code value="2809-2"/>
<display value="Porphobilinogen [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphobilinogen urine (qual)"/>
</designation>
</concept>
<concept>
<code value="28-1"/>
<display
value="Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ampicillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2811-8"/>
<display value="Porphobilinogen [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphobilinogen urine"/>
</designation>
</concept>
<concept>
<code value="2812-6"/>
<display
value="Porphobilinogen deaminase [Enzymatic activity/?volume] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphobilinogen deaminase RBC"/>
</designation>
</concept>
<concept>
<code value="2821-7"/>
<display value="Potassium [Moles/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Potassium fluid"/>
</designation>
</concept>
<concept>
<code value="2823-3"/>
<display value="Potassium [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Potassium"/>
</designation>
</concept>
<concept>
<code value="2828-2"/>
<display value="Potassium [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Potassium urine"/>
</designation>
</concept>
<concept>
<code value="2829-0"/>
<display value="Potassium [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Potassium urine 24h"/>
</designation>
</concept>
<concept>
<code value="28539-5"/>
<display value="MCH [Entitic mass]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MCH"/>
</designation>
</concept>
<concept>
<code value="28540-3"/>
<display value="MCHC [Mass/volume]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MCHC"/>
</designation>
</concept>
<concept>
<code value="28542-9"/>
<display value="Platelet mean volume [Entitic volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MPV"/>
</designation>
</concept>
<concept>
<code value="2857-1"/>
<display
value="Prostate specific Ag [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PSA"/>
</designation>
</concept>
<concept>
<code value="287-3"/>
<display
value="Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2880-3"/>
<display value="Protein [Mass/volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein CSF"/>
</designation>
</concept>
<concept>
<code value="2881-1"/>
<display value="Protein [Mass/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein body fluid"/>
</designation>
</concept>
<concept>
<code value="2885-2"/>
<display value="Protein [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein"/>
</designation>
</concept>
<concept>
<code value="2888-6"/>
<display value="Protein [Mass/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein urine"/>
</designation>
</concept>
<concept>
<code value="2889-4"/>
<display value="Protein [Mass/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein urine 24h"/>
</designation>
</concept>
<concept>
<code value="2890-2"/>
<display value="Protein/Creatinine [Mass Ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein/creat urine"/>
</designation>
</concept>
<concept>
<code value="2903-3"/>
<display
value="Pyrimidine-5'-Nucleotidase [Enzymatic activity/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyrimidine 5'Nucleotidase"/>
</designation>
</concept>
<concept>
<code value="291-5"/>
<display
value="Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Kanamycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2915-7"/>
<display value="Renin [Enzymatic activity/?volume] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Renin Activity "/>
</designation>
</concept>
<concept>
<code value="29247-4"/>
<display value="Sirolimus [Mass/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sirolimus blood"/>
</designation>
</concept>
<concept>
<code value="29254-0"/>
<display
value="Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Linezolid suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="29257-3"/>
<display
value="Mycoplasma pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="M. pneumoniae DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="29258-1"/>
<display value="Linezolid [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Linezolid suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="29265-6"/>
<display
value="Calcium [Moles/volume] corrected for albumin in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcium (albumin adjusted)"/>
</designation>
</concept>
<concept>
<code value="29300-1"/>
<display value="Procedure type"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sample procedure"/>
</designation>
</concept>
<concept>
<code value="2947-0"/>
<display value="Sodium [Moles/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sodium blood"/>
</designation>
</concept>
<concept>
<code value="2950-4"/>
<display value="Sodium [Moles/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sodium fluid"/>
</designation>
</concept>
<concept>
<code value="2951-2"/>
<display value="Sodium [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sodium"/>
</designation>
</concept>
<concept>
<code value="29520-4"/>
<display
value="5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="5HIAA/creat urine"/>
</designation>
</concept>
<concept>
<code value="29541-0"/>
<display
value="HIV 1 RNA [Log #/volume] (viral load) in Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HIV Viral Load (log#/volume)"/>
</designation>
</concept>
<concept>
<code value="2954-6"/>
<display value="Sodium [Moles/?volume] in Sweat"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sodium sweat"/>
</designation>
</concept>
<concept>
<code value="2955-3"/>
<display value="Sodium [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sodium urine"/>
</designation>
</concept>
<concept>
<code value="29558-4"/>
<display
value="Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Enterovirus RNA (NAAT) CSF"/>
</designation>
</concept>
<concept>
<code value="295-6"/>
<display
value="Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ketoconazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="2956-1"/>
<display value="Sodium [Moles/time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sodium urine 24h"/>
</designation>
</concept>
<concept>
<code value="29577-4"/>
<display value="Fungal susceptibility panel"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fungal susceptibility"/>
</designation>
</concept>
<concept>
<code value="29591-5"/>
<display
value="Enterovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Enterovirus RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="2963-7"/>
<display value="Somatotropin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Growth Hormone"/>
</designation>
</concept>
<concept>
<code value="29652-5"/>
<display value="Dothiepin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dothiepin - mass/volume"/>
</designation>
</concept>
<concept>
<code value="29653-3"/>
<display value="Dothiepin [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dothiepin - moles/volume"/>
</designation>
</concept>
<concept>
<code value="29659-0"/>
<display
value="Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bordetella IgG Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="29660-8"/>
<display
value="Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parvovirus Ab IgG"/>
</designation>
</concept>
<concept>
<code value="29662-4"/>
<display
value="Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Varicella zoster Ab IgM"/>
</designation>
</concept>
<concept>
<code value="29747-3"/>
<display value="Tocopherols [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vitamin E"/>
</designation>
</concept>
<concept>
<code value="29764-8"/>
<display value="Iron [Moles/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iron fluid"/>
</designation>
</concept>
<concept>
<code value="29765-5"/>
<display value="Cholesterol [Moles/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholesterol body fluid"/>
</designation>
</concept>
<concept>
<code value="29766-3"/>
<display value="Triglyceride [Moles/?volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Triglyceride fluid"/>
</designation>
</concept>
<concept>
<code value="29771-3"/>
<display
value="Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Occult blood (human Hb spec) "/>
</designation>
</concept>
<concept>
<code value="29877-8"/>
<display value="Methylmalonate [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methylmalonic Acid - in urine"/>
</designation>
</concept>
<concept>
<code value="29891-9"/>
<display
value="Helicobacter pylori [Presence] in Stomach by urea breath test"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urea Breath Test"/>
</designation>
</concept>
<concept>
<code value="29904-0"/>
<display
value="Toxoplasma gondii DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. gondii (NAAT)"/>
</designation>
</concept>
<concept>
<code value="29908-1"/>
<display
value="Parainfluenza virus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parainfluenza virus 1 RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="29909-9"/>
<display
value="Parainfluenza virus 2 RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parainfluenza virus 2 RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="29910-7"/>
<display
value="Parainfluenza virus 3 RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parainfluenza virus 3 RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="29953-7"/>
<display value="Nuclear Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antinuclear Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="29954-5"/>
<display
value="Extractable nuclear Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ENA screen (EIA)"/>
</designation>
</concept>
<concept>
<code value="299-8"/>
<display
value="Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lincomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="29990-9"/>
<display
value="Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Semen (post vasectomy) (qual)"/>
</designation>
</concept>
<concept>
<code value="30000-4"/>
<display value="Microalbumin/?Creatinine [Ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microalblumin:Creatinine Ratio"/>
</designation>
</concept>
<concept>
<code value="3002-3"/>
<display value="Thiocyanate [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thiocyanate"/>
</designation>
</concept>
<concept>
<code value="3004-9"/>
<display value="Thiocyanate [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thiocyanate urine"/>
</designation>
</concept>
<concept>
<code value="3013-0"/>
<display value="Thyroglobulin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thyroglobulin"/>
</designation>
</concept>
<concept>
<code value="30131-7"/>
<display
value="Complement total hemolytic CH50 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CH50"/>
</designation>
</concept>
<concept>
<code value="3016-3"/>
<display value="Thyrotropin [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="TSH"/>
</designation>
</concept>
<concept>
<code value="30173-9"/>
<display value="Cortisol Free [Moles/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cortisol (free) urine"/>
</designation>
</concept>
<concept>
<code value="30180-4"/>
<display value="Basophils/100 leukocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Basophils (%)"/>
</designation>
</concept>
<concept>
<code value="30206-7"/>
<display
value="Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="hCG (alpha free)"/>
</designation>
</concept>
<concept>
<code value="30246-3"/>
<display
value="Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV DNA (NAAT) (Serum/Plasma)"/>
</designation>
</concept>
<concept>
<code value="30248-9"/>
<display
value="Transferrin receptor.soluble [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Transferrin Receptor - mass/volume"/>
</designation>
</concept>
<concept>
<code value="30298-4"/>
<display value="Lamivudine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lamivudine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30299-2"/>
<display value="Amprenavir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amprenavir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30300-8"/>
<display value="Didanosine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Didanosine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30301-6"/>
<display value="Zalcitabine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Zalcitabine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30302-4"/>
<display value="Stavudine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Stavudine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30303-2"/>
<display value="Abacavir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Abacavir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30304-0"/>
<display value="Adefovir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adefovir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30305-7"/>
<display value="Delavirdine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Delavirdine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30306-5"/>
<display value="Efavirenz [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Efavirenz suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30307-3"/>
<display value="Indinavir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Indinavir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30308-1"/>
<display value="Ritonavir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ritonavir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30309-9"/>
<display value="Nelfinavir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nelfinavir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30310-7"/>
<display value="Saquinavir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Saquinavir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30311-5"/>
<display value="Nevirapine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nevirapine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="30313-1"/>
<display value="Hemoglobin [Mass/?volume] in Arterial blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haemoglobin blood "/>
</designation>
</concept>
<concept>
<code value="30316-4"/>
<display
value="Alpha subunit free [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gonadotrophin Alpha subunit (free)"/>
</designation>
</concept>
<concept>
<code value="30325-5"/>
<display
value="Cytomegalovirus IgM Ab [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV IgM (qual)"/>
</designation>
</concept>
<concept>
<code value="30339-6"/>
<display
value="Epstein Barr virus capsid IgG Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV VCA IgG"/>
</designation>
</concept>
<concept>
<code value="30340-4"/>
<display
value="Epstein Barr virus capsid IgM Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV VCA IgM"/>
</designation>
</concept>
<concept>
<code value="30341-2"/>
<display value="Erythrocyte sedimentation rate"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ESR"/>
</designation>
</concept>
<concept>
<code value="3034-6"/>
<display value="Transferrin [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Transferrin"/>
</designation>
</concept>
<concept>
<code value="30376-8"/>
<display value="Blasts [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blasts"/>
</designation>
</concept>
<concept>
<code value="303-8"/>
<display
value="Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lomefloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="30385-9"/>
<display value="Erythrocyte distribution width [Ratio]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RDW"/>
</designation>
</concept>
<concept>
<code value="30391-7"/>
<display value="Erythrocytes [#/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RBC urine"/>
</designation>
</concept>
<concept>
<code value="30392-5"/>
<display value="Nucleated erythrocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RBC (nucleated)"/>
</designation>
</concept>
<concept>
<code value="30397-4"/>
<display value="Hairy cells [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hairy Cells"/>
</designation>
</concept>
<concept>
<code value="3040-3"/>
<display
value="Lipase [Enzymatic activity/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lipase"/>
</designation>
</concept>
<concept>
<code value="30405-5"/>
<display value="Leukocytes [#/volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="WBC urine"/>
</designation>
</concept>
<concept>
<code value="3041-1"/>
<display value="Trichloroacetate [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trichloroacetic acid urine"/>
</designation>
</concept>
<concept>
<code value="30412-1"/>
<display value="Lymphocytes Abnormal [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphocytes (abnormal)"/>
</designation>
</concept>
<concept>
<code value="30422-0"/>
<display value="Lymphoma cells [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphoma cells"/>
</designation>
</concept>
<concept>
<code value="30428-7"/>
<display value="MCV [Entitic volume]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MCV"/>
</designation>
</concept>
<concept>
<code value="30433-7"/>
<display value="Metamyelocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Metamyelocytes"/>
</designation>
</concept>
<concept>
<code value="30446-9"/>
<display value="Myelocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Myelocytes"/>
</designation>
</concept>
<concept>
<code value="30449-3"/>
<display value="Neutrophils.hypersegmented [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophils (hyperseg)"/>
</designation>
</concept>
<concept>
<code value="30450-1"/>
<display value="Neutrophils.hypersegmented/100 leukocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophils (hyperseg) (%)"/>
</designation>
</concept>
<concept>
<code value="30458-4"/>
<display value="Plasma cells [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Plasma cells"/>
</designation>
</concept>
<concept>
<code value="30464-2"/>
<display value="Prolymphocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Prolymphocytes"/>
</designation>
</concept>
<concept>
<code value="30480-8"/>
<display value="Orotate [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Orotate urine"/>
</designation>
</concept>
<concept>
<code value="30522-7"/>
<display
value="C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CRP (high sensitivity)"/>
</designation>
</concept>
<concept>
<code value="30524-3"/>
<display
value="Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Triglycerides (fasting)"/>
</designation>
</concept>
<concept>
<code value="3056-9"/>
<display value="Trimethylamine [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trimethylamine urine"/>
</designation>
</concept>
<concept>
<code value="307-9"/>
<display
value="Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Loracarbef suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="30894-0"/>
<display value="Aldosterone/?Renin [Ratio] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aldosterone/Renin"/>
</designation>
</concept>
<concept>
<code value="30899-9"/>
<display value="Blood volume by Scintigraphy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blood volume"/>
</designation>
</concept>
<concept>
<code value="30903-9"/>
<display
value="Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophil oxidative burst"/>
</designation>
</concept>
<concept>
<code value="31022-7"/>
<display
value="Filaria identified in Unspecified specimen by Concentration"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Filaria blood (conc)"/>
</designation>
</concept>
<concept>
<code value="31036-7"/>
<display
value="Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gatifloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="31037-5"/>
<display
value="Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxifloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="31038-3"/>
<display value="Gatifloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gatifloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="31039-1"/>
<display value="Moxifloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxifloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="311-1"/>
<display
value="Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymecycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="31146-4"/>
<display value="Reagin Ab [Titer] in Cerebral spinal fluid by VDRL"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VDRL CSF (titre)"/>
</designation>
</concept>
<concept>
<code value="31152-2"/>
<display
value="Immunoglobulin light chains [Presence] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="B-J protein urine 24h (qual)"/>
</designation>
</concept>
<concept>
<code value="31156-3"/>
<display value="Hemoglobin Barts/?Hemoglobin.total in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hb Bart's"/>
</designation>
</concept>
<concept>
<code value="31204-1"/>
<display value="Hepatitis B virus core IgM Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B core IgM"/>
</designation>
</concept>
<concept>
<code value="31208-2"/>
<display value="Specimen source identified"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Specimen type/site"/>
</designation>
</concept>
<concept>
<code value="3129-4"/>
<display value="Menadione [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vitamin K"/>
</designation>
</concept>
<concept>
<code value="31348-6"/>
<display value="DNA double strand Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="DS DNA Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="31418-7"/>
<display value="Heterophile Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Infectious mono screen"/>
</designation>
</concept>
<concept>
<code value="315-2"/>
<display
value="Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Meclocycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3160-9"/>
<display value="Volume of Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Volume semen"/>
</designation>
</concept>
<concept>
<code value="31616-6"/>
<display value="Rubella virus IgM Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rubella IgM (qual)"/>
</designation>
</concept>
<concept>
<code value="31627-3"/>
<display value="Smith extractable nuclear Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Smith extractable nuclear Ab"/>
</designation>
</concept>
<concept>
<code value="3174-0"/>
<display
value="Antithrombin [Units/?volume] in Platelet poor plasma by Chromogenic method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antithrombin - units/volume"/>
</designation>
</concept>
<concept>
<code value="31798-2"/>
<display value="Dengue virus Ag [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dengue virus Ag"/>
</designation>
</concept>
<concept>
<code value="3181-5"/>
<display
value="Cardiolipin IgG Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cardiolipin Ab IgG"/>
</designation>
</concept>
<concept>
<code value="3182-3"/>
<display
value="Cardiolipin IgM Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cardiolipin Ab IgM"/>
</designation>
</concept>
<concept>
<code value="31834-5"/>
<display
value="Haemophilus influenzae B Ag [Presence] in Unspecified specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haemophilus inflenzae B Ag"/>
</designation>
</concept>
<concept>
<code value="31843-6"/>
<display value="Helicobacter pylori Ag [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="H. pylori Ag faeces"/>
</designation>
</concept>
<concept>
<code value="31844-4"/>
<display value="Hepatitis B virus e Ag [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B e Ag"/>
</designation>
</concept>
<concept>
<code value="3185-6"/>
<display
value="Coagulation factor IX inhibitor [Units/?volume] in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor IX Inhibitor assay"/>
</designation>
</concept>
<concept>
<code value="3186-4"/>
<display
value="Coagulation factor IX activated [Units/?volume] in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor IX assay - units/volume"/>
</designation>
</concept>
<concept>
<code value="31868-3"/>
<display value="Legionella pneumophila 1 Ag [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Legionella sero-group 1 Ag (urine)"/>
</designation>
</concept>
<concept>
<code value="31870-9"/>
<display value="Legionella pneumophila Ag [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Legionella Ag (urine)"/>
</designation>
</concept>
<concept>
<code value="3187-2"/>
<display
value="Coagulation factor IX activity actual/?normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor IX assay"/>
</designation>
</concept>
<concept>
<code value="31910-3"/>
<display
value="Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Unspecified specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="N. meningitidis A+?C+?w135+?Y Ag"/>
</designation>
</concept>
<concept>
<code value="31913-7"/>
<display
value="Neisseria meningitidis serogroup B Ag [Presence] in Unspecified specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="N. meningitidis B Ag"/>
</designation>
</concept>
<concept>
<code value="3193-0"/>
<display
value="Coagulation factor V activity actual/?normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor V assay"/>
</designation>
</concept>
<concept>
<code value="319-4"/>
<display
value="Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methacycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="31969-9"/>
<display
value="Streptococcus pneumoniae Ag [Presence] in Unspecified specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pneumococcal Ag"/>
</designation>
</concept>
<concept>
<code value="3198-9"/>
<display
value="Coagulation factor VII activity actual/?normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor VII assay"/>
</designation>
</concept>
<concept>
<code value="32018-4"/>
<display value="Hepatitis A virus IgG Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis A IgG (qual)"/>
</designation>
</concept>
<concept>
<code value="32042-4"/>
<display value="Thyroperoxidase Ab [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thyroid peroxidase Antibody"/>
</designation>
</concept>
<concept>
<code value="3204-5"/>
<display
value="Coagulation factor VIII inhibitor [Units/?volume] in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor VIII inhibitor assay"/>
</designation>
</concept>
<concept>
<code value="3209-4"/>
<display
value="Coagulation factor VIII activity actual/?normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor VIII assay"/>
</designation>
</concept>
<concept>
<code value="32095-2"/>
<display value="Methanol [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methanol urine"/>
</designation>
</concept>
<concept>
<code value="32098-6"/>
<display value="Mexiletine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mexiletine"/>
</designation>
</concept>
<concept>
<code value="3210-2"/>
<display
value="Coagulation factor VIII activity [Units/?volume] in Platelet poor plasma by Chromogenic method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor VIII assay - units/volume"/>
</designation>
</concept>
<concept>
<code value="32117-4"/>
<display value="Thiopental [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thiopentone"/>
</designation>
</concept>
<concept>
<code value="32140-6"/>
<display
value="Hemoglobin F [Presence] in Blood by Kleihauer-Betke method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HbF (qual, Kleihauer)"/>
</designation>
</concept>
<concept>
<code value="3218-5"/>
<display
value="Coagulation factor X activity actual/?normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor X "/>
</designation>
</concept>
<concept>
<code value="32210-7"/>
<display
value="Protein Fractions [interpretation] in 24 hour Urine by Electrophoresis"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Protein urine 24h (elph)"/>
</designation>
</concept>
<concept>
<code value="32217-2"/>
<display
value="von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VWF Multimers"/>
</designation>
</concept>
<concept>
<code value="32218-0"/>
<display
value="Cyclic citrullinated peptide Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CCP Ab"/>
</designation>
</concept>
<concept>
<code value="3226-8"/>
<display
value="Coagulation factor XI activity actual/?normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor XI "/>
</designation>
</concept>
<concept>
<code value="32286-7"/>
<display
value="Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis C genotype "/>
</designation>
</concept>
<concept>
<code value="32294-1"/>
<display value="Albumin/?Creatinine [Ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Albumin:creatinine ratio"/>
</designation>
</concept>
<concept>
<code value="32295-8"/>
<display value="Aluminum [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aluminium urine 24hr"/>
</designation>
</concept>
<concept>
<code value="32-3"/>
<display
value="Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ampicillin Sulb suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="32309-7"/>
<display
value="Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholesterol (total/HDL)"/>
</designation>
</concept>
<concept>
<code value="3232-6"/>
<display
value="Coagulation factor XII activity actual/?normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor XII "/>
</designation>
</concept>
<concept>
<code value="32352-7"/>
<display
value="Alkaline phosphatase.heat stable [Enzymatic activity/volume] in Serum or Plasma by Heat stability"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alk phosphatase (heat stable)"/>
</designation>
</concept>
<concept>
<code value="32356-8"/>
<display
value="Yeast [Presence] in Urine sediment by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Yeasts urine"/>
</designation>
</concept>
<concept>
<code value="323-6"/>
<display
value="Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methicillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="32364-2"/>
<display
value="Herpes virus 8 DNA [Presence] in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Herpes virus 8 DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="32368-3"/>
<display
value="Ureaplasma sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ureaplasma (culture)"/>
</designation>
</concept>
<concept>
<code value="32372-5"/>
<display value="Fleroxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fleroxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32373-3"/>
<display value="Arbekacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Arbekacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32374-1"/>
<display value="Cefotiam [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotiam suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32375-8"/>
<display value="Cefmenoxime [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefmenoxime suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32376-6"/>
<display value="Clinafloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clinafloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32377-4"/>
<display value="Cefetamet [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefetamet suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32378-2"/>
<display value="Caspofungin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Caspofungin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32379-0"/>
<display value="Voriconazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Voriconazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32381-6"/>
<display value="Isepamicin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isepamicin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32383-2"/>
<display value="Pristinamycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pristinamycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32384-0"/>
<display value="Thiacetazone [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thiacetazone suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="3241-7"/>
<display
value="Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor XIII screen"/>
</designation>
</concept>
<concept>
<code value="3243-3"/>
<display value="Thrombin time"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thrombin time"/>
</designation>
</concept>
<concept>
<code value="3244-1"/>
<display
value="Clot Lysis [Time] in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Euglobulin clot lysis time"/>
</designation>
</concept>
<concept>
<code value="32546-4"/>
<display
value="Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="G6PD"/>
</designation>
</concept>
<concept>
<code value="32547-2"/>
<display
value="Ketones [Moles/?volume] in Serum or Plasma by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ketones"/>
</designation>
</concept>
<concept>
<code value="32552-2"/>
<display
value="Pyruvate kinase [Enzymatic activity/mass] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyruvate kinase"/>
</designation>
</concept>
<concept>
<code value="32554-8"/>
<display value="Thiamine [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vitamin B1 blood"/>
</designation>
</concept>
<concept>
<code value="3255-7"/>
<display
value="Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fibrinogen"/>
</designation>
</concept>
<concept>
<code value="32597-7"/>
<display value="Natamycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Natamycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32603-3"/>
<display value="Itraconazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Itraconazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="32610-8"/>
<display
value="Amino acids [Moles/?volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amino Acids CSF (quant)"/>
</designation>
</concept>
<concept>
<code value="32631-4"/>
<display
value="Nitroblue Tetrazolium Test (NBT) [Presence] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="NBT Test"/>
</designation>
</concept>
<concept>
<code value="32637-1"/>
<display value="Urease [Presence] in Tissue"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CLO test"/>
</designation>
</concept>
<concept>
<code value="32654-6"/>
<display
value="6-Methylmercaptopurine [Entitic substance] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="6-Methylmercatopurine"/>
</designation>
</concept>
<concept>
<code value="32660-3"/>
<display
value="6-Thioguanine [Entitic substance] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="6-Thioguanine nucleotides blood"/>
</designation>
</concept>
<concept>
<code value="32661-1"/>
<display value="Adrenal Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adrenal Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="32672-8"/>
<display value="Cold agglutinin [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cold Agglutinin (screen)"/>
</designation>
</concept>
<concept>
<code value="32673-6"/>
<display
value="Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CKMB"/>
</designation>
</concept>
<concept>
<code value="32674-4"/>
<display value="Cryptococcus sp Ag [Titer] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cryptococcus Ag CSF (titre)"/>
</designation>
</concept>
<concept>
<code value="32677-7 "/>
<display
value="DNA double strand Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="DS DNA Ab (EIA)"/>
</designation>
</concept>
<concept>
<code value="32693-4"/>
<display value="Lactate [Moles/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lactate blood"/>
</designation>
</concept>
<concept>
<code value="32709-8"/>
<display value="Neutrophils [#/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophils body fluid"/>
</designation>
</concept>
<concept>
<code value="3271-4"/>
<display
value="LMW Heparin [Units/?volume] in Platelet poor plasma by Chromogenic method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anti Xa"/>
</designation>
</concept>
<concept>
<code value="32724-7"/>
<display
value="Trichomonas sp [Presence] in Urine by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trichomonas urine (microscopy)"/>
</designation>
</concept>
<concept>
<code value="32766-8"/>
<display
value="Trichomonas vaginalis [Presence] in Unspecified specimen by Wet preparation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trichomonas (microscopy)"/>
</designation>
</concept>
<concept>
<code value="327-7"/>
<display
value="Metronidazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Metronidazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="32786-6"/>
<display value="Thyroperoxidase Ab [Titer] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thyroid microsomal Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="32789-0"/>
<display value="Viscosity of Semen Qualitative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Viscosity semen"/>
</designation>
</concept>
<concept>
<code value="3289-6"/>
<display
value="Prothrombin activity actual/?normal in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor II assay"/>
</designation>
</concept>
<concept>
<code value="3299-5"/>
<display value="Acetaminophen [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Paracetamol urine"/>
</designation>
</concept>
<concept>
<code value="33006-8"/>
<display
value="Cytomegalovirus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV Viral load "/>
</designation>
</concept>
<concept>
<code value="33007-6"/>
<display value="Protoporphyrin.zinc [Mass/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Zinc protoporphyrin blood"/>
</designation>
</concept>
<concept>
<code value="33037-3"/>
<display value="Anion gap in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anion gap"/>
</designation>
</concept>
<concept>
<code value="33048-0"/>
<display
value="Eosin-5-Maleimide binding [Presence] in Blood by Flow cytometry (FC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EMA Binding"/>
</designation>
</concept>
<concept>
<code value="331-9"/>
<display
value="Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mezlocillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3319-1"/>
<display value="Amikacin [Mass/volume] in Serum or Plasma --peak"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin peak"/>
</designation>
</concept>
<concept>
<code value="33204-9"/>
<display value="Troponin T.cardiac [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Troponin T (qual)"/>
</designation>
</concept>
<concept>
<code value="33210-6"/>
<display
value="Transferrin receptor.soluble [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Transferrin Receptor - moles/volume"/>
</designation>
</concept>
<concept>
<code value="3321-7"/>
<display value="Amikacin [Mass/volume] in Serum or Plasma --trough"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin trough"/>
</designation>
</concept>
<concept>
<code value="33271-8"/>
<display
value="Microscopic observation [Identifier] in Blood by Malaria thin smear"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Malaria thin blood film"/>
</designation>
</concept>
<concept>
<code value="33288-2"/>
<display
value="Galactose 1 phosphate uridyl transferase [Presence] in DBS"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Galactose 1 phosphate uridyl transferase dried blood spot (qual)"/>
</designation>
</concept>
<concept>
<code value="33295-7"/>
<display
value="JC virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="JC virus (NAAT)"/>
</designation>
</concept>
<concept>
<code value="33313-8"/>
<display value="Rheumatoid factor IgA [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rheumatoid factor IgA"/>
</designation>
</concept>
<concept>
<code value="33314-6"/>
<display value="Rheumatoid factor IgG [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rheumatoid factor IgG"/>
</designation>
</concept>
<concept>
<code value="3333-2"/>
<display value="Amitriptyline [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amitriptyline - mass/volume"/>
</designation>
</concept>
<concept>
<code value="3335-7"/>
<display
value="Amitriptyline+?Nortriptyline [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amitriptyline+Nortriptyline�"/>
</designation>
</concept>
<concept>
<code value="3349-8"/>
<display value="Amphetamines [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amphetamine-type substances, urine"/>
</designation>
</concept>
<concept>
<code value="335-0"/>
<display
value="Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Minocycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="33525-7"/>
<display
value="Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thrombin time (+ N plasma)"/>
</designation>
</concept>
<concept>
<code value="33526-5"/>
<display
value="Reptilase time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reptilase time (+ N plasma)"/>
</designation>
</concept>
<concept>
<code value="33614-9"/>
<display
value="Transferrin.carbohydrate deficient.XXX/Transferrin.total in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carbohydrate Deficient Transferrin "/>
</designation>
</concept>
<concept>
<code value="33617-2"/>
<display value="HLA-DR+? cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="lymphocyte markers - Cells.HLA-DR+"/>
</designation>
</concept>
<concept>
<code value="33627-1"/>
<display value="Tenofovir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tenofovir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="33628-9"/>
<display value="Cidofovir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cidofovir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="33666-9"/>
<display
value="Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dysmorphic RBC urine"/>
</designation>
</concept>
<concept>
<code value="33673-5"/>
<display
value="Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thrombin time (+protamine SO4)"/>
</designation>
</concept>
<concept>
<code value="33721-2"/>
<display value="Bone marrow Pathology biopsy report"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bone marrow trephine"/>
</designation>
</concept>
<concept>
<code value="33723-8"/>
<display value="Specimen length "/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Size"/>
</designation>
</concept>
<concept>
<code value="33725-3"/>
<display value="Tumor site"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tumour site"/>
</designation>
</concept>
<concept>
<code value="33728-7"/>
<display value="Size.maximum dimension in Tumor"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Width of tumour"/>
</designation>
</concept>
<concept>
<code value="33732-9"/>
<display value=" Histology grade [Identifier] in Cancer specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Histological grade (tumour differentiation)"/>
</designation>
</concept>
<concept>
<code value="33739-4"/>
<display
value="Lymphatic.small vessel.invasion [Identifier] in Specimen by CAP cancer protocols"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphatic invasion"/>
</designation>
</concept>
<concept>
<code value="33748-5"/>
<display value="Distance from anal verge"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Distance from anal verge"/>
</designation>
</concept>
<concept>
<code value="33763-4"/>
<display
value="Natriuretic peptide.B prohormone N-Terminal [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ProBNP"/>
</designation>
</concept>
<concept>
<code value="3377-9"/>
<display value="Barbiturates [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Barbiturate urine"/>
</designation>
</concept>
<concept>
<code value="33783-2"/>
<display value="Atrial natriuretic factor [Moles/?volume] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Atrial Naturietic Peptide"/>
</designation>
</concept>
<concept>
<code value="33824-4"/>
<display value="Iron [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iron urine"/>
</designation>
</concept>
<concept>
<code value="33872-3"/>
<display value="Cystine [Moles/?mass] in Leukocytes"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cystine (WBC) blood"/>
</designation>
</concept>
<concept>
<code value="33899-6"/>
<display
value="Bilirubin.conjugated+?indirect [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bilirubin neonatal"/>
</designation>
</concept>
<concept>
<code value="3390-2"/>
<display value="Benzodiazepines [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Benzodiazepine urine"/>
</designation>
</concept>
<concept>
<code value="339-2"/>
<display
value="Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Miocamycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3393-6"/>
<display value="Benzoylecgonine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Benzoylecgonine urine"/>
</designation>
</concept>
<concept>
<code value="33941-6"/>
<display
value="Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Herpes virus 6 DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="33944-0"/>
<display
value="Lambda light chains.free [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Immunoglobulin Light Chains lambda (free)"/>
</designation>
</concept>
<concept>
<code value="33950-7"/>
<display value="Magnesium/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Magnesium/creatinine urine"/>
</designation>
</concept>
<concept>
<code value="33959-8"/>
<display value="Procalcitonin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Procalcitonin"/>
</designation>
</concept>
<concept>
<code value="3397-7"/>
<display value="Cocaine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cocaine urine"/>
</designation>
</concept>
<concept>
<code value="3-4"/>
<display
value="Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Almecillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3414-0"/>
<display value="Buprenorphine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Buprenorphine urine"/>
</designation>
</concept>
<concept>
<code value="34235-2"/>
<display value="Amylase/Creatinine [Ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amylase/creat urine"/>
</designation>
</concept>
<concept>
<code value="34268-3"/>
<display value="Cobalt [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cobalt urine"/>
</designation>
</concept>
<concept>
<code value="34304-6"/>
<display value="Fluoride [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fluoride urine"/>
</designation>
</concept>
<concept>
<code value="34320-2"/>
<display value="Iodine [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iodine urine - moles/volume"/>
</designation>
</concept>
<concept>
<code value="34338-4"/>
<display value="Mercury [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mercury urine"/>
</designation>
</concept>
<concept>
<code value="343-4"/>
<display
value="Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxalactam suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="34343-4"/>
<display value="Nickel [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nickel urine"/>
</designation>
</concept>
<concept>
<code value="34350-9"/>
<display value="Oxalate/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxalate/creat urine"/>
</designation>
</concept>
<concept>
<code value="34357-4"/>
<display value="Porphobilinogen/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphobilinogen/creat urine"/>
</designation>
</concept>
<concept>
<code value="34375-6"/>
<display value="Streptokinase Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Streptokinase Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="34382-2"/>
<display
value="Treponema pallidum Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. pallidum Ab (IF)"/>
</designation>
</concept>
<concept>
<code value="34385-5"/>
<display value="Urate/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urate/creatinine urine"/>
</designation>
</concept>
<concept>
<code value="34387-1"/>
<display value="Zinc [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Zinc urine"/>
</designation>
</concept>
<concept>
<code value="34413-5"/>
<display value="Moclobemide [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moclobemide"/>
</designation>
</concept>
<concept>
<code value="34487-9"/>
<display
value="Influenza virus A RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Influenza A RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="3453-8"/>
<display value="Cephalexin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cephalexin"/>
</designation>
</concept>
<concept>
<code value="34571-0"/>
<display value="aPTT.lupus sensitive (LA screen)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="aPTT.lupus sensitive"/>
</designation>
</concept>
<concept>
<code value="34594-2"/>
<display value="Schistosoma sp Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Schistosomal Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="34615-5"/>
<display
value="Iron.microscopic observation [Identifier] in Blood by Potassium ferrocyanide stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iron stain blood"/>
</designation>
</concept>
<concept>
<code value="34616-3"/>
<display value="Amino acids [Identifier] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amino acids CSF (ident)"/>
</designation>
</concept>
<concept>
<code value="34628-8"/>
<display
value="Methotrexate [Moles/?volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methotrexate CSF"/>
</designation>
</concept>
<concept>
<code value="34645-2"/>
<display
value="Chlamydophila pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C. pneumoniae DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="34701-3"/>
<display value="Heparin induced platelet AB [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HITS"/>
</designation>
</concept>
<concept>
<code value="34713-8"/>
<display
value="Clostridioides difficile toxin A+B [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cl. difficile toxin faeces"/>
</designation>
</concept>
<concept>
<code value="34717-9"/>
<display
value="Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Coxiella Ab"/>
</designation>
</concept>
<concept>
<code value="3472-8"/>
<display value="Chlorpromazine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chlorpromazine urine"/>
</designation>
</concept>
<concept>
<code value="347-5"/>
<display
value="Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nafcillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3491-8"/>
<display value="Clomipramine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clomipramine - mass/volume"/>
</designation>
</concept>
<concept>
<code value="34918-3"/>
<display value="Sezary cells [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sezary Cells"/>
</designation>
</concept>
<concept>
<code value="34926-6"/>
<display value="Promonocytes [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Promonocytes"/>
</designation>
</concept>
<concept>
<code value="3493-4"/>
<display
value="Clomipramine+?Norclomipramine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clomipramine+Norclomipramine�- mass/volume"/>
</designation>
</concept>
<concept>
<code value="34993-6"/>
<display value="Smudge cells [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Smear cells"/>
</designation>
</concept>
<concept>
<code value="35026-4"/>
<display value="Monocytes [#/volume] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Monocytes CSF"/>
</designation>
</concept>
<concept>
<code value="35039-7"/>
<display value="Lymphocytes Plasmacytoid [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphocytes (plasmacytoid)"/>
</designation>
</concept>
<concept>
<code value="3507-1"/>
<display value="Codeine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Codeine urine"/>
</designation>
</concept>
<concept>
<code value="35076-9"/>
<display value="Monocytes [#/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Monocytes body fluid"/>
</designation>
</concept>
<concept>
<code value="35082-7"/>
<display value="Lymphocytes Large Granular [#/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphocytes (large granular)"/>
</designation>
</concept>
<concept>
<code value="35112-2"/>
<display value="Floxacillin [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Flucloxacillin"/>
</designation>
</concept>
<concept>
<code value="351-7"/>
<display
value="Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nalidixate suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3520-4"/>
<display value="Cyclosporine [Mass/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cyclosporin blood"/>
</designation>
</concept>
<concept>
<code value="35275-7"/>
<display
value="Measles virus IgG Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Measles IgG"/>
</designation>
</concept>
<concept>
<code value="35276-5"/>
<display
value="Measles virus IgM Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Measles IgM"/>
</designation>
</concept>
<concept>
<code value="35279-9"/>
<display
value="Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophil cytoplasmic Ab"/>
</designation>
</concept>
<concept>
<code value="35280-7"/>
<display
value="Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="TTG Ab IgA (qual)"/>
</designation>
</concept>
<concept>
<code value="3531-1"/>
<display value="Desipramine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Desipramine - mass/volume"/>
</designation>
</concept>
<concept>
<code value="35352-4"/>
<display
value="Mycobacterium tuberculosis genotype [Identifier] in Isolate"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="M. TB (genotype)"/>
</designation>
</concept>
<concept>
<code value="3548-5"/>
<display value="Diazepam [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Diazepam"/>
</designation>
</concept>
<concept>
<code value="35491-0"/>
<display
value="Leptospira sp DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Leptospira DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="3550-1"/>
<display value="Diazepam [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Diazepam urine"/>
</designation>
</concept>
<concept>
<code value="35570-1"/>
<display value="Renin [Mass/?volume] in Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Renin"/>
</designation>
</concept>
<concept>
<code value="355-8"/>
<display
value="Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35668-3"/>
<display value="Gentamicin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gentamicin"/>
</designation>
</concept>
<concept>
<code value="35670-9"/>
<display value="Tobramycin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tobramycin"/>
</designation>
</concept>
<concept>
<code value="35698-0"/>
<display value="Metformin [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MetFORMIN [Mass/Vol]"/>
</designation>
</concept>
<concept>
<code value="35745-9"/>
<display value="Fat/?Total solids [Mass Ratio] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Steatocrit faeces"/>
</designation>
</concept>
<concept>
<code value="35755-8"/>
<display
value="Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Avilamycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35756-6"/>
<display value="Avilamycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Avilamycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35761-6"/>
<display
value="Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefditoren suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35762-4"/>
<display value="Cefditoren [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefditoren suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35765-7"/>
<display
value="Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefetamet suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35770-7"/>
<display
value="Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotaxime Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35771-5"/>
<display value="Cefotaxime+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotaxime Clav suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35773-1"/>
<display
value="Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotiam suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35775-6"/>
<display
value="Ceftazidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftazidime Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35776-4"/>
<display value="Ceftazidime+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftazidime Clav suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35778-0"/>
<display
value="Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftibuten suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35779-8"/>
<display value="Ceftibuten [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftibuten suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35781-4"/>
<display
value="Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftiofur suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35783-0"/>
<display value="Cefuroxime Oral [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefuroxime oral suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35786-3"/>
<display
value="Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clinafloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35788-9"/>
<display
value="Daptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Daptomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35789-7"/>
<display value="Daptomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Daptomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="3579-0"/>
<display value="Doxepin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Doxepin - mass/volume"/>
</designation>
</concept>
<concept>
<code value="35791-3"/>
<display
value="Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Difloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35792-1"/>
<display value="Difloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Difloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35794-7"/>
<display
value="Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dirithromycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35795-4"/>
<display value="Dirithromycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dirithromycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35798-8"/>
<display
value="Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Enrofloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35801-0"/>
<display
value="Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ertapenem suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35802-8"/>
<display value="Ertapenem [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ertapenem suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35804-4"/>
<display
value="Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bambermycins suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35805-1"/>
<display value="Bambermycins [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bambermycins suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35808-5"/>
<display
value="Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Florfenicol suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35812-7"/>
<display
value="Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Garenoxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35813-5"/>
<display value="Garenoxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Garenoxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35815-0"/>
<display
value="Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gemifloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35816-8"/>
<display value="Gemifloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gemifloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35821-8"/>
<display
value="Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isepamicin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35823-4"/>
<display
value="Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mupirocin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35826-7"/>
<display
value="Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Orbifloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35827-5"/>
<display value="Orbifloxacin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Orbifloxacin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35830-9"/>
<display
value="Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pirlimycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35831-7"/>
<display value="Pirlimycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pirlimycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35834-1"/>
<display
value="Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pristinamycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35837-4"/>
<display
value="Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Salinomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35838-2"/>
<display value="Salinomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Salinomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35844-0"/>
<display
value="Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Telithromycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35845-7"/>
<display value="Telithromycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Telithromycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35847-3"/>
<display
value="Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tiamulin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35848-1"/>
<display value="Tiamulin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tiamulin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35850-7"/>
<display
value="Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tilmicosin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35851-5"/>
<display value="Tilmicosin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tilmicosin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35853-1"/>
<display
value="Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trospectinomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35854-9"/>
<display value="Trospectinomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trospectinomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35857-2"/>
<display
value="Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tylosin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35858-0"/>
<display value="Tylosin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tylosin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35860-6"/>
<display
value="Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Virginiamycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="35861-4"/>
<display value="Virginiamycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Virginiamycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="35863-0"/>
<display
value="Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Voriconazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="359-0"/>
<display
value="Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Netilmicin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="363-2"/>
<display
value="Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nitrofurantoin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="36-4"/>
<display
value="Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Azithromycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3644-2"/>
<display value="Fluoxetine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fluoxetine"/>
</designation>
</concept>
<concept>
<code value="3663-2"/>
<display value="Gentamicin [Mass/volume] in Serum or Plasma --peak"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gentamicin peak"/>
</designation>
</concept>
<concept>
<code value="3665-7"/>
<display
value="Gentamicin [Mass/volume] in Serum or Plasma --trough"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gentamicin trough"/>
</designation>
</concept>
<concept>
<code value="367-3"/>
<display
value="Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Norfloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="36903-3"/>
<display
value="Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lymphogranuloma venerum DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="3690-5"/>
<display value="Imipramine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Imipramine - mass/volume"/>
</designation>
</concept>
<concept>
<code value="36916-5"/>
<display value="Kappa light chains.free [Mass/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Immunoglobulin Light Chains kappa (free)"/>
</designation>
</concept>
<concept>
<code value="36921-5"/>
<display
value="Herpes simplex virus 1+?2 IgG Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV Ab (Type 1 and 2)"/>
</designation>
</concept>
<concept>
<code value="371-5"/>
<display
value="Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Novobiocin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="375-6"/>
<display
value="Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ofloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3772-1"/>
<display value="Methadone [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methadone - mass/volume"/>
</designation>
</concept>
<concept>
<code value="3773-9"/>
<display value="Methadone [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methadone urine"/>
</designation>
</concept>
<concept>
<code value="379-8"/>
<display
value="Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oleandomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="38180-6"/>
<display
value="Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis C Viral Load (logIU/mL)"/>
</designation>
</concept>
<concept>
<code value="3827-3"/>
<display value="Morphine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Morphine"/>
</designation>
</concept>
<concept>
<code value="383-0"/>
<display
value="Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxacillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3830-7"/>
<display value="Morphine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Morphine urine"/>
</designation>
</concept>
<concept>
<code value="38370-3"/>
<display value="Voriconazole [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Voriconazole"/>
</designation>
</concept>
<concept>
<code value="38379-4"/>
<display
value="Mycobacterium tuberculosis complex DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mycobacterium complexDNA (NAAT) "/>
</designation>
</concept>
<concept>
<code value="38387-7"/>
<display value="C3 nephritic factor [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C3 nephritic factor"/>
</designation>
</concept>
<concept>
<code value="38445-3"/>
<display value="Calprotectin [Mass/?mass] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calprotectin faeces"/>
</designation>
</concept>
<concept>
<code value="38504-7"/>
<display
value="Thyroglobulin Ab [Titer] in Serum by Immunoflourescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thyroglob Ab Titr Ser IF"/>
</designation>
</concept>
<concept>
<code value="3862-0"/>
<display value="Nordoxepin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nordoxepin - mass/volume"/>
</designation>
</concept>
<concept>
<code value="387-1"/>
<display
value="Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxytetracycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3872-9"/>
<display value="Nortriptyline [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nortriptyline - mass/volume"/>
</designation>
</concept>
<concept>
<code value="3879-4"/>
<display value="Opiates [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Opiates urine"/>
</designation>
</concept>
<concept>
<code value="38917-1"/>
<display
value="Human metapneumovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Metapneumovirus (NAAT)"/>
</designation>
</concept>
<concept>
<code value="3893-5"/>
<display value="Oxycodone [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oxycodone"/>
</designation>
</concept>
<concept>
<code value="390-5"/>
<display
value="Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pefloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="392-1"/>
<display
value="Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Penicillin G suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="3924-8"/>
<display value="Pentobarbital [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pentobarbitone"/>
</designation>
</concept>
<concept>
<code value="39354-6"/>
<display
value="Cholinesterase in Serum or Plasma --dibucaine/Cholinesterase"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholinesterase phenotype"/>
</designation>
</concept>
<concept>
<code value="3936-2"/>
<display value="Phencyclidine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phencyclidine urine"/>
</designation>
</concept>
<concept>
<code value="39469-2"/>
<display
value="Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholesterol (LDL) (calculated)"/>
</designation>
</concept>
<concept>
<code value="39528-5"/>
<display
value="Adenovirus DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adenovirus DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="39536-8"/>
<display
value="Influenza virus A Ab [Units/?volume] in Serum by Complement fixation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Influenza A Ab"/>
</designation>
</concept>
<concept>
<code value="396-2"/>
<display
value="Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Penicillin V suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="39771-1"/>
<display value="Porphyrins [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphyrins urine"/>
</designation>
</concept>
<concept>
<code value="39774-5"/>
<display value="Porphyrins [Moles/?mass] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphyrins faeces"/>
</designation>
</concept>
<concept>
<code value="39782-8"/>
<display
value="Delta aminolevulinate/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ALA/creatinine urine"/>
</designation>
</concept>
<concept>
<code value="39784-4"/>
<display value="Porphyrins [Moles/?volume] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphyrin RBC"/>
</designation>
</concept>
<concept>
<code value="39798-4"/>
<display value="Warfarin [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Warfarin"/>
</designation>
</concept>
<concept>
<code value="400-2"/>
<display
value="Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Phenethicillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="4020-4"/>
<display value="Quinine [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Quinine - presence"/>
</designation>
</concept>
<concept>
<code value="4023-8"/>
<display value="Salicylates [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Salicylate -presence"/>
</designation>
</concept>
<concept>
<code value="4025-3"/>
<display value="Salicylates [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Salicylate urine"/>
</designation>
</concept>
<concept>
<code value="40417-8"/>
<display value="Chromium [Moles/?time] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chromium urine 24hr"/>
</designation>
</concept>
<concept>
<code value="404-4"/>
<display
value="Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pipemidate suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="40440-0"/>
<display
value="XXX microorganism serotype [Identifier] in Isolate by Agglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Micro-organism (serotyping)"/>
</designation>
</concept>
<concept>
<code value="40498-8"/>
<display
value="Yersinia enterocolitica Ab [Titer] in Serum by Agglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Yersinia Ab"/>
</designation>
</concept>
<concept>
<code value="4057-6"/>
<display value="Tobramycin [Mass/volume] in Serum or Plasma --peak"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tobramycin peak"/>
</designation>
</concept>
<concept>
<code value="4059-2"/>
<display
value="Tobramycin [Mass/volume] in Serum or Plasma --trough"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tobramycin trough"/>
</designation>
</concept>
<concept>
<code value="40-6"/>
<display
value="Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Azlocillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="40614-0"/>
<display value="Brucella sp Ab [Presence] in Serum by Agglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Brucella sp Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="40658-7"/>
<display
value="Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parvovirus Ab IgM"/>
</designation>
</concept>
<concept>
<code value="40674-4"/>
<display
value="Toxocara canis IgG Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Toxocara Ab IgG"/>
</designation>
</concept>
<concept>
<code value="40727-0"/>
<display
value="Hepatitis D virus Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis D Ab"/>
</designation>
</concept>
<concept>
<code value="40745-2"/>
<display value="Filaria identified in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Filaria blood"/>
</designation>
</concept>
<concept>
<code value="40768-4"/>
<display value="Cryptococcus sp Ag [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cryptococcus Ag (titre)"/>
</designation>
</concept>
<concept>
<code value="408-5"/>
<display
value="Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Piperacillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="4092-3"/>
<display
value="Vancomycin [Mass/volume] in Serum or Plasma --trough"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vancomycin trough"/>
</designation>
</concept>
<concept>
<code value="40958-1"/>
<display value="Cryptosporidium parvum identified in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cryptosporidium identification faeces"/>
</designation>
</concept>
<concept>
<code value="40982-1"/>
<display
value="Influenza virus B RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Influenza B RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="40988-8"/>
<display
value="Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RSV (NAAT)"/>
</designation>
</concept>
<concept>
<code value="41001-9"/>
<display
value="Human coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Coronavirus RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="41010-0"/>
<display
value="Parainfluenza virus 4 RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parainfluenza virus 4 RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="41163-7"/>
<display
value="Treponema pallidum DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. pallidum (NAAT) "/>
</designation>
</concept>
<concept>
<code value="41171-0"/>
<display
value="Collagen crosslinked C-telopeptide [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C- Telopeptide"/>
</designation>
</concept>
<concept>
<code value="412-7"/>
<display
value="Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Piperacillin Tazob suscep MIC"/>
</designation>
</concept>
<concept>
<code value="41479-7"/>
<display
value="BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="BK virus (NAAT)"/>
</designation>
</concept>
<concept>
<code value="41499-5"/>
<display
value="Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Legionella sero-group 1 Ag (urine) (EIA)"/>
</designation>
</concept>
<concept>
<code value="41647-9"/>
<display
value="Carbon dioxide, total [Moles/?volume] in Arterial blood by calculation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CO2 blood ( total) In Arterial blood"/>
</designation>
</concept>
<concept>
<code value="41662-8"/>
<display
value="Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aztreonam Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41665-1"/>
<display
value="Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Biapenem suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41672-7"/>
<display
value="Cefotetan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotetan Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41675-0"/>
<display
value="Cefoxitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefoxitin Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41679-2"/>
<display
value="Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefpodoxime Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="416-8"/>
<display
value="Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pivampicillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41681-8"/>
<display
value="Ceftriaxone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftriaxone Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41687-5"/>
<display
value="Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clavulanate suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41689-1"/>
<display
value="Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dalbavancin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41694-1"/>
<display
value="Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Everninomicin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41708-9"/>
<display
value="Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oritavancin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41710-5"/>
<display
value="Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ramoplanin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41713-9"/>
<display
value="Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rosamicin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41718-8"/>
<display
value="Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulbactam suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41721-2"/>
<display
value="Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tazobactam suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41725-3"/>
<display
value="Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thiamphenicol suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="41727-9"/>
<display value="Aztreonam+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aztreonam Clav suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41728-7"/>
<display value="Biapenem [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Biapenem suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41729-5"/>
<display value="Cefotetan+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefotetan Clav suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41730-3"/>
<display value="Cefoxitin+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefoxitin Clav suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41731-1"/>
<display value="Cefpodoxime+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefpodoxime Clav suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41732-9"/>
<display value="Ceftriaxone+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftriaxone Clav suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41733-7"/>
<display value="Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clavulanate suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41734-5"/>
<display value="Dalbavancin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dalbavancin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41735-2"/>
<display value="Everninomicin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Everninomicin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41736-0"/>
<display value="Oritavancin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Oritavancin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41737-8"/>
<display value="Ramoplanin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ramoplanin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41738-6"/>
<display value="Rosamicin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rosamicin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41739-4"/>
<display value="Sulbactam [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulbactam suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41740-2"/>
<display value="Tazobactam [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tazobactam suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="41853-3"/>
<display
value="Orthopoxvirus DNA [Presence] in Specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Orthopoxvirus DNA NAA+probe Ql (Specimen)"/>
</designation>
</concept>
<concept>
<code value="41858-2"/>
<display
value="2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EDDP urine"/>
</designation>
</concept>
<concept>
<code value="41984-6"/>
<display value="Lipoprotein analysis status/?results Set CPHS"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lipid Interpretation"/>
</designation>
</concept>
<concept>
<code value="41993-7"/>
<display value="Atazanavir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Atazanavir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="420-0"/>
<display
value="Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Polymyxin B suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="42180-0"/>
<display
value="C peptide [Moles/?volume] in Serum or Plasma --fasting"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C-Peptide "/>
</designation>
</concept>
<concept>
<code value="42200-6"/>
<display
value="DNA double strand Ab [Units/?volume] in Serum by Radioimmunoassay (RIA)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="DS DNA Ab (RIA)"/>
</designation>
</concept>
<concept>
<code value="42217-0"/>
<display value="Striated muscle IgG Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Skeletal muscle Ab"/>
</designation>
</concept>
<concept>
<code value="42219-6"/>
<display value="Chromium [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chromium urine"/>
</designation>
</concept>
<concept>
<code value="42221-2"/>
<display value="Manganese [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Manganese urine - moles/volume"/>
</designation>
</concept>
<concept>
<code value="42247-7"/>
<display
value="Hemoglobin pattern [interpretation] in Blood by HPLC Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HPLC Chromatogram"/>
</designation>
</concept>
<concept>
<code value="42330-1"/>
<display
value="Bordetella pertussis IgG Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bordetella IgG Ab"/>
</designation>
</concept>
<concept>
<code value="42351-7"/>
<display
value="Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefepime Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="42353-3"/>
<display value="Cefepime+Clavulanate [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefepime Clavu suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="42355-8"/>
<display
value="Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tigecycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="42357-4"/>
<display value="Tigecycline [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tigecycline suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="424-2"/>
<display
value="Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyrazinamide suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="42535-5"/>
<display value="Tipranavir [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tipranavir suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="42595-9"/>
<display
value="Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B Viral Load (IU/mL)"/>
</designation>
</concept>
<concept>
<code value="42807-8"/>
<display value="Parasite identified in Isolate"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parasite (ident)"/>
</designation>
</concept>
<concept>
<code value="428-3"/>
<display
value="Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rifampin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="43092-6"/>
<display value="Arbovirus NOS Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Arbovirus Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="43180-9"/>
<display
value="Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV Ab (Type 2)"/>
</designation>
</concept>
<concept>
<code value="43198-1"/>
<display
value="Gamma hydroxybutyrate [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gamma hydroxybutyrate urine - mass/volume"/>
</designation>
</concept>
<concept>
<code value="432-5"/>
<display
value="Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ristocetin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="43271-6"/>
<display
value="Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftobiprole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="43272-4"/>
<display value="Ceftobiprole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ceftobiprole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="43279-9"/>
<display
value="Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B virus mutation"/>
</designation>
</concept>
<concept>
<code value="43583-4"/>
<display value="Lipoprotein a [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lipoprotein (a) - moles/volume"/>
</designation>
</concept>
<concept>
<code value="43590-9"/>
<display
value="Rabies virus Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rabies Ab"/>
</designation>
</concept>
<concept>
<code value="436-6"/>
<display
value="Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rolitetracycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="43913-3"/>
<display
value="Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bordetella DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="43979-4"/>
<display
value="Aspergillus sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aspergillus culture"/>
</designation>
</concept>
<concept>
<code value="440-8"/>
<display
value="Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rosoxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="44357-2"/>
<display
value="Galactomannan Ag [Units/?volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Galactomannan Ag"/>
</designation>
</concept>
<concept>
<code value="444-0"/>
<display
value="Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Roxithromycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="44448-9"/>
<display
value="Beta 2 glycoprotein 1 IgG Ab [Units/?volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Beta-2-Glycoprotein 1 antibodies"/>
</designation>
</concept>
<concept>
<code value="44534-6"/>
<display value="HLA Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HLA Antibodies (qual)"/>
</designation>
</concept>
<concept>
<code value="4476-8"/>
<display
value="Complement C1 esterase inhibitor.functional [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C1 Inhibitor function"/>
</designation>
</concept>
<concept>
<code value="4477-6"/>
<display
value="Complement C1 esterase inhibitor [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C1 inhibitor"/>
</designation>
</concept>
<concept>
<code value="44798-7"/>
<display
value="Burkholderia sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Burkholderia (culture)"/>
</designation>
</concept>
<concept>
<code value="44-8"/>
<display
value="Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aztreonam suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="448-1"/>
<display
value="Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sisomicin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="4484-2"/>
<display value="Complement C2 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C2"/>
</designation>
</concept>
<concept>
<code value="4485-9"/>
<display value="Complement C3 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C3"/>
</designation>
</concept>
<concept>
<code value="44918-1"/>
<display value="Dopamine/Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dopamine/creat urine 24h"/>
</designation>
</concept>
<concept>
<code value="44924-9"/>
<display
value="Normetanephrine/?Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Normetanephrine/creat urine 24h"/>
</designation>
</concept>
<concept>
<code value="4498-2"/>
<display value="Complement C4 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C4"/>
</designation>
</concept>
<concept>
<code value="4505-4"/>
<display value="Complement C5 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C5"/>
</designation>
</concept>
<concept>
<code value="4507-0"/>
<display value="Complement C6 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C6"/>
</designation>
</concept>
<concept>
<code value="4508-8"/>
<display value="Complement C7 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C7"/>
</designation>
</concept>
<concept>
<code value="4509-6"/>
<display value="Complement C8 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C8"/>
</designation>
</concept>
<concept>
<code value="4510-4"/>
<display value="Complement C9 [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C9"/>
</designation>
</concept>
<concept>
<code value="4519-5"/>
<display
value="Complement factor H [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Factor H, I, CD46 Complement [Complement Factor H]"/>
</designation>
</concept>
<concept>
<code value="452-3"/>
<display
value="Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Spectinomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="45323-3"/>
<display
value="Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tuberculin test (interferon)"/>
</designation>
</concept>
<concept>
<code value="45335-7"/>
<display
value="Bacteria Identification [Presence] in Isolate by Culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Micro-organism (ident)"/>
</designation>
</concept>
<concept>
<code value="4542-7"/>
<display value="Haptoglobin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haptoglobin"/>
</designation>
</concept>
<concept>
<code value="4548-4"/>
<display value="Hemoglobin A1c/Hemoglobin.total in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HbA1c"/>
</designation>
</concept>
<concept>
<code value="4551-8"/>
<display value="Hemoglobin A2/Hemoglobin.total in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HbA2"/>
</designation>
</concept>
<concept>
<code value="456-4"/>
<display
value="Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Spiramycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="4576-5"/>
<display value="Hemoglobin F/Hemoglobin.total in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HbF"/>
</designation>
</concept>
<concept>
<code value="460-6"/>
<display
value="Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Streptomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="46094-9"/>
<display value="Plasmodium sp Ag [Presence] in Blood by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Malaria Ag (EIA)"/>
</designation>
</concept>
<concept>
<code value="46126-9"/>
<display
value="Endomysium IgA Ab [Presence] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Endomysial Ab IgA"/>
</designation>
</concept>
<concept>
<code value="46127-7"/>
<display
value="Haptoglobin [Mass/volume] in Serum or Plasma by Nephelometry"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haptoglobin by Nephelometry"/>
</designation>
</concept>
<concept>
<code value="46128-5"/>
<display
value="Tissue transglutaminase IgA Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="TTG Ab IgA"/>
</designation>
</concept>
<concept>
<code value="46130-1"/>
<display
value="Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pre albumin"/>
</designation>
</concept>
<concept>
<code value="46218-4"/>
<display value="5-Fluorocytosine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Flucytosine"/>
</designation>
</concept>
<concept>
<code value="46266-3"/>
<display
value="Myeloperoxidase Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Myeloperoxidase Ab"/>
</designation>
</concept>
<concept>
<code value="46267-1"/>
<display
value="Proteinase 3 Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Proteinase 3 Ab"/>
</designation>
</concept>
<concept>
<code value="46268-9"/>
<display
value="ABO +? Rh group [Type] in Blood from Blood product unit--after transfusion reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ABO +? Rh Group (Blood Product Post Tx Rxn)"/>
</designation>
</concept>
<concept>
<code value="46270-5"/>
<display
value="ABO group [Type] in Blood--after transfusion reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ABO Group (Post Tx Rxn)"/>
</designation>
</concept>
<concept>
<code value="46271-3"/>
<display
value="Blood group antibody screen [Presence] in Serum or Plasma --after transfusion reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blood Group Ab (screen Post Tx Rxn)"/>
</designation>
</concept>
<concept>
<code value="46272-1"/>
<display value="Appearance of Urine--after transfusion reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Appearance Urine (Post Tx Rxn)"/>
</designation>
</concept>
<concept>
<code value="46273-9"/>
<display value="Appearance of Serum--after transfusion reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Appearance Serum (Post Tx Rxn)"/>
</designation>
</concept>
<concept>
<code value="46274-7"/>
<display
value="Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells --after transfusion reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="AHG (direct, polyspecific Post Tx Rxn)"/>
</designation>
</concept>
<concept>
<code value="46276-2"/>
<display value="Rh [Type] in Blood--after transfusion reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rh Group (Post Tx Rxn)"/>
</designation>
</concept>
<concept>
<code value="4633-4"/>
<display
value="Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HbF (Kleihauer)"/>
</designation>
</concept>
<concept>
<code value="4639-1"/>
<display value="Unstable Hemoglobin [Presence] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hb (unstable)"/>
</designation>
</concept>
<concept>
<code value="4644-1"/>
<display value="Hemosiderin [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haemosiderin"/>
</designation>
</concept>
<concept>
<code value="464-8"/>
<display
value="Sulfadiazine [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulfadiazine suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="4679-7"/>
<display value="Reticulocytes/100 erythrocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reticulocytes (%)"/>
</designation>
</concept>
<concept>
<code value="4685-4"/>
<display value="Sulfhemoglobin/Hemoglobin.total in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulphaemoglobin"/>
</designation>
</concept>
<concept>
<code value="468-9"/>
<display
value="Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulfamethoxazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="4691-2"/>
<display value="Viscosity of Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Viscosity"/>
</designation>
</concept>
<concept>
<code value="47092-2"/>
<display
value="Natriuretic peptide B [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="BNP"/>
</designation>
</concept>
<concept>
<code value="472-1"/>
<display
value="Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulfisoxazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="47255-5"/>
<display
value="Procollagen type I.N-terminal propeptide [Mass/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Procollagen"/>
</designation>
</concept>
<concept>
<code value="47299-3"/>
<display
value="DNA double strand Ab [Units/?volume] in Serum by Farr method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="DS DNA Ab (Farr)"/>
</designation>
</concept>
<concept>
<code value="47309-0"/>
<display
value="Haemophilus influenzae B IgG Ab [Ratio] in Serum --2nd specimen/?1st specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="H Influenza Type2 vaccine response"/>
</designation>
</concept>
<concept>
<code value="47393-4"/>
<display
value="Gliadin peptide IgA Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="DGP/MGP Ab IgA"/>
</designation>
</concept>
<concept>
<code value="47394-2"/>
<display
value="Gliadin peptide IgG Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gliadin peptide"/>
</designation>
</concept>
<concept>
<code value="47532-7"/>
<display
value="Mumps virus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mumps RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="47545-9"/>
<display
value="5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="5HIAA/creat urine 24h"/>
</designation>
</concept>
<concept>
<code value="47596-2"/>
<display
value="Calcium.ionized [Moles/?volume] in Blood by Ion-selective membrane electrode (ISE)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcium ( ionised) blood"/>
</designation>
</concept>
<concept>
<code value="476-2"/>
<display
value="Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulfonamide suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="47828-9"/>
<display value="Adiponectin [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adiponectin"/>
</designation>
</concept>
<concept>
<code value="47994-9"/>
<display value="Bilirubin.total [Moles/?volume] in Cord blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bilirubin cord"/>
</designation>
</concept>
<concept>
<code value="480-4"/>
<display
value="Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Talampicillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="48062-4"/>
<display
value="Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cryptosporidium & Giardia Ag faeces (IF)"/>
</designation>
</concept>
<concept>
<code value="48063-2"/>
<display
value="Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cryptosporidium & Giardia Ag"/>
</designation>
</concept>
<concept>
<code value="48111-9"/>
<display
value="Glutathione.reduced [Moles/?mass] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reduced glutathione"/>
</designation>
</concept>
<concept>
<code value="48326-3"/>
<display value="Glipizide [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glipizide"/>
</designation>
</concept>
<concept>
<code value="48327-1"/>
<display value="Glyburide [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glibenclamide"/>
</designation>
</concept>
<concept>
<code value="48329-7"/>
<display value="Chlorpropamide [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chlorpropamide"/>
</designation>
</concept>
<concept>
<code value="48344-6"/>
<display
value="Activated clotting time.kaolin induced of Platelet poor plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="KCT"/>
</designation>
</concept>
<concept>
<code value="48357-8"/>
<display value="Testosterone [Moles/?volume] in Saliva (oral fluid)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Testosterone saliva"/>
</designation>
</concept>
<concept>
<code value="48359-4"/>
<display
value="Echinococcus granulosus Ab [Titer] in Serum by Hemagglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hydatid Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="48377-6"/>
<display
value="Mullerian inhibiting substance [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mullerian Hormone Ab"/>
</designation>
</concept>
<concept>
<code value="48378-4"/>
<display
value="Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Immunoglobulin Light Chains (free)"/>
</designation>
</concept>
<concept>
<code value="48391-7"/>
<display
value="Carbon dioxide, total [Moles/?volume] in Venous blood by calculation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CO2 blood ( total) in Venous blood"/>
</designation>
</concept>
<concept>
<code value="48398-2"/>
<display
value="Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B Viral Load (log IU/mL)"/>
</designation>
</concept>
<concept>
<code value="48419-6"/>
<display
value="Immune complex.IgG [Mass/?volume] in Serum or Plasma by C1q binding assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C1q Binding Assay"/>
</designation>
</concept>
<concept>
<code value="48425-3"/>
<display value="Troponin T.cardiac [Mass/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Troponin T (rapid)"/>
</designation>
</concept>
<concept>
<code value="48432-9"/>
<display value="Fructose [Molar amount] in unspecified time Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fructose seminal fluid (unspecified time)"/>
</designation>
</concept>
<concept>
<code value="484-6"/>
<display
value="Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Teicoplanin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="48508-6"/>
<display
value="Measles virus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Measles RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="48509-4"/>
<display
value="Influenza virus A and B RNA [Identifier] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Influenza A+B RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="48618-3"/>
<display
value="Cholesterol in VLDL [Mass/?volume] in Serum or Plasma ultracentrifugate"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cholesterol in VLDL"/>
</designation>
</concept>
<concept>
<code value="48721-5"/>
<display
value="Bartonella henselae IgG Ab [Units/?volume] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bartonella Ab"/>
</designation>
</concept>
<concept>
<code value="48807-2"/>
<display value="Bone marrow aspiration report"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bone marrow aspirate"/>
</designation>
</concept>
<concept>
<code value="488-7"/>
<display
value="Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Temafloxacin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="48-9"/>
<display
value="Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bacampicillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="49117-5"/>
<display value="Norovirus Ag [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Norovirus Ag faeces"/>
</designation>
</concept>
<concept>
<code value="49233-0"/>
<display
value="Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Rapid, less than 30 minutes"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cryptosporidium & Giardia Ag Rapid"/>
</designation>
</concept>
<concept>
<code value="49243-9"/>
<display
value="Alkaline phosphatase isoenzymes [interpretation] in Serum or Plasma Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alk Phosphatase isoenzymes"/>
</designation>
</concept>
<concept>
<code value="49244-7"/>
<display
value="Alpha 1 antitrypsin phenotype [Interpretation] in Serum or Plasma Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alpha 1 antitrypsin phenotyping"/>
</designation>
</concept>
<concept>
<code value="49248-8"/>
<display
value="Amino acid pattern [interpretation] in Urine Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amino Acids urine (pattern)"/>
</designation>
</concept>
<concept>
<code value="49252-0"/>
<display
value="Calculus analysis [interpretation] in Stone Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calculus analysis stone"/>
</designation>
</concept>
<concept>
<code value="49268-6"/>
<display
value="Glycosaminoglycans pattern [interpretation] in Urine Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glycosamino Glycan urine (pattern)"/>
</designation>
</concept>
<concept>
<code value="49279-3"/>
<display
value="Lactate dehydrogenase isoenzymes [interpretation] in Serum or Plasma Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="LDH isoenzymes (electrophoresis) "/>
</designation>
</concept>
<concept>
<code value="492-9"/>
<display
value="Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Temocillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="49290-0"/>
<display value="Porphyrins [interpretation] in Stool Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphyrin full analysis faeces"/>
</designation>
</concept>
<concept>
<code value="49291-8"/>
<display value="Porphyrins [interpretation] in Urine Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphyrin full analysis (HPLC) urine"/>
</designation>
</concept>
<concept>
<code value="49308-0"/>
<display
value="Neutrophil cytoplasmic Ab pattern [interpretation] in Serum by Immunofluorescence Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Neutrophil cytoplasmic Ab (interpretation)"/>
</designation>
</concept>
<concept>
<code value="49316-3"/>
<display
value="Hemoglobin pattern [interpretation] in Blood by Electrophoresis"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haemoglobin pattern"/>
</designation>
</concept>
<concept>
<code value="49323-9"/>
<display
value="Hemoglobin pattern [interpretation] in Blood by Electrophesis citrate agar"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hb electrophoresis - acid gel"/>
</designation>
</concept>
<concept>
<code value="496-0"/>
<display
value="Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tetracycline suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="49671-1"/>
<display
value="Neisseria meningitidis DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="N. meningitidis DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="49755-2"/>
<display
value="Crystals [Presence] in Urine sediment by Light microscopy "/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Crystals urine - presence"/>
</designation>
</concept>
<concept>
<code value="49836-0"/>
<display
value="Platelet function (closure time) [interpretation] in Blood Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PFA interpretation"/>
</designation>
</concept>
<concept>
<code value="49863-4"/>
<display
value="Aspergillus sp DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aspergillus DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="4996-5"/>
<display
value="Cytomegalovirus DNA [Presence] in Blood by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV DNA (NAAT) (Blood)"/>
</designation>
</concept>
<concept>
<code value="5000-5"/>
<display
value="Cytomegalovirus DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV DNA (NAAT) "/>
</designation>
</concept>
<concept>
<code value="500-9"/>
<display
value="Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ticarcillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="5014-6"/>
<display
value="Herpes simplex virus DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="50377-1"/>
<display
value="von Willebrand factor (vWf).collagen binding activity actual/?normal in Platelet poor plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VWF:CBA"/>
</designation>
</concept>
<concept>
<code value="50378-9"/>
<display
value="von Willebrand factor (vWf).collagen binding activity/von Willebrand factor Ag [Ratio] in Platelet poor plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VWF:CBA - ratio"/>
</designation>
</concept>
<concept>
<code value="504-1"/>
<display
value="Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ticarcillin Clav suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="50410-0"/>
<display
value="dRVVT/dRVVT W excess phospholipid (screen to confirm ratio)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Dilute Russell viper venom time - screen to confirm ratio"/>
</designation>
</concept>
<concept>
<code value="5043-5"/>
<display value="Adrenal Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adrenal Ab (titre) by Immunofluorescence"/>
</designation>
</concept>
<concept>
<code value="5052-6"/>
<display
value="Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aspergillus Ab (precipitins)"/>
</designation>
</concept>
<concept>
<code value="50544-6"/>
<display value="Everolimus [Mass/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Everolimus blood"/>
</designation>
</concept>
<concept>
<code value="50548-7"/>
<display
value="Respiratory virus DNA+RNA [Identifier] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Resp virus DNA+RNA XXX NAA+probe"/>
</designation>
</concept>
<concept>
<code value="50592-5"/>
<display
value="Ecgonine methyl ester [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ecgonine"/>
</designation>
</concept>
<concept>
<code value="5064-1"/>
<display
value="Borrelia burgdorferi IgM Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lyme Disease Ab"/>
</designation>
</concept>
<concept>
<code value="50761-6"/>
<display value="A IgG Ab [Titer] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anti-A IgG (titre)"/>
</designation>
</concept>
<concept>
<code value="50762-4"/>
<display value="A IgM Ab [Titer] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anti-A (IgM) Titre"/>
</designation>
</concept>
<concept>
<code value="50763-2"/>
<display value="B IgM Ab [Titer] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anti-B (IgM) Titre"/>
</designation>
</concept>
<concept>
<code value="50764-0"/>
<display value="B IgG Ab [Titer] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anti-B IgG (Titre)"/>
</designation>
</concept>
<concept>
<code value="508-2"/>
<display
value="Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tobramycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="50903-4"/>
<display value="Selenium [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Selenium urine"/>
</designation>
</concept>
<concept>
<code value="50936-4"/>
<display value="Vanadium [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vanadium urine"/>
</designation>
</concept>
<concept>
<code value="50968-7"/>
<display value="HLA Ab [Type] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HLA Antibodies (ident)"/>
</designation>
</concept>
<concept>
<code value="51164-2"/>
<display value="CD34 blasts [Units/?volume] in Bone marrow"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CD34 Assay, bone marrow"/>
</designation>
</concept>
<concept>
<code value="512-4"/>
<display
value="Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trimethoprim suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="5133-4"/>
<display value="Streptococcal DNAse B [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Strep DNAse B Ab"/>
</designation>
</concept>
<concept>
<code value="51480-2"/>
<display value="Bacteria [#/volume] in Urine by Automated count"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bacteria count urine (auto)"/>
</designation>
</concept>
<concept>
<code value="51597-3"/>
<display
value="Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose (1h post 75g glucose)"/>
</designation>
</concept>
<concept>
<code value="516-5"/>
<display
value="Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trimethoprim Sulfa suscep MIC"/>
</designation>
</concept>
<concept>
<code value="51694-8"/>
<display value="Carumonam [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carumonam suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="51698-9"/>
<display value="Dapsone [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dapsone suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="51710-2"/>
<display
value="Leishmania sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Leishmania culture"/>
</designation>
</concept>
<concept>
<code value="51719-3"/>
<display value="Paromomycin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Paramomycin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="51724-3"/>
<display value="Cefuroxime [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefuroxime suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="51774-8"/>
<display
value="Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefuroxime suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="51775-5"/>
<display value="Chromatin Ab [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chromatin Ab"/>
</designation>
</concept>
<concept>
<code value="51776-3"/>
<display
value="7-Aminoclonazepam [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="7-aminoclonazepam urine"/>
</designation>
</concept>
<concept>
<code value="51777-1"/>
<display
value="7-Aminoflunitrazepam [Mass/?volume] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="7-aminoflunitrazepam urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="51781-3"/>
<display
value="Carbon dioxide, total [Moles/?volume] in Capillary blood by calculation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CO2 blood ( total) - in Capillary blood"/>
</designation>
</concept>
<concept>
<code value="51844-9"/>
<display value="Cortisol [Moles/?volume] in Saliva (oral fluid)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cortisol saliva"/>
</designation>
</concept>
<concept>
<code value="51916-5"/>
<display
value="Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV Ab (Type 1)"/>
</designation>
</concept>
<concept>
<code value="5195-3"/>
<display value="Hepatitis B virus surface Ag [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis B surface Ag"/>
</designation>
</concept>
<concept>
<code value="5199-5"/>
<display
value="Hepatitis C virus Ab [Presence] in Serum by Immunoblot"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis C Ab (IB)"/>
</designation>
</concept>
<concept>
<code value="520-7"/>
<display
value="Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Troleandomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="52-1"/>
<display
value="Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Butirosin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="52114-6"/>
<display
value="Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="AHG (direct, IgG)"/>
</designation>
</concept>
<concept>
<code value="5226-6"/>
<display value="HTLV I+II Ab [Units/volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HTLV 1+2 Ab"/>
</designation>
</concept>
<concept>
<code value="5230-8"/>
<display
value="Influenza virus B Ab [Titer] in Serum by Complement fixation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Influenza B Ab"/>
</designation>
</concept>
<concept>
<code value="524-9"/>
<display
value="Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vancomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="5253-0"/>
<display
value="Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="M. pneumoniae Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="5265-4"/>
<display
value="Pancreatic islet cell Ab [Presence] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Islet cell autoantibody"/>
</designation>
</concept>
<concept>
<code value="5271-2"/>
<display
value="Parietal cell Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parietal cell Ab (titre) by Immunofluorescence"/>
</designation>
</concept>
<concept>
<code value="528-0"/>
<display
value="Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Viomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="52901-6"/>
<display value="Vanadium/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vanadium/creat urine"/>
</designation>
</concept>
<concept>
<code value="5290-2"/>
<display
value="Reagin Ab [Presence] in Cerebral spinal fluid by VDRL"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VDRL CSF (qual)"/>
</designation>
</concept>
<concept>
<code value="52913-1"/>
<display value="Selenium [Moles/?volume] in Red Blood Cells"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Selenium RBC"/>
</designation>
</concept>
<concept>
<code value="52915-6"/>
<display value="Aluminum [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aluminium urine"/>
</designation>
</concept>
<concept>
<code value="52929-7"/>
<display value="Mercury/?Creatinine [Molar ratio] in 24 hour Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mercury/creat urine 24hr"/>
</designation>
</concept>
<concept>
<code value="5295-1"/>
<display
value="Respiratory syncytial virus Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RSV Ab (IF)"/>
</designation>
</concept>
<concept>
<code value="52961-0"/>
<display value="Paraquat [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Paraquat urine"/>
</designation>
</concept>
<concept>
<code value="52984-2"/>
<display
value="Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV IgG avidity"/>
</designation>
</concept>
<concept>
<code value="53007-1"/>
<display
value="PM-SCL extractable nuclear Ab [Presence] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PM-Scl Ab (IF)"/>
</designation>
</concept>
<concept>
<code value="53020-4"/>
<display value="Complement C1q Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C1q Ab"/>
</designation>
</concept>
<concept>
<code value="53115-2"/>
<display
value="Immature granulocytes [#/?volume] in Blood by Automated count"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Immature Granulocytes"/>
</designation>
</concept>
<concept>
<code value="531-4"/>
<display value="Zidovudine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Zidovudine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="53523-7"/>
<display
value="Vasoactive intestinal peptide [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vasoactive Intestinal Peptide"/>
</designation>
</concept>
<concept>
<code value="53556-7"/>
<display
value="Erythrocytes.Plasmodium sp infected/?100 erythrocytes in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Malaria parasite load"/>
</designation>
</concept>
<concept>
<code value="53622-7"/>
<display
value="von Willebrand factor (vWf) cleaving protease actual/?normal in Platelet poor plasma by Chromogenic method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ADAMSTS-13"/>
</designation>
</concept>
<concept>
<code value="5369-4"/>
<display value="Streptokinase Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Streptokinase Ab"/>
</designation>
</concept>
<concept>
<code value="5370-2"/>
<display value="Streptolysin O Ab [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Streptolysin O Ab"/>
</designation>
</concept>
<concept>
<code value="53731-6"/>
<display value="Posaconazole [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Posaconazole"/>
</designation>
</concept>
<concept>
<code value="53812-4"/>
<display
value="Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Micafungin (MIC)"/>
</designation>
</concept>
<concept>
<code value="5381-9"/>
<display
value="Thyroglobulin Ab [Titer] in Serum by Latex agglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thyroglob Ab Titr Ser LA"/>
</designation>
</concept>
<concept>
<code value="53819-9"/>
<display
value="Thiopurine methyltransferase [Enzymatic activity/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thiopurine Methyl Transferase blood"/>
</designation>
</concept>
<concept>
<code value="5386-8"/>
<display
value="Toxocara canis Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Toxocara Ab"/>
</designation>
</concept>
<concept>
<code value="53903-1"/>
<display value="Collection method - Specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Spec collection/description"/>
</designation>
</concept>
<concept>
<code value="5393-4"/>
<display
value="Treponema pallidum Ab [Presence] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Syphilis Confirmation "/>
</designation>
</concept>
<concept>
<code value="53946-0"/>
<display
value="Escherichia coli shiga-like toxin identified in Unspecified specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Enterohaemorrhagic E. coli (EHEC) toxin antigen (verotoxin, shiga toxin) - specimen"/>
</designation>
</concept>
<concept>
<code value="54067-4"/>
<display
value="Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cl. difficile DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="54091-4"/>
<display
value="Rubella virus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rubella (NAAT)"/>
</designation>
</concept>
<concept>
<code value="54187-0"/>
<display
value="Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Posaconazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="54188-8"/>
<display value="Posaconazole [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Posaconazole suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="54218-3"/>
<display
value="CD3+?CD4+? (T4 helper) cells/?CD3+?CD8+? (T8 suppressor cells) cells [# Ratio] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="lymphocyte markers - Cells.CD3+CD4+/Cells.CD3+CD8+"/>
</designation>
</concept>
<concept>
<code value="54285-2"/>
<display value="Glycerol [Moles/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glycerol urine"/>
</designation>
</concept>
<concept>
<code value="54309-0"/>
<display
value="Lactate/?Pyruvate [Molar ratio] in Cerebral spinal fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lactate/Pyruvate CSF"/>
</designation>
</concept>
<concept>
<code value="543-9"/>
<display
value="Mycobacterium sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mycobacterium (culture)"/>
</designation>
</concept>
<concept>
<code value="54905-5"/>
<display
value="Norovirus Genogroup I RNA [Presence] in Stool by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Norovirus GI RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="54906-3"/>
<display
value="Norovirus Genogroup II RNA [Presence] in Stool by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Norovirus GII RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="54914-7"/>
<display
value="Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis C Ag"/>
</designation>
</concept>
<concept>
<code value="54941-0"/>
<display value="Tungsten [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tungsten urine"/>
</designation>
</concept>
<concept>
<code value="55100-2"/>
<display
value="Respiratory syncytial virus [Presence] in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RSV culture"/>
</designation>
</concept>
<concept>
<code value="55343-8"/>
<display
value="Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anidulafungin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="55580-5"/>
<display value="Sulfapyridine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulphapyridine"/>
</designation>
</concept>
<concept>
<code value="55581-3"/>
<display value="Sulfasalazine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sulphasalazine"/>
</designation>
</concept>
<concept>
<code value="5568-1"/>
<display value="Acetone [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Acetone"/>
</designation>
</concept>
<concept>
<code value="5570-7"/>
<display value="Acetone [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Acetone urine"/>
</designation>
</concept>
<concept>
<code value="55805-6"/>
<display value="Cyclosporine [Mass/?volume] in Blood by LC/?MS/?MS"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cyclosporin blood - by LC/MS/MS"/>
</designation>
</concept>
<concept>
<code value="5581-4"/>
<display value="Antimony [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antimony urine"/>
</designation>
</concept>
<concept>
<code value="5590-5"/>
<display value="Barium [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Barium urine"/>
</designation>
</concept>
<concept>
<code value="5598-8"/>
<display value="Bismuth [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bismuth urine"/>
</designation>
</concept>
<concept>
<code value="560-3"/>
<display
value="Chlamydia sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chlamydia (culture)"/>
</designation>
</concept>
<concept>
<code value="56126-6"/>
<display value="Copper [Mass/?mass] in Liver"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Copper liver"/>
</designation>
</concept>
<concept>
<code value="56145-6"/>
<display
value="CD55+?CD59 deficient RBC+?Granulocytes [interpretation] in Blood Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PNH by flow cytometry"/>
</designation>
</concept>
<concept>
<code value="56-2"/>
<display
value="Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Capreomycin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="562-9"/>
<display
value="Clostridioides difficile [Presence] in Stool by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cl.difficile culture"/>
</designation>
</concept>
<concept>
<code value="5646-5"/>
<display
value="Ethylene glycol [Mass/volume] in Serum, Plasma or Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethylene glycol - mass/volume"/>
</designation>
</concept>
<concept>
<code value="5647-3"/>
<display value="Ethylene glycol [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethylene glycol urine"/>
</designation>
</concept>
<concept>
<code value="56536-6"/>
<display
value="Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thyroglob Ab Ser EIA-aCnc"/>
</designation>
</concept>
<concept>
<code value="56537-4"/>
<display
value="Tissue transglutaminase IgG Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="TTG Ab IgG"/>
</designation>
</concept>
<concept>
<code value="56539-0"/>
<display
value="Intrinsic factor Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Intrinsic factor Ab"/>
</designation>
</concept>
<concept>
<code value="56540-8"/>
<display
value="Glutamate decarboxylase 65 Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="GAD Ab"/>
</designation>
</concept>
<concept>
<code value="56717-2"/>
<display value="Histone Ab [Presence] in Serum by Immunoblot"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Histone Ab"/>
</designation>
</concept>
<concept>
<code value="56718-0"/>
<display
value="Islet cell 512 Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="IA2 Ab"/>
</designation>
</concept>
<concept>
<code value="56721-4"/>
<display
value="PM-SCL extractable nuclear Ab [Presence] in Serum by Immunoblot"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PM-Scl Ab (IB)"/>
</designation>
</concept>
<concept>
<code value="56722-2"/>
<display value="Soluble liver Ab [Presence] in Serum by Immunoblot"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Soluble liver antibody"/>
</designation>
</concept>
<concept>
<code value="567-8"/>
<display
value="Diphtheria identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C. diphtheriae (culture)"/>
</designation>
</concept>
<concept>
<code value="5681-2"/>
<display value="Manganese [Mass/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Manganese blood - mass/volume"/>
</designation>
</concept>
<concept>
<code value="5684-6"/>
<display value="Manganese [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Manganese urine - mass/volume"/>
</designation>
</concept>
<concept>
<code value="56888-1"/>
<display
value="HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HIV 1+2 Ab plus HIV1 Ag (qual)"/>
</designation>
</concept>
<concept>
<code value="56940-0"/>
<display
value="Inhibin B [Mass/?volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Inhibin B"/>
</designation>
</concept>
<concept>
<code value="56972-3"/>
<display
value="Prolactin [Mass/?volume] in Serum or Plasma --post precipitation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Macroprolaction"/>
</designation>
</concept>
<concept>
<code value="56991-3"/>
<display
value="Toxoplasma gondii IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. gondii IgG avidity"/>
</designation>
</concept>
<concept>
<code value="5699-4"/>
<display value="Molybdenum [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Molybdenum urine"/>
</designation>
</concept>
<concept>
<code value="57028-3"/>
<display value="Iron [Mass/?mass] in Liver"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Iron liver"/>
</designation>
</concept>
<concept>
<code value="57095-2"/>
<display value="Anidulafungin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anidulafungin suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="5711-7"/>
<display value="Pentachlorophenol [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pentachlorophenol urine"/>
</designation>
</concept>
<concept>
<code value="5722-4"/>
<display value="Selenium [Mass/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Selenium blood"/>
</designation>
</concept>
<concept>
<code value="5734-9"/>
<display value="Silver [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Silver"/>
</designation>
</concept>
<concept>
<code value="5735-6"/>
<display value="Silver [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Silver urine"/>
</designation>
</concept>
<concept>
<code value="57378-2"/>
<display value="Porphyrins/?Creatinine [Molar ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Porphyrins/creat urine"/>
</designation>
</concept>
<concept>
<code value="57416-0"/>
<display
value="Thyrotropin receptor Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="TSH receptorAb"/>
</designation>
</concept>
<concept>
<code value="5745-5"/>
<display value="Thallium [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thallium urine"/>
</designation>
</concept>
<concept>
<code value="57502-7"/>
<display
value="11-Deoxycortisol [Moles/?volume] in Serum or Plasma --1 day post dose metyrapone"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="11-Deoxycortisol (1d p metyrapone)"/>
</designation>
</concept>
<concept>
<code value="5770-3"/>
<display value="Bilirubin.total [Presence] in Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bilirubin urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="57734-6"/>
<display value="Ketones [Presence] in Urine by Automated test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ketones urine (qual)"/>
</designation>
</concept>
<concept>
<code value="57744-5"/>
<display
value="Striated muscle Ab [Presence] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Striated muscle Antibody"/>
</designation>
</concept>
<concept>
<code value="57745-2"/>
<display
value="Adrenal Ab [Presence] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adrenal Ab(qual)"/>
</designation>
</concept>
<concept>
<code value="57746-0"/>
<display
value="Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gamma hydroxybutyrate urine"/>
</designation>
</concept>
<concept>
<code value="57761-9"/>
<display
value="Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HITS - by Immunoassay"/>
</designation>
</concept>
<concept>
<code value="5782-8"/>
<display
value="Crystals [type] in Urine sediment by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Crystals urine - type"/>
</designation>
</concept>
<concept>
<code value="57838-5"/>
<display value="dRVVT W excess phospholipid (LA confirm)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="dRVVT excess phospholipid (PPP) [Time]"/>
</designation>
</concept>
<concept>
<code value="57844-3"/>
<display value="Imatinib mesylate [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Imatinib"/>
</designation>
</concept>
<concept>
<code value="57901-1"/>
<display
value="Clostridioides difficile glutamate dehydrogenase [Presence] in Stool"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cl. difficile Ag"/>
</designation>
</concept>
<concept>
<code value="5794-3"/>
<display value="Hemoglobin [Presence] in Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haemoglobin urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="5799-2"/>
<display
value="Leukocyte esterase [Presence] in Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Leuc esterase urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="580-1"/>
<display
value="Fungus identified in Unspecified specimen by Culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Fungi (culture)"/>
</designation>
</concept>
<concept>
<code value="5802-4"/>
<display value="Nitrite [Presence] in Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Nitrite urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="5803-2"/>
<display value="pH of Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="pH urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="5811-5"/>
<display value="Specific gravity of Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SG urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="5818-0"/>
<display value="Urobilinogen [Presence] in Urine by Test strip"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Urobilinogen urine (dipstick)"/>
</designation>
</concept>
<concept>
<code value="58416-9"/>
<display
value="MLH1 gene methylation [Presence] in Blood or Tissue by Molecular genetics method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MLH12 promoter methylation testing"/>
</designation>
</concept>
<concept>
<code value="58436-7"/>
<display value="Casts [Type] in Urine sediment by Light microscopy "/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Casts urine sediment (type)"/>
</designation>
</concept>
<concept>
<code value="5843-8"/>
<display
value="Enterovirus identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Enterovirus culture"/>
</designation>
</concept>
<concept>
<code value="5846-1"/>
<display
value="Herpes simplex virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV1 Ag (IF)"/>
</designation>
</concept>
<concept>
<code value="5849-5"/>
<display
value="Herpes simplex virus 2 Ag [Presence] in Unspecified specimen by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV2 Ag (IF)"/>
</designation>
</concept>
<concept>
<code value="5854-5"/>
<display
value="Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV Ag (EIA)"/>
</designation>
</concept>
<concept>
<code value="5855-2"/>
<display
value="Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV Ag (IF)"/>
</designation>
</concept>
<concept>
<code value="58570-3"/>
<display
value="Corticotropin [Moles/?volume] in Plasma --1 day post dose metyrapone"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ACTH (1d p metyrapone)"/>
</designation>
</concept>
<concept>
<code value="5859-4"/>
<display
value="Herpes simplex virus identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HSV (culture)"/>
</designation>
</concept>
<concept>
<code value="586-8"/>
<display
value="Streptococcus agalactiae [Presence] in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Group B Streptococcus (cult)"/>
</designation>
</concept>
<concept>
<code value="587-6"/>
<display
value="Helicobacter pylori [Presence] in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="H.pylori culture"/>
</designation>
</concept>
<concept>
<code value="5877-6"/>
<display
value="Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="RSV Ag"/>
</designation>
</concept>
<concept>
<code value="58897-0"/>
<display
value="Methyl ethyl ketone/?Creatinine [Mass Ratio] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methylethylketone urine"/>
</designation>
</concept>
<concept>
<code value="58900-2"/>
<display
value="HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HIV 1+2 Ab plus HIV1 Ag"/>
</designation>
</concept>
<concept>
<code value="5894-1"/>
<display value="Prothrombin time (PT) actual/Normal"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PR"/>
</designation>
</concept>
<concept>
<code value="590-0"/>
<display
value="Legionella sp identified in Sputum by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Legionella (culture)"/>
</designation>
</concept>
<concept>
<code value="5901-4"/>
<display
value="Prothrombin time (PT) in control Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Prothrombin time (control)"/>
</designation>
</concept>
<concept>
<code value="5902-2"/>
<display value="Prothrombin time (PT)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Prothrombin time"/>
</designation>
</concept>
<concept>
<code value="59070-3"/>
<display value="Paraquat [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Paraquat"/>
</designation>
</concept>
<concept>
<code value="5909-7"/>
<display
value="Blood smear finding [Identifier] in Blood by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blood film morphology"/>
</designation>
</concept>
<concept>
<code value="59176-8"/>
<display value="Zopiclone [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Zopiclone urine"/>
</designation>
</concept>
<concept>
<code value="59186-7"/>
<display value="Cyanide [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cyanide blood"/>
</designation>
</concept>
<concept>
<code value="59261-8"/>
<display
value="Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HbA1c by IFCC protocol"/>
</designation>
</concept>
<concept>
<code value="59287-3"/>
<display value="Benzylpiperazine [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Benzylpiperazine (BZP) urine"/>
</designation>
</concept>
<concept>
<code value="59394-7"/>
<display
value="Glomerular basement membrane Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="GBM Ab"/>
</designation>
</concept>
<concept>
<code value="594-2"/>
<display
value="Leptospira sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Leptospira (culture)"/>
</designation>
</concept>
<concept>
<code value="59420-0"/>
<display
value="Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HPV DNA (NAAT) - in Cervix"/>
</designation>
</concept>
<concept>
<code value="5942-8"/>
<display
value="Reptilase time in control Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reptilase time (control)"/>
</designation>
</concept>
<concept>
<code value="5946-9"/>
<display
value="aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="APTT (+ N plasma)"/>
</designation>
</concept>
<concept>
<code value="59472-1"/>
<display
value="Calcium.ionized [Mass/?volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Calcium (ph 7.4), blood"/>
</designation>
</concept>
<concept>
<code value="5949-3"/>
<display
value="aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="APTT (+ N plasma, control)"/>
</designation>
</concept>
<concept>
<code value="5955-0"/>
<display
value="Thrombin time in control Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thrombin time (control)"/>
</designation>
</concept>
<concept>
<code value="5956-8"/>
<display
value="Prothrombin time (PT) factor substitution in control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PT (+ N plasma, control)"/>
</designation>
</concept>
<concept>
<code value="5959-2"/>
<display
value="Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Prothrombin time (+ N plasma)"/>
</designation>
</concept>
<concept>
<code value="59965-4"/>
<display value="Quinine [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Quinine - moles volume"/>
</designation>
</concept>
<concept>
<code value="60017-1"/>
<display
value="Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="LDH fluid by Pyruvate to lactate reaction"/>
</designation>
</concept>
<concept>
<code value="60023-9"/>
<display
value="Lactate dehydrogenase [Enzymatic activity/?volume] in Cerebral spinal fluid by Pyruvate to lactate reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="LDH CSF by Pyruvate to lactate reaction"/>
</designation>
</concept>
<concept>
<code value="60024-7"/>
<display
value="Lactate dehydrogenase [Enzymatic activity/?volume] in Cerebral spinal fluid by Lactate to pyruvate reaction"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="LDH CSF by Lactate to pyruvate reaction"/>
</designation>
</concept>
<concept>
<code value="60088-2"/>
<display value="Hyoscyamine [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hyoscyamine urine"/>
</designation>
</concept>
<concept>
<code value="6014-5"/>
<display
value="von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VWF:Rco - by Platelet aggregation"/>
</designation>
</concept>
<concept>
<code value="60-4"/>
<display
value="Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Carbenicillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="60422-3"/>
<display
value="Measles virus genotype [Identifier] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Measles genotype"/>
</designation>
</concept>
<concept>
<code value="60463-7"/>
<display value="Insulin Ab [Moles/?volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Insulin Ab"/>
</designation>
</concept>
<concept>
<code value="60517-0"/>
<display value="Iron/?Transferrin [Ratio] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Transferrin saturation - ratio"/>
</designation>
</concept>
<concept>
<code value="61030-3"/>
<display value="7-Aminoclonazepam [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="7-aminoclonazepam urine"/>
</designation>
</concept>
<concept>
<code value="61033-7"/>
<display value="7-Aminoflunitrazepam [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="7-aminoflunitrazepam urine"/>
</designation>
</concept>
<concept>
<code value="61036-0"/>
<display value="Alpha hydroxyalprazolam [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alpha hydroxy alprazolam urine"/>
</designation>
</concept>
<concept>
<code value="61152-5"/>
<display
value="Albumin [Mass/?volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Albumin by BCP"/>
</designation>
</concept>
<concept>
<code value="61365-3"/>
<display
value="Parainfluenza virus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parainfluenza virus RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="61406-5"/>
<display value="XXX blood group Ab [Titer] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blood Group Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="614-8"/>
<display
value="Mycobacterium sp identified in Isolate by Mycobacterial subtyping"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mycobacterium (ident)"/>
</designation>
</concept>
<concept>
<code value="62238-1"/>
<display
value="Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (CKD-EPI)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="eGFR"/>
</designation>
</concept>
<concept>
<code value="623-9"/>
<display
value="Bacteria identified in Sputum by Cystic fibrosis respiratory culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sputum (cystic fibrosis, cult)"/>
</designation>
</concept>
<concept>
<code value="62467-6"/>
<display
value="Galactomannan Ag [Units/?volume] in Unspecified specimen by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Galactomannan Ag unspecified specimen"/>
</designation>
</concept>
<concept>
<code value="6298-4"/>
<display value="Potassium [Moles/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Potassium blood"/>
</designation>
</concept>
<concept>
<code value="6301-6"/>
<display value="INR in Platelet poor plasma by Coagulation assay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="INR"/>
</designation>
</concept>
<concept>
<code value="6303-2"/>
<display value="dRVVT (LA screen)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dilute Russell viper venom time"/>
</designation>
</concept>
<concept>
<code value="6306-5"/>
<display
value="Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Adenovirus faecal Ag"/>
</designation>
</concept>
<concept>
<code value="6317-2"/>
<display
value="Bordetella sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bordetella (culture)"/>
</designation>
</concept>
<concept>
<code value="6325-5"/>
<display
value="Brucella abortus Ab [Titer] in Serum by Complement fixation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Br. abortus Ab "/>
</designation>
</concept>
<concept>
<code value="63437-8"/>
<display
value="Brucella abortus Ab [Titer] in Serum by Antihuman globulin"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Br. abortus Ab (AHG)"/>
</designation>
</concept>
<concept>
<code value="635-3"/>
<display
value="Bacteria identified in Unspecified specimen by Anaerobe culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anaerobes (culture)"/>
</designation>
</concept>
<concept>
<code value="6354-5"/>
<display
value="Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C. trachomatis Ag (EIA)"/>
</designation>
</concept>
<concept>
<code value="6355-2"/>
<display
value="Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C. trachomatis Ag (IF)"/>
</designation>
</concept>
<concept>
<code value="637-9"/>
<display value="Plasmodium sp identified in Blood by Thick film"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Malaria thick blood film"/>
</designation>
</concept>
<concept>
<code value="64013-6"/>
<display
value="Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Enterohaemorrhagic E. coli (EHEC) toxin antigen (verotoxin, shiga toxin) - stool"/>
</designation>
</concept>
<concept>
<code value="64233-0"/>
<display
value="Benzylpiperazine [Presence] in Urine by Confirmatory method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Benzylpiperazine (BZP) urine by Confirmatory method"/>
</designation>
</concept>
<concept>
<code value="6450-1"/>
<display
value="Legionella sp Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Legionella sp Ab (IF)"/>
</designation>
</concept>
<concept>
<code value="64-6"/>
<display
value="Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefadroxil suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="6463-4"/>
<display
value="Bacteria identified in Unspecified specimen by Culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bacteria (culture)"/>
</designation>
</concept>
<concept>
<code value="6476-6"/>
<display
value="Mumps virus IgG Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mumps IgG"/>
</designation>
</concept>
<concept>
<code value="6478-2"/>
<display
value="Mumps virus IgM Ab [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mumps IgM"/>
</designation>
</concept>
<concept>
<code value="6486-5"/>
<display
value="Mycoplasma sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mycoplasma (culture)"/>
</designation>
</concept>
<concept>
<code value="65340-2"/>
<display value="Micafungin [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Micafungin (qual)"/>
</designation>
</concept>
<concept>
<code value="6562-3"/>
<display value="Treponema pallidum IgM Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Syphilis Ab IgM"/>
</designation>
</concept>
<concept>
<code value="6579-7"/>
<display
value="Vibrio sp identified in Stool by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vibrio culture"/>
</designation>
</concept>
<concept>
<code value="6584-7"/>
<display value="Virus identified in Unspecified specimen by Culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Viruses (culture)"/>
</designation>
</concept>
<concept>
<code value="6598-7"/>
<display value="Troponin T.cardiac [Mass/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Troponin T"/>
</designation>
</concept>
<concept>
<code value="660-1"/>
<display
value="Microscopic observation [Identifier] in Unspecified specimen by Dark field examination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microscopy (dark field exam)"/>
</designation>
</concept>
<concept>
<code value="6604-3"/>
<display
value="Influenza virus identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Influenza culture"/>
</designation>
</concept>
<concept>
<code value="6609-2"/>
<display
value="Listeria sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Listeria (culture)"/>
</designation>
</concept>
<concept>
<code value="6630-8"/>
<display
value="Schistosoma sp Ab [Presence] in Serum by Hemagglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Schistosomal Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="664-3"/>
<display
value="Microscopic observation [Identifier] in Unspecified specimen by Gram stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microscopy (Gram stain)"/>
</designation>
</concept>
<concept>
<code value="6644-9"/>
<display
value="Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefepime suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="6652-2"/>
<display
value="Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Meropenem suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="666-8"/>
<display
value="Microscopic observation [Identifier] in Unspecified specimen by India ink prep"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microscopy (Indian ink prep)"/>
</designation>
</concept>
<concept>
<code value="66736-0"/>
<display
value="Normalized silica clotting time of Platelet poor plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Silica clotting time"/>
</designation>
</concept>
<concept>
<code value="667-6"/>
<display
value="Microscopic observation [Identifier] in Unspecified specimen by KOH preparation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microscopy (KOH prep)"/>
</designation>
</concept>
<concept>
<code value="6683-7"/>
<display value="Reptilase time"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reptilase time"/>
</designation>
</concept>
<concept>
<code value="66878-0"/>
<display value="Skin Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Skin Ab"/>
</designation>
</concept>
<concept>
<code value="6689-4"/>
<display value="Glucose [Mass/volume] in Blood -- 2 hours post meal"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Glucose (2h post meal) blood"/>
</designation>
</concept>
<concept>
<code value="6-7"/>
<display value="Amantadine [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amantadine suscep (qual)"/>
</designation>
</concept>
<concept>
<code value="6709-0"/>
<display value="Hippurate [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hippurate urine - mass/volume"/>
</designation>
</concept>
<concept>
<code value="675-9"/>
<display
value="Enterobius vermicularis [Presence] in Unspecified specimen by Pinworm exam"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pinworm examination"/>
</designation>
</concept>
<concept>
<code value="6768-6"/>
<display
value="Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Alkaline phosphatase"/>
</designation>
</concept>
<concept>
<code value="678-3"/>
<display
value="Microscopic observation [Identifier] in Unspecified specimen by Trichrome stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microscopy (Trichrome stain)"/>
</designation>
</concept>
<concept>
<code value="680-9"/>
<display
value="Microscopic observation [Identifier] in Unspecified specimen by Wet preparation"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Microscopy (wet prep)"/>
</designation>
</concept>
<concept>
<code value="6825-4"/>
<display value="Crystals [type] in Body fluid by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Crystals body fluid"/>
</designation>
</concept>
<concept>
<code value="6827-0"/>
<display
value="Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bacitracin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="68324-3"/>
<display
value="von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="VWF:Rco - by Immunoassay"/>
</designation>
</concept>
<concept>
<code value="6864-3"/>
<display value="Hemoglobin S [Presence] in Blood by Solubility test"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HbS (solubility)"/>
</designation>
</concept>
<concept>
<code value="68-7"/>
<display
value="Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefamandole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="6873-4"/>
<display
value="Beta hydroxybutyrate [Moles/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Beta hydroxybutyrate"/>
</designation>
</concept>
<concept>
<code value="6875-9"/>
<display value="Cancer Ag 15-3 [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CA 15-3"/>
</designation>
</concept>
<concept>
<code value="68916-6"/>
<display
value="dRVVT W excess phospholipid actual/normal (normalized LA confirm)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Dilute Russell viper venom time - phospholipid actual/normal"/>
</designation>
</concept>
<concept>
<code value="68936-4"/>
<display
value="Baker's yeast Ab [Units/?volume] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Anti Saccharomyces Cerevisiae Antibodies"/>
</designation>
</concept>
<concept>
<code value="68969-5"/>
<display
value="Relative activated clotting time (ACT) of Platelet poor plasma by Kaolin induced method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="KCTI"/>
</designation>
</concept>
<concept>
<code value="6913-8"/>
<display
value="Chlamydophila pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C. pneumoniae Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="6916-1"/>
<display
value="Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="C. psittaci Ab"/>
</designation>
</concept>
<concept>
<code value="6932-8"/>
<display
value="Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Penicillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="6933-6"/>
<display
value="Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Streptomycin high suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="6948-4"/>
<display value="Lamotrigine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lamotrigine - mass/volume"/>
</designation>
</concept>
<concept>
<code value="6954-2"/>
<display
value="Bartonella henselae IgG Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bartonella Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="698-1"/>
<display
value="Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="N. gonorrhoeae (culture)"/>
</designation>
</concept>
<concept>
<code value="6984-9"/>
<display value="Beta lactamase.extended spectrum [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="B-lactamase ESBL (qual)"/>
</designation>
</concept>
<concept>
<code value="6985-6"/>
<display value="Beta lactamase.usual [Susceptibility]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="B-lactamase usual (qual)"/>
</designation>
</concept>
<concept>
<code value="69935-5"/>
<display
value="Mycoplasma genitalium DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mycoplasma DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="69937-1"/>
<display
value="Trichomonas vaginalis DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Trichomonas (NAAT)"/>
</designation>
</concept>
<concept>
<code value="69938-9"/>
<display
value="Astrovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Astrovirus RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="69949-6"/>
<display
value="Epstein Barr virus capsid IgG Ab avidity [Presence] in Serum by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV VCA IgG avidity"/>
</designation>
</concept>
<concept>
<code value="69951-2"/>
<display value="Amylase.pancreatic/Creatinine(Ratio) in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amylase (pancreatic)/creat ur"/>
</designation>
</concept>
<concept>
<code value="70061-7"/>
<display
value="Human papilloma virus 16 and 18 DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HPV DNA (NAAT) - Specimen"/>
</designation>
</concept>
<concept>
<code value="70147-4"/>
<display value="Methadone [Mass/?volume] in Urine by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methadone urine - mass/volume by Screen method"/>
</designation>
</concept>
<concept>
<code value="7018-5"/>
<display
value="Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gentamicin high suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="70205-0"/>
<display
value="Clonazepam [Moles/?volume] in Serum or Plasma by Screen method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clonazepam - by Screen method"/>
</designation>
</concept>
<concept>
<code value="7024-3"/>
<display
value="Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Kanamycin high suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="70569-9"/>
<display
value="Plasmodium sp Ag [Identifier] in Blood by Rapid immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Malaria antigen"/>
</designation>
</concept>
<concept>
<code value="7106-8"/>
<display value="Aspergillus sp IgE Ab [Units/?volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aspergillus IgE"/>
</designation>
</concept>
<concept>
<code value="716-1"/>
<display
value="Heinz bodies [Presence] in Blood by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Heinz bodies"/>
</designation>
</concept>
<concept>
<code value="71792-6"/>
<display
value="Procollagen type III.N-terminal propeptide [Mass/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="P3NP"/>
</designation>
</concept>
<concept>
<code value="71793-4"/>
<display
value="Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. pallidum Ab (PA)"/>
</designation>
</concept>
<concept>
<code value="718-7"/>
<display value="Hemoglobin [Mass/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haemoglobin"/>
</designation>
</concept>
<concept>
<code value="72111-8"/>
<display
value="Sapovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sapovirus RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="72160-5"/>
<display value="Holo-transcobalamin II [Moles/?volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Active B12"/>
</designation>
</concept>
<concept>
<code value="72493-0"/>
<display
value="Cytomegalovirus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV Viral load (serum/plasma)"/>
</designation>
</concept>
<concept>
<code value="725-2"/>
<display value="Hemoglobin [Presence] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haemoglobin urine"/>
</designation>
</concept>
<concept>
<code value="72624-0"/>
<display value="Rivaroxaban [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rivaroxaban Assay"/>
</designation>
</concept>
<concept>
<code value="72625-7"/>
<display value="Dabigatran [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Dabigatran assay"/>
</designation>
</concept>
<concept>
<code value="72-9"/>
<display
value="Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefatrizine suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="73654-6"/>
<display
value="Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis C genotyping (NS3)"/>
</designation>
</concept>
<concept>
<code value="73655-3"/>
<display
value="Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis C genotyping (NS5)"/>
</designation>
</concept>
<concept>
<code value="73723-9"/>
<display value="Riboflavin [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vitamin B2 blood"/>
</designation>
</concept>
<concept>
<code value="74096-9"/>
<display value="Tacrolimus [Mass/?volume] in Blood by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tacrolimus blood - by Immunoassay"/>
</designation>
</concept>
<concept>
<code value="74097-7"/>
<display value="Tacrolimus [Mass/?volume] in Blood by LC/?MS/?MS"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Tacrolimus blood - by LC/MS/MS"/>
</designation>
</concept>
<concept>
<code value="74442-5"/>
<display value="Pyridoxal phosphate [Moles/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Vitamin B6 blood"/>
</designation>
</concept>
<concept>
<code value="75050-5"/>
<display value="Coenzyme Q10 [Moles/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Coenzyme Q10"/>
</designation>
</concept>
<concept>
<code value="75515-7"/>
<display
value="Lupus anticoagulant aPTT and dRVVT screening panel W Reflex"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Lupus anticoagulant two screening tests W Reflex panel Coag (PPP)"/>
</designation>
</concept>
<concept>
<code value="76-0"/>
<display
value="Cefazolin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefazolin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="76346-6"/>
<display value="Microorganism identified in Isolate by MS.MALDI-TOF"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Micro-organism (ident MS.MALDI-TOF)"/>
</designation>
</concept>
<concept>
<code value="7799-0"/>
<display
value="Fibrin D-dimer [Units/volume] in Platelet poor plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="D-dimer"/>
</designation>
</concept>
<concept>
<code value="7808-9"/>
<display value="Aspergillus sp Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Aspergillus precipitins"/>
</designation>
</concept>
<concept>
<code value="7852-7"/>
<display
value="Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV IgG"/>
</designation>
</concept>
<concept>
<code value="7853-5"/>
<display
value="Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CMV IgM"/>
</designation>
</concept>
<concept>
<code value="7883-2"/>
<display
value="Epstein Barr virus nuclear IgG Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="EBV NA IgG "/>
</designation>
</concept>
<concept>
<code value="7905-3"/>
<display
value="Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hep B (HBsAg) Surface Ag (Neut)"/>
</designation>
</concept>
<concept>
<code value="7906-1"/>
<display
value="Hepatitis D virus RNA [Presence] in Serum by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Hepatitis D DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="7918-6"/>
<display value="HIV 1+2 Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HIV1+2 Ab (screen)"/>
</designation>
</concept>
<concept>
<code value="7948-3"/>
<display
value="Legionella pneumophila 1 Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Legionella sero-group 1 Ab (IF)"/>
</designation>
</concept>
<concept>
<code value="7959-0"/>
<display value="Leptospira sp Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Leptospira Ab (screen) (titre)"/>
</designation>
</concept>
<concept>
<code value="7968-1"/>
<display
value="Mumps virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Mumps RNA (NAAT) CSF"/>
</designation>
</concept>
<concept>
<code value="7993-9"/>
<display
value="Rhinovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rhinoviurs (NAAT)"/>
</designation>
</concept>
<concept>
<code value="7994-7"/>
<display value="Rickettsia sp Ab [Units/?volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rickettsia Ab"/>
</designation>
</concept>
<concept>
<code value="8012-7"/>
<display
value="Rotavirus dsRNA [Presence] in Stool by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rotavirus RNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="8013-5"/>
<display value="Rubella virus Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rubella Ab"/>
</designation>
</concept>
<concept>
<code value="8014-3"/>
<display value="Rubella virus IgG Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rubella IgG"/>
</designation>
</concept>
<concept>
<code value="8015-0"/>
<display value="Rubella virus IgM Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rubella IgM"/>
</designation>
</concept>
<concept>
<code value="80-2"/>
<display
value="Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefixime suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="8039-0"/>
<display value="Toxoplasma gondii IgG Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. gondii IgG"/>
</designation>
</concept>
<concept>
<code value="8040-8"/>
<display value="Toxoplasma gondii IgM Ab [Units/volume] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T. gondii IgM"/>
</designation>
</concept>
<concept>
<code value="80515-0"/>
<display
value="Kappa light chains.free [Mass/volume] in Serum by Nephelometry"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Immunoglobulin Light Chains kappa (free Nephelometry)"/>
</designation>
</concept>
<concept>
<code value="80516-8"/>
<display
value="Lambda light chains.free [Mass/volume] in Serum by Nephelometry"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Immunoglobulin Light Chains (free Nephelometry)"/>
</designation>
</concept>
<concept>
<code value="80517-6"/>
<display
value="Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum by Nephelometry"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Immunoglobulin Light Chains lambda (free Nephelometry)"/>
</designation>
</concept>
<concept>
<code value="8061-4"/>
<display value="Nuclear Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Antinuclear Ab (qual)"/>
</designation>
</concept>
<concept>
<code value="8076-2"/>
<display value="Jo-1 extractable nuclear Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Jo-1 extractable nuclear Ab"/>
</designation>
</concept>
<concept>
<code value="8091-1"/>
<display
value="Ribonucleoprotein extractable nuclear Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ribonucleoprotein extractable nuclear Ab "/>
</designation>
</concept>
<concept>
<code value="8092-9"/>
<display value="SCL-70 extractable nuclear Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SCL-70 extractable nuclear Ab"/>
</designation>
</concept>
<concept>
<code value="8093-7"/>
<display
value="Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sjogrens syndrome-A extractable nuclear Ab"/>
</designation>
</concept>
<concept>
<code value="8094-5"/>
<display
value="Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sjogrens syndrome-B extractable nuclear Ab "/>
</designation>
</concept>
<concept>
<code value="8095-2"/>
<display value="Smooth muscle Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Smooth muscle Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="8098-6"/>
<display value="Thyroglobulin Ab [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thyroglobulin Antibody - units/volume"/>
</designation>
</concept>
<concept>
<code value="8099-4"/>
<display
value="Thyroperoxidase Ab [Units/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Thyroperoxidase Ab"/>
</designation>
</concept>
<concept>
<code value="8116-6"/>
<display value="CD19 cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="lymphocyte markers - CD19 cells"/>
</designation>
</concept>
<concept>
<code value="81169-5"/>
<display
value="Residual tumor [Interpretation] Cancer Narrative --postoperative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Margin - polypectomy"/>
</designation>
</concept>
<concept>
<code value="8122-4"/>
<display value="CD3 cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Immunodeficiency Lymphocyte Markers (Subsets)"/>
</designation>
</concept>
<concept>
<code value="81317-0"/>
<display
value="Additional pathological findings [Identifier] in Specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Other pathological finding"/>
</designation>
</concept>
<concept>
<code value="8150-5"/>
<display value="Amphetamines [Mass/?volume] in Urine"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amphetamines-type substances urine - mass/volume"/>
</designation>
</concept>
<concept>
<code value="8161-2"/>
<display value="Bismuth [Mass/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bismuth blood"/>
</designation>
</concept>
<concept>
<code value="81691-8"/>
<display
value="DNA mismatch repair protein Mlh1 [Presence] in Cancer specimen by Immune stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MMR prot Mlh1 Ca spec Ql ImStn"/>
</designation>
</concept>
<concept>
<code value="81692-6"/>
<display
value="DNA mismatch repair protein Msh2 [Presence] in Cancer specimen by Immune stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MMR prot Msh2 Ca spec Ql ImStn"/>
</designation>
</concept>
<concept>
<code value="81693-4"/>
<display
value="DNA mismatch repair protein Msh6 [Presence] in Cancer specimen by Immune stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MMR prot Msh6 Ca spec Ql ImStn"/>
</designation>
</concept>
<concept>
<code value="81694-2"/>
<display
value="Mismatch repair endonuclease PMS2 [Presence] in Cancer specimen by Immune stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MMR endo PMS2 Ca spec Ql ImStn"/>
</designation>
</concept>
<concept>
<code value="8275-0"/>
<display
value="Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefpirome suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="8-3"/>
<display
value="Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amdinocillin suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="83121-4"/>
<display
value="Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Free T4 IA [Moles/Vol]"/>
</designation>
</concept>
<concept>
<code value="83126-3"/>
<display
value="Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Free T3 IA [Moles/Vol]"/>
</designation>
</concept>
<concept>
<code value="84-4"/>
<display
value="Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefaclor suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="84882-0"/>
<display
value="Histologic type in Colorectal cancer specimen by WHO classification"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Main diagnosis"/>
</designation>
</concept>
<concept>
<code value="84883-8"/>
<display
value="Deepest extent of tumor invasion [Type] in Colorectal cancer specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Depth of invasion"/>
</designation>
</concept>
<concept>
<code value="85291-3"/>
<display
value="Surgical margin tumor involvement.deep [Presence] in Colorectal cancer specimen by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Deep margin status"/>
</designation>
</concept>
<concept>
<code value="85299-6"/>
<display
value="BRAF V600E mutant protein [Presence] in Cancer specimen by Immune stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="BRAF V600E mutation status"/>
</designation>
</concept>
<concept>
<code value="882-1"/>
<display value="ABO and Rh group [Type] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="ABO and Rh group"/>
</designation>
</concept>
<concept>
<code value="88-5"/>
<display
value="Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefmetazole suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="888-8"/>
<display
value="Blood group antibodies identified in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blood Group Ab (ident) "/>
</designation>
</concept>
<concept>
<code value="890-4"/>
<display
value="Blood group antibody screen [Presence] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blood Group Ab (screen)"/>
</designation>
</concept>
<concept>
<code value="897-9"/>
<display
value="Blood group antibody screen [Presence] in Serum or Plasma by Elution"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blood Group Ab Elution"/>
</designation>
</concept>
<concept>
<code value="89873-4"/>
<display value="Unique identifier [Identifier] of Initial sample"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Specimen identifier"/>
</designation>
</concept>
<concept>
<code value="92-7"/>
<display
value="Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefodizime suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="92837-4"/>
<display value="Perineural invasion [Presence] in Cancer specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Perineural invasion"/>
</designation>
</concept>
<concept>
<code value="933-2"/>
<display value="Blood product type"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Blood Product Type"/>
</designation>
</concept>
<concept>
<code value="9335-1"/>
<display value="Appearance of Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Appearance body fluid"/>
</designation>
</concept>
<concept>
<code value="94306-8"/>
<display
value="SARS-CoV-2 (COVID-19) RNA panel - Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94307-6"/>
<display
value="SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N1"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94308-4"/>
<display
value="SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N2"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N2 Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94309-2"/>
<display
value="SARS-CoV-2 (COVID-19) RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94310-0"/>
<display
value="SARS-like Coronavirus N gene [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-like CoV N gene NAA+probe Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94311-8"/>
<display
value="SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N1"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 (Unsp spec) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94312-6"/>
<display
value="SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N2"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N2 (Unsp spec) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94313-4"/>
<display
value="SARS-like Coronavirus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-like CoV N gene NAA+probe (Unsp spec) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94314-2"/>
<display
value="SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94315-9"/>
<display
value="SARS-related coronavirus E gene [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-related coronavirus E gene NAA+probe Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94316-7"/>
<display
value="SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94499-1"/>
<display
value="Respiratory viral pathogens DNA and RNA panel - Respiratory specimen Qualitative by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Respiratory viral pathogens DNA and RNA panel NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94500-6"/>
<display
value="SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 RNA NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94501-4"/>
<display
value="Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="MERS-CoV RNA NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94502-2"/>
<display
value="SARS coronavirus+SARS-like coronavirus+SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-related CoV RNA NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94503-0"/>
<display
value="SARS coronavirus 2 IgG and IgM panel - Serum or Plasma Qualitative by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgG and IgM panel IA.rapid Ql"/>
</designation>
</concept>
<concept>
<code value="94504-8"/>
<display
value="SARS coronavirus 2 IgG and IgM panel - Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgG and IgM panel IA"/>
</designation>
</concept>
<concept>
<code value="94505-5"/>
<display
value="SARS coronavirus 2 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgG IA Qn"/>
</designation>
</concept>
<concept>
<code value="94506-3"/>
<display
value="SARS coronavirus 2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgM IA Qn"/>
</designation>
</concept>
<concept>
<code value="94507-1"/>
<display
value="SARS coronavirus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgG IA.rapid Ql"/>
</designation>
</concept>
<concept>
<code value="94508-9"/>
<display
value="SARS coronavirus 2 IgM Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgM IA.rapid Ql"/>
</designation>
</concept>
<concept>
<code value="94509-7"/>
<display
value="SARS coronavirus 2 E gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 E gene NAA+probe (Unsp spec) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94510-5"/>
<display
value="SARS coronavirus 2 N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 N gene NAA+probe (Unsp spec) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94511-3"/>
<display
value="SARS coronavirus 2 ORF1ab region [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 ORF1ab region NAA+probe (Unsp spec) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94531-1"/>
<display
value="SARS Coronavirus 2 RNA panel - Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 RNA panel NAA+probe (Resp)"/>
</designation>
</concept>
<concept>
<code value="94532-9"/>
<display
value="SARS coronavirus+SARS-like coronavirus+SARS coronavirus 2+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-related CoV+MERS coronavirus RNA NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94533-7"/>
<display
value="SARS coronavirus 2 N gene [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 N gene NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94534-5"/>
<display
value="SARS coronavirus 2 RdRp gene [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 RdRp gene NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94547-7"/>
<display
value="SARS coronavirus 2 IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgG+IgM IA Ql"/>
</designation>
</concept>
<concept>
<code value="94558-4"/>
<display
value="SARS coronavirus 2 Ag [Presence] in Respiratory specimen by Rapid immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 Ag IA.rapid Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94559-2"/>
<display
value="SARS coronavirus 2 ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 ORF1ab region NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94562-6"/>
<display
value="SARS coronavirus 2 IgA Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgA IA Ql"/>
</designation>
</concept>
<concept>
<code value="94563-4"/>
<display
value="SARS coronavirus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgG IA Ql"/>
</designation>
</concept>
<concept>
<code value="94564-2"/>
<display
value="SARS coronavirus 2 IgM Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgM IA Ql"/>
</designation>
</concept>
<concept>
<code value="94565-9"/>
<display
value="SARS coronavirus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 RNA NAA+non-probe Ql (Nph)"/>
</designation>
</concept>
<concept>
<code value="94639-2"/>
<display
value="SARS coronavirus 2 ORF1ab region [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 ORF1ab region NAA+probe Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94640-0"/>
<display
value="SARS coronavirus 2 S gene [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 S gene NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94641-8"/>
<display
value="SARS coronavirus 2 S gene [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 S gene NAA+probe Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94642-6"/>
<display
value="SARS coronavirus 2 S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 S gene NAA+probe (Resp) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94643-4"/>
<display
value="SARS coronavirus 2 S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 S gene NAA+probe (Unsp spec) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94644-2"/>
<display
value="SARS coronavirus 2 ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 ORF1ab region NAA+probe (Resp) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94645-9"/>
<display
value="SARS coronavirus 2 RdRp gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 RdRp gene NAA+probe (Unsp spec) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94646-7"/>
<display
value="SARS coronavirus 2 RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 RdRp gene NAA+probe (Resp) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94647-5"/>
<display
value="SARS-related coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-related CoV RNA NAA+probe Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94660-8"/>
<display
value="SARS coronavirus 2 RNA [Presence] in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 RNA NAA+probe Ql"/>
</designation>
</concept>
<concept>
<code value="94661-6"/>
<display
value="SARS coronavirus 2 Ab [Interpretation] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 Ab [Interp]"/>
</designation>
</concept>
<concept>
<code value="94720-0"/>
<display
value="SARS coronavirus 2 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 IgA IA Qn"/>
</designation>
</concept>
<concept>
<code value="94745-7"/>
<display
value="SARS coronavirus 2 RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID19) RNA NAA+probe (Resp) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94746-5"/>
<display
value="SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) RNA NAA+probe (Specimen) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="94756-4"/>
<display
value="SARS coronavirus 2 N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 N gene NAA+probe CDC primer-probe set N1 Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94757-2"/>
<display
value="SARS coronavirus 2 N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N2"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 N gene NAA+probe CDC primer-probe set N2 Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94758-0"/>
<display
value="SARS coronavirus 2 E gene [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 E gene NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="94759-8"/>
<display
value="SARS coronavirus 2 RNA [Presence] in Nasopharynx by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Nph)"/>
</designation>
</concept>
<concept>
<code value="94760-6"/>
<display
value="SARS-CoV-2 (COVID19) N gene [Presence] in Nasopharynx by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) N gene NAA+probe Ql (Nph)"/>
</designation>
</concept>
<concept>
<code value="94761-4"/>
<display
value="SARS coronavirus 2 IgG Ab [Presence] in DBS by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) IgG IA Ql (DBS)"/>
</designation>
</concept>
<concept>
<code value="94762-2"/>
<display
value="SARS coronavirus 2 Ab [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) Ab IA Ql"/>
</designation>
</concept>
<concept>
<code value="94763-0"/>
<display
value="SARS coronavirus 2 [Presence] in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) Org specific cx Ql (Unsp spec)"/>
</designation>
</concept>
<concept>
<code value="94764-8"/>
<display
value="SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) genome sequence Nom (Islt/Spec)"/>
</designation>
</concept>
<concept>
<code value="94765-5"/>
<display
value="SARS coronavirus 2 E gene [Presence] in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 E gene NAA+probe Ql"/>
</designation>
</concept>
<concept>
<code value="94766-3"/>
<display
value="SARS coronavirus 2 N gene [Presence] in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 N gene NAA+probe Ql"/>
</designation>
</concept>
<concept>
<code value="94767-1"/>
<display
value="SARS coronavirus 2 S gene [Presence] in Serum or Plasma by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 S gene NAA+probe Ql"/>
</designation>
</concept>
<concept>
<code value="94768-9"/>
<display
value="SARS coronavirus 2 IgA Ab [Presence] in Serum or Plasma by Rapid immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) IgA IA.rapid Ql"/>
</designation>
</concept>
<concept>
<code value="94769-7"/>
<display
value="SARS coronavirus 2 Ab [Units/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) Ab IA Qn"/>
</designation>
</concept>
<concept>
<code value="94819-0"/>
<display
value="SARS coronavirus 2 RNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID19) RNA NAA+probe (Unsp spec) [Log #/Vol]"/>
</designation>
</concept>
<concept>
<code value="94822-4"/>
<display
value="SARS coronavirus 2 RNA [Presence] in Saliva (oral fluid) by Sequencing"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) RNA Sequencing Ql (Sal)"/>
</designation>
</concept>
<concept>
<code value="94845-5"/>
<display
value="SARS coronavirus 2 RNA [Presence] in Saliva (oral fluid) by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Sal)"/>
</designation>
</concept>
<concept>
<code value="95125-1"/>
<display
value="SARS-CoV-2 (COVID19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) IgA+IgM IA Ql"/>
</designation>
</concept>
<concept>
<code value="95209-3"/>
<display
value="SARS-CoV+SARS-CoV-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV+SARS-CoV-2 (COVID19) Ag IA.rapid Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="95380-2"/>
<display
value="Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel NAA+probe (Resp)"/>
</designation>
</concept>
<concept>
<code value="95383-6"/>
<display value="Symptom resolution status"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Symptomatic"/>
</designation>
</concept>
<concept>
<code value="95406-5"/>
<display
value="SARS-CoV-2 (COVID19) RNA [Presence] in Nose by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Nose)"/>
</designation>
</concept>
<concept>
<code value="95409-9"/>
<display
value="SARS-CoV-2 (COVID19) N gene [Presence] in Nose by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) N gene NAA+probe Ql (Nose)"/>
</designation>
</concept>
<concept>
<code value="95410-7"/>
<display
value="SARS-CoV-2 (COVID19) neutralizing antibody [Titer] in Serum by pVNT"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) neut ab pVNT (S) [Titer]"/>
</designation>
</concept>
<concept>
<code value="95411-5"/>
<display
value="SARS-CoV-2 (COVID19) neutralizing antibody [Presence] in Serum by pVNT"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID19) neut ab pVNT Ql (S)"/>
</designation>
</concept>
<concept>
<code value="95416-4"/>
<display
value="SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) IgM IA Ql (DBS)"/>
</designation>
</concept>
<concept>
<code value="95422-2"/>
<display
value="Long Common NameInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Resp)"/>
</designation>
</concept>
<concept>
<code value="95423-0"/>
<display
value="Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Influenza virus A and B and SARS-CoV-2 (COVID-19) identified NAA+probe Nom (Resp)"/>
</designation>
</concept>
<concept>
<code value="95424-8"/>
<display
value="SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) RNA Sequencing Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="95425-5"/>
<display
value="Long Common NameSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Sal)"/>
</designation>
</concept>
<concept>
<code value="95427-1"/>
<display
value="SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) IgA IF [Titer]"/>
</designation>
</concept>
<concept>
<code value="95428-9"/>
<display
value="SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) IgM IF [Titer]"/>
</designation>
</concept>
<concept>
<code value="95429-7"/>
<display
value="SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) IgG IF [Titer]"/>
</designation>
</concept>
<concept>
<code value="95521-1"/>
<display
value="Long Common NameSARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) N gene NAA+probe (Resp) [#/Vol]"/>
</designation>
</concept>
<concept>
<code value="95522-9"/>
<display
value="SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) N gene NAA+probe (Resp) [Log #/Vol]"/>
</designation>
</concept>
<concept>
<code value="95542-7"/>
<display
value="SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) IgG+IgM IA.rapid Ql (S/P/Bld)"/>
</designation>
</concept>
<concept>
<code value="9558-8"/>
<display value="CD20 cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="CD20 assay"/>
</designation>
</concept>
<concept>
<code value="9559-6"/>
<display value="CD5 cells [#/?volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="lymphocyte markers - CD5 cells"/>
</designation>
</concept>
<concept>
<code value="95608-6"/>
<display
value="SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) RNA NAA+non-probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="95609-4"/>
<display
value="SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) S gene Sequencing Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="9571-1"/>
<display
value="Parvovirus B19 DNA [Presence] in Unspecified specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Parvovirus DNA (NAAT)"/>
</designation>
</concept>
<concept>
<code value="95823-1"/>
<display
value="SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-related coronavirus E gene NAA+probe Ql (Sal) "/>
</designation>
</concept>
<concept>
<code value="95824-9"/>
<display
value="SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe Ql (Sal)"/>
</designation>
</concept>
<concept>
<code value="95825-6"/>
<display
value="SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) Ab IA Ql (DBS)"/>
</designation>
</concept>
<concept>
<code value="95826-4"/>
<display
value="SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Sal)"/>
</designation>
</concept>
<concept>
<code value="95941-1"/>
<display
value="Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel NAA+probe (Resp)"/>
</designation>
</concept>
<concept>
<code value="95942-9"/>
<display
value="Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel IA.rapid (Upper resp)"/>
</designation>
</concept>
<concept>
<code value="95970-0"/>
<display
value="SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements Sequencing Ql (Bld)"/>
</designation>
</concept>
<concept>
<code value="95971-8"/>
<display
value="SARS CoV-2 stimulated gamma interferon [Presence] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS CoV-2 stimulated gamma interferon Ql (Bld)"/>
</designation>
</concept>
<concept>
<code value="95972-6"/>
<display
value="SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS CoV-2 stimulated gamma interferon release by T-cells corrected for background Qn (Bld)"/>
</designation>
</concept>
<concept>
<code value="95973-4"/>
<display
value="SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS CoV-2 stimulated gamma interferon release by T-cells Qn (Bld)"/>
</designation>
</concept>
<concept>
<code value="95974-2"/>
<display
value="SARS CoV-2 stimulated gamma interferon panel - Blood"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS CoV-2 stimulated gamma interferon panel (Bld)"/>
</designation>
</concept>
<concept>
<code value="96091-4"/>
<display
value="SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) RdRp gene, Saliva"/>
</designation>
</concept>
<concept>
<code value="96094-8"/>
<display
value="SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel NAA+probe (Resp)"/>
</designation>
</concept>
<concept>
<code value="96115-1"/>
<display
value="Long Common NameLevel of tumor invasion [Type] in Colorectal cancer specimen by Haggitt"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Haggitt level"/>
</designation>
</concept>
<concept>
<code value="96118-5"/>
<display value="SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) Ab Panel IA (DBS)"/>
</designation>
</concept>
<concept>
<code value="96119-3"/>
<display
value="SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) Ag IA Ql (Upper resp)"/>
</designation>
</concept>
<concept>
<code value="96120-1"/>
<display
value="SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Lower resp)"/>
</designation>
</concept>
<concept>
<code value="96121-9"/>
<display
value="SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-related coronavirus E gene NAA+probe Ql (Lower resp)"/>
</designation>
</concept>
<concept>
<code value="96122-7"/>
<display
value="SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-related coronavirus E gene NAA+probe Ql (Upper resp)"/>
</designation>
</concept>
<concept>
<code value="96123-5"/>
<display
value="SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Upper resp)"/>
</designation>
</concept>
<concept>
<code value="9627-1"/>
<display
value="Imipramine+?Desipramine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Imipramine + Desipramine"/>
</designation>
</concept>
<concept>
<code value="96603-6"/>
<display
value="SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) S protein RBD neut ab sVNT Ql"/>
</designation>
</concept>
<concept>
<code value="96741-4"/>
<display
value="SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) variant Sequencing Nom (Specimen)"/>
</designation>
</concept>
<concept>
<code value="96742-2"/>
<display
value="SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) IgG IA [Mass/Vol]"/>
</designation>
</concept>
<concept>
<code value="96751-3"/>
<display
value="SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) S gene mutation detected Molgen Nom (Specimen)"/>
</designation>
</concept>
<concept>
<code value="96752-1"/>
<display
value="SARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) S gene mutation Molgen Ql (Specimen)"/>
</designation>
</concept>
<concept>
<code value="96755-4"/>
<display
value="SARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) variant interpretation Nar (Specimen)"/>
</designation>
</concept>
<concept>
<code value="96763-8"/>
<display
value="SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) E gene NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="96764-6"/>
<display
value="SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) E gene NAA+probe (Resp) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="96765-3"/>
<display
value="SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) S gene NAA+probe Ql (Sal)"/>
</designation>
</concept>
<concept>
<code value="96797-6"/>
<display
value="SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Oropharyngeal wash)"/>
</designation>
</concept>
<concept>
<code value="96-8"/>
<display
value="Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC)"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cefonicid suscep (MIC)"/>
</designation>
</concept>
<concept>
<code value="96829-7"/>
<display
value="SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Specimen donor)"/>
</designation>
</concept>
<concept>
<code value="96894-1"/>
<display
value="SARS coronavirus 2 (COVID-19) whole genome sequencing and identification panel - Specimen by Molecular genetics method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS coronavirus 2 (COVID-19) whole genome sequencing and identification panel Molgen (Specimen)"/>
</designation>
</concept>
<concept>
<code value="96895-8"/>
<display
value="SARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) lineage Molgen Nom (Specimen)"/>
</designation>
</concept>
<concept>
<code value="96896-6"/>
<display
value="SARS coronavirus 2 (COVID-19) clade [Type] in Specimen by Molecular genetics method"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS coronavirus 2 (COVID-19) clade Molgen Nom (Specimen)"/>
</designation>
</concept>
<concept>
<code value="96897-4"/>
<display
value="SARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Oropharyngeal wash)"/>
</designation>
</concept>
<concept>
<code value="96898-2"/>
<display
value="SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) N gene NAA+probe (Oropharyngeal wash) [ThreshNum] "/>
</designation>
</concept>
<concept>
<code value="96899-0"/>
<display
value="SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe (Oropharyngeal wash) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="96900-6"/>
<display
value="SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) S gene NAA+probe (Oropharyngeal wash) [ThreshNum]"/>
</designation>
</concept>
<concept>
<code value="96957-6"/>
<display
value="SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) M gene NAA+probe Ql (Upper resp)"/>
</designation>
</concept>
<concept>
<code value="96986-5"/>
<display
value="SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) N gene NAA+non-probe Ql (Nose)"/>
</designation>
</concept>
<concept>
<code value="9699-0"/>
<display value="Paroxetine [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Paroxetine"/>
</designation>
</concept>
<concept>
<code value="97097-0"/>
<display
value="SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) Ag IA.rapid Ql (Upper resp)"/>
</designation>
</concept>
<concept>
<code value="97098-8"/>
<display
value="SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) Nsp2 gene NAA+probe Ql (Upper resp)"/>
</designation>
</concept>
<concept>
<code value="97104-4"/>
<display
value="SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe Qn (Upper resp)"/>
</designation>
</concept>
<concept>
<code value="9721-2"/>
<display value="Salivary gland Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Salivary gland Ab (titre)"/>
</designation>
</concept>
<concept>
<code value="9780-8"/>
<display value="Spermatozoa [#/volume] in Semen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Sperm count semen"/>
</designation>
</concept>
<concept>
<code value="9781-6"/>
<display
value="Acanthamoeba sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Acanthamoeba (culture)"/>
</designation>
</concept>
<concept>
<code value="9786-5"/>
<display
value="Microscopic observation [Identifier] in Blood or Marrow by Periodic acid-Schiff stain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="PAS Stain"/>
</designation>
</concept>
<concept>
<code value="9787-3"/>
<display
value="Sarcoptes scabiei identified in Skin by Light microscopy"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Scabies skin scraping"/>
</designation>
</concept>
<concept>
<code value="9790-7"/>
<display value="Methyl bromide [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Methyl Bromide"/>
</designation>
</concept>
<concept>
<code value="98069-8"/>
<display
value="SARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) Ab IA.rapid Ql (Sal)"/>
</designation>
</concept>
<concept>
<code value="9811-1"/>
<display value="Chromogranin A [Mass/?volume] in Serum or Plasma"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Chromogranin A"/>
</designation>
</concept>
<concept>
<code value="98131-6"/>
<display
value="SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) ORF1b region NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="98132-4"/>
<display
value="SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory specimen by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) ORF1a region NAA+probe Ql (Resp)"/>
</designation>
</concept>
<concept>
<code value="9816-0"/>
<display
value="Actinomyces sp identified in Unspecified specimen by Organism specific culture"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Actinomyces (culture)"/>
</designation>
</concept>
<concept>
<code value="9826-9"/>
<display
value="Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Syphilis Confirmation CSF"/>
</designation>
</concept>
<concept>
<code value="9838-4"/>
<display
value="Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Liver/Kidney Ab -Titer"/>
</designation>
</concept>
<concept>
<code value="98493-0"/>
<display
value="SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) ORF1b region NAA+probe Ql (Sal)"/>
</designation>
</concept>
<concept>
<code value="98494-8"/>
<display
value="SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) ORF1a region NAA+probe Ql (Sal)"/>
</designation>
</concept>
<concept>
<code value="98732-1"/>
<display
value="SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS-CoV-2 (COVID-19) S protein RBD neut ab IA [Titer]"/>
</designation>
</concept>
<concept>
<code value="98733-9"/>
<display
value="Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="Percent neutralization by SARS-CoV-2 (COVID-19) spike protein receptor binding domain (RBD) neut ab IA [%]"/>
</designation>
</concept>
<concept>
<code value="98734-7"/>
<display
value="SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="SARS-CoV-2 (COVID-19) S protein RBD neut ab IA Qn"/>
</designation>
</concept>
<concept>
<code value="98846-9"/>
<display
value="SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells corrected for background IA Qn (Bld)"/>
</designation>
</concept>
<concept>
<code value="98847-7"/>
<display
value="SARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value
value="SARS coronavirus 2 stimulated gamma interferon release by lymphocytes corrected for background IA Qn (Bld)"/>
</designation>
</concept>
<concept>
<code value="11481-9"/>
<display value="Human papilloma virus identified in Specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="HPV Test Results"/>
</designation>
</concept>
<concept>
<code value="15212-4"/>
<display value="Lipase [Enzymatic activity/volume] in Body fluid"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Lipase (Body fld) [Catalytic activity/Vol]"/>
</designation>
</concept>
<concept>
<code value="20373-7"/>
<display
value="Amikacin [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin SlowMyco"/>
</designation>
</concept>
<concept>
<code value="20376-0"/>
<display
value="Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clofazimine SlowMyco"/>
</designation>
</concept>
<concept>
<code value="20377-8"/>
<display
value="Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ciprofloxacin SlowMyco"/>
</designation>
</concept>
<concept>
<code value="20381-0"/>
<display
value="Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethambutol SlowMyco"/>
</designation>
</concept>
<concept>
<code value="20382-8"/>
<display
value="Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethionamide SlowMyco"/>
</designation>
</concept>
<concept>
<code value="20383-6"/>
<display
value="Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid SlowMyco"/>
</designation>
</concept>
<concept>
<code value="20385-1"/>
<display
value="rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="rifAMPin SlowMyco"/>
</designation>
</concept>
<concept>
<code value="20386-9"/>
<display
value="Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rifabutin SlowMyco"/>
</designation>
</concept>
<concept>
<code value="20461-0"/>
<display
value="Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyrazinamide SlowMyco"/>
</designation>
</concept>
<concept>
<code value="21976-6"/>
<display value="Cancer outcome status"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Cancer outcome status"/>
</designation>
</concept>
<concept>
<code value="21978-2"/>
<display value="Source of follow-up information Cancer"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Source of follow-up information"/>
</designation>
</concept>
<concept>
<code value="22633-2"/>
<display value="Pathology report site of origin Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Site of origin"/>
</designation>
</concept>
<concept>
<code value="22634-0"/>
<display value="Pathology report gross observation Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Gross observation"/>
</designation>
</concept>
<concept>
<code value="22637-3"/>
<display value="Pathology report final diagnosis Narrative"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Final diagnosis"/>
</designation>
</concept>
<concept>
<code value="23607-5"/>
<display
value="Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Capreomycin SlowMyco"/>
</designation>
</concept>
<concept>
<code value="23608-3"/>
<display
value="cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="cycloSERINE SlowMyco"/>
</designation>
</concept>
<concept>
<code value="23611-7"/>
<display
value="Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Para aminosalicylate SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25174-4"/>
<display
value="Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 8.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25175-1"/>
<display
value="Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 16.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25176-9"/>
<display
value="Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 32.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25177-7"/>
<display
value="Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 12.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25178-5"/>
<display
value="Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 30.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25179-3"/>
<display
value="Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 6.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25180-1"/>
<display
value="Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ciprofloxacin 2.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25181-9"/>
<display
value="Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ciprofloxacin 4.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25183-5"/>
<display
value="Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethionamide 11.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25184-3"/>
<display
value="rifAMPin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="rifAMPin 14.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25186-8"/>
<display
value="Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyrazinamide 25.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25187-6"/>
<display
value="Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethambutol 7.5 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25188-4"/>
<display
value="Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ciprofloxacin 8.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25189-2"/>
<display
value="Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ciprofloxacin 5.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25194-2"/>
<display
value="Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethambutol 5.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25195-9"/>
<display
value="Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethambutol 10.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25196-7"/>
<display
value="Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethionamide 5.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25198-3"/>
<display
value="Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethionamide 15.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25199-1"/>
<display
value="Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rifabutin 1.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25200-7"/>
<display
value="Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rifabutin 2.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25201-5"/>
<display
value="Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rifabutin 4.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25202-3"/>
<display
value="rifAMPin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="rifAMPin 1.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25203-1"/>
<display
value="rifAMPin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="rifAMPin 2.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25204-9"/>
<display
value="rifAMPin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="rifAMPin 5.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25207-2"/>
<display
value="cycloSERINE 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="cycloSERINE 10.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25208-0"/>
<display
value="cycloSERINE 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="cycloSERINE 20.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25209-8"/>
<display
value="cycloSERINE 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="cycloSERINE 30.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25210-6"/>
<display
value="Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Capreomycin 10.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25211-4"/>
<display
value="Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Capreomycin 20.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25212-2"/>
<display
value="Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Capreomycin 30.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25215-5"/>
<display
value="Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Para aminosalicylate 2.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25216-3"/>
<display
value="Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Para aminosalicylate 8.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25217-1"/>
<display
value="Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid 0.1 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25218-9"/>
<display
value="Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid 0.2 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25219-7"/>
<display
value="Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid 1.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25229-6"/>
<display
value="Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyrazinamide 100.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25230-4"/>
<display
value="Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethambutol 2.5 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="25231-2"/>
<display
value="Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethionamide 10.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="29315-9"/>
<display
value="Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid 0.4 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="29757-2"/>
<display value="Colposcopy study"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Colposcopy study"/>
</designation>
</concept>
<concept>
<code value="41500-0"/>
<display
value="Linezolid [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Linezolid SlowMyco"/>
</designation>
</concept>
<concept>
<code value="41502-6"/>
<display
value="Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxifloxacin SlowMyco"/>
</designation>
</concept>
<concept>
<code value="42642-9"/>
<display
value="Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 2.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="42651-0"/>
<display
value="Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid 5.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="42655-1"/>
<display
value="Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rifabutin 0.5 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="43986-9"/>
<display
value="Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clofazimine 2.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="43988-5"/>
<display
value="Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clofazimine 0.5 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="43989-3"/>
<display
value="Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Clofazimine 1.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="45215-1"/>
<display
value="Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid 2.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="48169-7"/>
<display
value="Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 1.5 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="48170-5"/>
<display
value="Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Capreomycin 3.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="48685-2"/>
<display
value="Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Para aminosalicylate 10.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="55194-5"/>
<display
value="Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ciprofloxacin 1.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="55674-6"/>
<display
value="Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethambutol 2.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="55685-2"/>
<display
value="Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Isoniazid 10.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="55711-6"/>
<display
value="Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyrazinamide 200.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="55712-4"/>
<display
value="rifAMPin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="rifAMPin 40.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="56025-0"/>
<display
value="Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Ethambutol 8.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="56026-8"/>
<display
value="Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Pyrazinamide 300.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="60564-2"/>
<display
value="Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 1.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="60565-9"/>
<display
value="Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Amikacin 4.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="61355-4"/>
<display
value="Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Capreomycin 5.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="63565-6"/>
<display
value="Prothionamide [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Prothionamide SlowMyco"/>
</designation>
</concept>
<concept>
<code value="76043-9"/>
<display
value="Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxifloxacin 0.5 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="76044-7"/>
<display
value="Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxifloxacin 1.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="76045-4"/>
<display
value="Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxifloxacin 2.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="8100-0"/>
<display value="Specimen preparation [Type]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Specimen preparation"/>
</designation>
</concept>
<concept>
<code value="85690-6"/>
<display value="Rubella virus genotype in Specimen"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Rubella virus genotype (Specimen)"/>
</designation>
</concept>
<concept>
<code value="88704-2"/>
<display
value="Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Bedaquiline SlowMyco"/>
</designation>
</concept>
<concept>
<code value="88706-7"/>
<display
value="Linezolid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Linezolid 1.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="88707-5"/>
<display
value="Moxifloxacin 0.25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxifloxacin 0.25 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="93497-6"/>
<display
value="Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Moxifloxacin 3.0 ug/mL SlowMyco"/>
</designation>
</concept>
<concept>
<code value="48013-7"/>
<display value="Genomic reference sequence [ID]"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Genomic reference sequence ID"/>
</designation>
</concept>
<concept>
<code value="5394-2"/>
<display
value="Treponema pallidum Ab [Titer] in Serum by Latex agglutination"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="T pallidum Ab Titr Ser LA"/>
</designation>
</concept>
<concept>
<code value="66746-9"/>
<display value="Specimen type"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Specimen type"/>
</designation>
</concept>
<concept>
<code value="615-5"/>
<display value="Viral strain"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Viral strain [Type] in Isolate by Viral subtyping"/>
</designation>
</concept>
<concept>
<code value="9398-9"/>
<display value="Reticulin Ab [Titer] in Serum"/>
<designation>
<language value="en-NZ"/>
<use>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use"/>
<code value="ConsumerName"/>
</use>
<value value="Reticulin Ab (titre)"/>
</designation>
</concept>
</include>
<include>
<system
value="https://standards.digital.health.nz/ns/loinc-nz-local-code"/>
<version value="20240401"/>
</include>
</compose>
</ValueSet>